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vSUMMARY
        Cullin RING ubiquitin ligases (CRLs) constitute the largest family of cellular ubiquitin 
ligases that mediate polyubiquitination of numerous substrates. CRLs consist of one of seven 
homologous cullin proteins which form a scaffold onto which the RING protein Rbx1/2 and 
substrate receptor subunits assemble. For instance, Cullin1 assembles to form a Skp1-Cullin1-F-
box protein (SCF) E3 ligase, in which Cullin1 binds to Rbx1 via its C-terminus and to the Skp1 
adaptor protein and an F-box protein substrate receptor via its N-terminus. Conjugation of the 
ubiquitin-like molecule Nedd8 to a conserved lysine residue on the cullin scaffold is essential for 
the activity of CRLs. Cullin neddylation is reversible via the action of the Cop9 Signalosome 
(CSN) which mediates cullin deneddylation. Cycles of neddylation and deneddylation have been 
reported to be essential for CRL activity. Furthermore, CAND1 is a positive regulator of CRLs 
in vivo and binds to cullins that are not conjugated with Nedd8 and not associated with substrate 
receptors. Different functional roles for CAND1 have been proposed.
        In this study, we used a mammalian cellular system to investigate the global regulatory 
mechanisms that govern CRL activity. Specifically we studied the mechanisms through which 
CRL activity is regulated by CAND1 and Nedd8 in vivo. We further characterized the inhibitory 
mode of an additional CRL interacting protein, the bacteria effector protein, Cycle Inhibitng 
Factor (Cif). Cif has been previously shown to deamidate Nedd8 and inhibit CRL function. 
However, the mechanism involved in this regulation had not been identified. On the basis of our 
findings, we provide evidence that contrary to previously proposed models, only small fractions 
of CAND1 are associated with Cul1 and the binding of CAND1 to Cul1 in vivo is weak 
compared to F-box protein substrate receptors. This suggests that CAND1 does not, as 
previously suggested, function to sequester inactive cullin ligases. We also show that the cellular 
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ratio of the Cul1 and CAND1 proteins is inconsistent with this model. Importantly, inhibiting 
binding of substrate receptors to Cul1 failed to increase CAND1 binding, suggesting that in vivo
CAND1 does not play a major role in regulating CRL assembly and is likely to regulate CRL
activity via alternative mechanisms. 
        We also addressed the mechanism of CRL activation by neddylation in vivo. To test the 
proposed model of Nedd8-induced conformational activation of the cullin C-terminal domain, 
we designed experiments in which cellular neddylation was inhibited by either treating cells with 
an inhibitor of Nedd8 Activating Enzyme, MLN4924 or by a system of tetracycline-induced 
expression of a dominant negative Nedd8 conjugating enzyme (dnUBC12). We then introduced
different Cul2, Cul3 and Rbx1 mutants which have a constitutively active conformation even in 
the absence of neddylation and determined whether they are able to rescue CRL activity in intact 
cells. Our results support the model for Cul1 activation by Nedd8 and indicate that a similar 
mechanism operates for Cul2 and Cul3 E3 ligases. These findings support the notion that in vivo 
neddylation activates CRLs by inducing conformational changes in the C-terminal domain of 
cullins that free the RING domain of Rbx1 and bridge the gap for ubiquitin transfer onto the 
substrate. Moreover, these neddylation-mimicked, constitutively active CRLs were found to 
preferentially recruit CSN which may then exert functions important for CRL regulation.
       Our studies to investigate the inhibitory mechanism of CRLs by the ubiquitin/Nedd8 
deamidase, Cif, indicate that Burkholderia pseudomallei Cif (CHBP) interferes with Nedd8-
induced conformational control, which is dependent on the interaction between the Nedd8 
hydrophobic patch and the cullin winged-helix B subdomain. This perturbation consequently 
results in reduced CSN binding and inhibition of deneddylation in vivo. We also found that Cif-
mediated deamidation mimicking Q40E mutant ubiquitin inhibits the interaction between the
vii
hydrophobic surface of ubiquitin and the ubiquitin-binding protein p62/SQSTM1, showing 
conceptually that Cif activity impairs ubiquitin/ubiquitin-like protein non-covalent interactions.
Together, our findings delineate several aspects of the regulatory mode for CRLs and potentially 
contribute to the understanding of underlying mechanisms vital for manipulation of CRLs by 
synthetic small molecules in the future.
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11. INTRODUCTION AND LITERATURE REVIEW
1.1 Ubiquitin proteasome system
        A well orchestrated modulation of diverse biological processes is essential to 
maintain cellular homeostasis. To achieve timely and spatial regulation of fundamental 
cellular processes, proteins with key regulatory roles and functions in a vast array of
biological pathways, such as cell cycle regulators and transcription factors are constantly 
subjected to intracellular degradation. Ubiquitin is a small protein of 76 amino acids that 
can be reversibly conjugated to other proteins and this covalent modification with 
ubiquitin (termed ubiquitination) and other ubiquitin-like proteins (UBLs) have emerged 
as important regulatory mechanisms in modulating cellular processes. Ubiquitin 
proteasome system (UPS) dependent proteolysis has been implicated in the degradation 
of proteins that regulate vital processes such as cell cycle progression, signal transduction, 
transcription and apoptosis. In addition, the UPS serves to ensure cellular quality control 
by eliminating defective proteins from the cytosol and endoplasmic reticulum. These 
defective proteins include misfolded proteins, proteins that fail to assemble into 
complexes, or nascent prematurely terminated polypeptides.
      Given the diverse roles in which the UPS plays in intracellular proteolysis, it is not 
surprising that their function, and often malfunction, are important factors in various 
human diseases, including numerous cancer types, inflammation, autoimmunity, 
neurodegenerative diseases, cardiovascular disease and viral diseases (Schwartz and 
Ciechanover 1999). With regards to cancer biology, dysregulation of the UPS often leads 
to the onset of tumorigenesis since the turnover of many tumor suppressors and 
oncoproteins for instance; p53 and c-Myc are generally controlled through the UPS.
2Despite the wealth of knowledge that has been gained on the correlation between the UPS 
with certain diseases, intense efforts are still being pursued to elucidate the pathways 
leading to UPS malfunction in many of these pathological conditions. For the past one 
decade, emerging developments in our understanding of the role of the components of the 
UPS have enabled researchers and clinicians to harness this knowledge in disease
prevention.
         The therapeutic potential of inhibiting UPS in tumorigenesis has been substantiated
by the proteasome inhibitor bortezomib (Velcade; Millennium Pharmaceuticals), which 
was approved by the US Food and Drug Administration for the treatment of multiple 
myeloma. Ongoing research to delineate the roles of other components of the UPS and 
UBL conjugation pathways has identified putative enzymes that could be therapeutic
targets for intervention using small-molecule inhibitors. MLN4924 (Millennium
Pharmaceutical) is a recently developed potent, specific and reversible inhibitor of the 
UBL Nedd8 Activating Enzyme (NAE1). MLN4924 has been reported to inhibit cell 
growth across a wide range of tumors including lung, breast, and diffuse large B cell 
lymphomas (Soucy et al. 2009).
    Intracellular proteolysis catalyzed by the UPS can be simplified into two discrete 
phases requiring an ensemble of players: ubiquitin conjugation (ubiquitination) and 
degradation.
1.2 Ubiquitination
         Ubiquitin and UBLs typically modulate protein function following covalent 
conjugation to a substrate protein, usually by forming an isopeptide bond between the 
3carboxyl terminal glycine residue of ubiquitin with an ε-amino side chain of a lysine
residue on the substrate. Protein ubiquitination represent one of cellular major post 
translational modifications catalyzed by the concerted actions of three enzymes, namely 
the E1 (ubiquitin activating enzyme), E2 (ubiquitin conjugating enzyme) and E3 
(ubiquitin ligating enzyme) (Hershko and Ciechanover 1998). In an ATP dependent 
manner, an E1 initially adenylates the carboxyl-terminal glycine of ubiquitin and then 
forms a high energy thioester bond between the activated glycine residue and a cysteine 
residue on the E1 catalytic site. Subsequently, the activated ubiquitin is passed to one of 
several E2 conjugating enzymes through a transthioesterification reaction to form a 
similar thioester bond between the E2 active-site cysteine and the activated ubiquitin. 
Ultimately, with a bound target substrate, E3 facilitates the transfer of the activated 
ubiquitin from the ubiquitin-charged E2 enzyme to the substrate. In this regard, an ε-NH2
group of a lysine residue on the substrate attacks the thioester bond of the ubiquitin-
charged E2 to form an isopeptide bond, linking the activated carboxyl-terminal glycine of 
ubiquitin to the NH2 group in the attacking lysine of the target substrate. The process is 
repeated in a cyclic manner where, in each step, additional ubiquitin can be conjugated to 
any of the seven lysine residues of ubiquitin to form a polyubiquitin chain on the 
substrate (Figure 1). In addition, alternative mechanisms have been proposed. Li et al. 
(2007) demonstrated in a reconstituted in vitro system that a preformed polyubiquitin 
chain can be initially assembled on the active-site cysteine of E2 (UBE2G2). Once 
assembled, an E3 enzyme (gp78) catalyzes the transfer of the polyubiquitin chain to a 
lysine residue of the target substrate, HERP. The human genome encodes 2 E1s, at least 
38 E2s and 600–1,000 E3s (Schulman and Harper 2009). Given that E3 ligases provide 
4substrate specificity for ubiquitination reaction, this multitude of E3s can target a plethora 
of substrates for ubiquitination.
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Figure 1.1 The ubiquitin-proteasome system. In an ATP-dependent manner, ubiquitin 
(Ub) and ubiquitin-like proteins are activated by an E1 ubiquitin (like)-activating enzyme. 
Activated ubiquitin is transferred from the thioester linkage with the active-site cysteine 
of E1 to the active-site cysteine of an E2 ubiquitin-conjugating enzyme. An E3 ubiquitin 
ligase binds both a molecule of substrate and a ubiquitin-thioesterified E2 enzyme to 
facilitate ubiquitin transfer, resulting in the mono-, multi- (not shown) or 
polyubiquitination on lysine residue(s) of the substrate. The mode of ubiquitination 
determines whether the substrate protein is degraded via the 26S proteasome or altered in 
a non-proteolytic manner.
        Conjugation of ubiquitin molecule onto substrates as a single moiety 
(monoubiquitination) has been shown to play a role in lysosomal sorting and trafficking
(Haglund et al., 2003; Hicke and Dunn 2003). Monoubiquitination can act as a signal for 
internalization of cell surface proteins into the endocytic pathway and has also been 
found to alter the activity of certain endocytic enzymes. Moreover, monoubiquitination of 
5histones can contribute to transcriptional regulation and DNA damage response (MacKay 
et al. 2010).
       Ubiquitin contains seven lysine residues. Accordingly, seven different topologies of 
polyubiquitination can be generated (excluding mixed topologies). Lys48- and Lys11-
linked ubiquitin chains target proteins for degradation by the 26S proteasome (reviewed 
by Ye and Rape, 2009). Proteins that are conjugated with Lys63-linked polyubiquitin 
chains are generally not degraded but have been described to create docking sites for 
scaffold proteins involved in the regulation of nuclear factor-κB (NF-κB) and mitogen-
activated protein kinase (MAPK) pathways (Martinez-Forero et al., 2009). Other 
ubiquitin chains, such as Lys6- or Lys29-linked chains, have been detected in vitro or in 
vivo, but substrates or enzymes responsible for their assembly are not fully defined
(reviewed by Ye and Rape, 2009). 
1.3 Degradation
Assembly of more than 4 ubiquitin molecules on target proteins via Lysine 48-
linked polyubiquitin chain marks cellular proteins for degradation by the large, highly 
conserved multiprotein complex 26S proteasome (reviewed by Hershko and 
Ciechanover, 1998). Recently, several lines of evidence also demonstrated that mitotic 
proteins conjugated with Lys 11-linked polyubiquitin chain were recognized and 
degraded via the 26S proteasome (reviewed by Ye and Rape, 2009). The proteasome can 
be dissected into two smaller subcomponents: namely the 20S core particle, which 
mediates substrate proteolysis, and the 19S regulatory particle, which appears to be 
6responsible for recruiting, unfolding, and translocating polyubiquitinated substrates into 
the core particle for degradation (Nickell et al., 2009).
            The 19S regulatory particle can be further separated into two components—the lid 
and base (reviewed by Pickart and Cohen 2004). The lid is thought to play two main roles 
in target degradation. First, the lid can recognize and bind to polyubiquitinated proteins
through at least one of several multiubiquitin chain receptors (Verma et al. 2004). 
Subsequently, the polyubiquitinated substrates undergo deubiquitination mediated by a 
metalloenzyme present in the Rpn11 protein (Verma et al. 2002). Through an allosteric
mechanism that is not fully elucidated, the concerted actions between the two steps above 
with the base facilitate the unfolding (probably through ATPase activity in the base) and 
entry of deubiquitinated substrates into the catalytic core for proteolysis (reviewed by 
Pickart and Cohen 2004).
      The 20S proteasome is a barrel shape protein complex. This core particle has at least 
three peptidase activities, i.e. chymotryptic, tryptic and caspase-like, which are mediated 
by different subunits within the complex to hydrolyze substrates fed into the proteasome 
chamber (reviewed by Pickart and Cohen 2004). The 20S proteasome is capped by the 
19S regulatory particle at both ends, which are thought to mediate both substrate 
translocation to and peptide release from the core. Regulation of substrates entry into and 
exit from the core has been shown to be mediated at least in part by the base protein Rpt2. 
(Kohler et al. 2001). Alternatively, the 20S proteasome forms complexes with non-
ATPase activators with stronger trypsin- and chymotrypsin-like activities to produce 
degradation peptides suitable for antigen presentation in the immune system. Despite
extensive efforts of research on the mechanistic regulation of the 26S proteasome, the 
7concerted mechanisms on substrate recognition, deubiquitination, unfolding, 
translocation and proteolysis by 26S proteasome still remain to be fully elucidated. 
1.4 E3 Ubiquitin Ligases
The enormous numbers of E3 ubiquitin ligases recruit particular substrates
containing specific interacting domains, and hence confer substrate specificity in 
ubiquitination reaction. The roles of E3 ubiquitin ligases can be broadly characterized as 
substrate recognition and polyubiquitin chain formation with the aid from E2 enzyme.
Most E3 ligases are identified through the conserved domains that mediate polyubiquitin 
chain formation. Based on this structural classification, two types of E3s are commonly 
found: the RING (Really Interesting New Gene) ligase and the HECT (Homologous to 
E6-AP Carboxy Terminus) ligase. 
Early studies with the human papillomavirus (HPV) led to characterization of the 
HECT ubiquitin ligase domain (reviewed by Pickart 2001). HECT is a domain of ~350 
amino acids that is found at the C terminus of proteins. The E6 proteins of HPV types 16 
and 18 can complex with and promote the ubiquitin dependent degradation of p53
mediated by an E6 associated-protein, E6-AP (Scheffner et al. 1993). The highly 
conserved C-terminus of E6-AP, which later termed the HECT domain, plays a critical 
role in p53 ubiquitination and homologs containing this domain were found in several 
different proteins (Huibregtse et al. 1995). The HECT E3s contain a conserved catalytic 
Cys, which acts as an acceptor of ubiquitin from ubiquitin-charged E2 conjugating 
enzymes to form a thioester intermediate. Ubiquitin is then directly transferred to a 
specific Lys residue in the substrate.
8              The RING finger ligases are the most abundant class of E3 ubiquitin ligases 
(approximately 600 or more), defined by the presence of a consensus sequence that uses 
an octet of cysteines and histidines to coordinate two zinc ions (reviewed by Deshaies 
and Joazeiro, 2009). The RING does not form a catalytic thioester bond between itself 
and the charged ubiquitin from the E2; rather it is generally conceived that the RING-
type E3 ligases serve as scaffolds that simultaneously bind to a substrate protein and 
anchor the E2 through the RING domain for optimal transfer of ubiquitin directly from 
the E2 to its bound target protein. Various RING variants have been noted over time, one 
such variant is the U-box E3s. The ~70 amino acids containing U-box domain uses 
intramolecular interactions instead of zinc chelation to maintain the RING finger motif
like function and E3 ligase activity. The anaphase-promoting complex (APC) and Skp1-
Cullin1-F-box (SCF) ubiquitin ligases are the most notable RING-containing E3 ligases 
characterized to date. 
1.5 Non-cullin based RING family E3 ligases
There are several hundred non-cullin based mammalian E3 ubiquitin ligases. 
Two important E3 ligases that have been implicated in human disease are Mdm2 and 
Parkin, which are discussed in more detail below.
In response to genomic damage, the transcription factor p53 functions as a 
tumour suppressor which can induce both cell cycle arrest and apoptosis. Up to 50% of 
human cancers exhibit mutations that inactivate p53 and there is prevailing evidence that
aberrant cellular processes which suppress p53 activity are present in many other cancers 
(Wade et al., 2010). p53 is regulated at the level of its stability and the oncoprotein 
9MDM2 (known as HDM2 in humans) is the RING family E3 ligase that interacts with 
p53 and targets it for ubiquitination and proteasomal degradation (Haupt et al., 1997; 
Kubbutat et al., 1997; Honda and Yasuda, 2000, Fang et al., 2000). MDM2 is under the 
transcriptional control of p53 (Marine and Lozano, 2010; Lee and Gu, 2010). 
Amplification of MDM2 or p53 mutations is often associated with aberrant growth
control in cancers (Marine and Lozano, 2010). The other interacting protein in the p53-
MDM2 pathway is MDMX (Wade et al., 2010; Lee and Gu, 2010). MDMX itself lacks 
E3 activity even though it interacts with p53 and shares the domain structure of MDM2. 
MDM2 can either form homodimers or heterodimerize with MDMX through their RING 
fingers (Uldrijan et al., 2007; Poyurovsky et al., 2007; Linke et al., 2008), and both types 
of dimers are active E3s. The exact mechanism through which these interacting proteins 
exert activity on p53 remains to be fully elucidated but it is perceived that expressed 
MDMX enhances p53 ubiquitination (Okamoto and Nakagama, 2009; Linares et al., 
2003). MDM2-mediated degradation of p53 is regulated by various protein post-
translational modifications. DNA damage- or other genomic stress-induced 
phosphorylation of p53, MDM2 and MDMX, acts to modulate p53 ubiquitylation (Wade 
et al., 2010). The acetylation of carboxy-terminal lysines on p53 interferes with 
MDM2-mediated ubiquitylation and therefore activates p53 (Vousden and Prives, 2009). 
Inhibiting the functional interactions between these proteins is of great therapeutic 
interest. Nutlin is a competitive inhibitor of MDM2-p53 interaction and the drug has been 
reported to exert beneficial effects in preclinical models (Vassilev, 2004; Tovar et al., 
2011). 
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            Parkin is a RING family E3 ubiquitin ligase mutated in autosomal recessive 
juvenile Parkinson’s disease (ARJPD). The diagnosis of Parkin-associated ARJPD is 
considered primarily in individuals with early-onset parkinsonism (age <40 years), 
particularly with suspected autosomal recessive inheritance (Brice et al., 2007).
Parkinson’s disease (PD) is a neurodegenerative disorder characterised by slowness of 
movement, tremors and rigidity, symptoms caused by the premature loss of dopaminergic
neurons in the substantia nigra (Samii et al., 2004).  The multidomain protein Parkin 
comprises of an N-terminal ubiquitin-like domain (Ubl), a cysteine-rich RING domain 
(Hristova et al., 2009), and two C-terminal RING domains (RING1 and RING2) 
separated by a cysteine-rich, zinc-binding in between RING (IBR) domain. The RING2 
domain is indispensable for Parkin E3 ligase activity, as any deletion of this domain leads
to the inactivation of Parkin function. Albeit there have been accumulating reports on 
numerous putative Parkin substrates, yet the functional significance of many of these 
substrates remains controversial. 
        There is prevailing evidence suggesting that one functional implication of Parkin 
dysfunction is loss of the quality control elimination of depolarised and fragmented 
mitochondria through mitophagy (Youle and Narendra, 2011; Pilsl and Winklhofer, 
2012). In support of this notion, among the few putative substrates that have been 
identified are the mitochondrial-associated proteins Mitofusin 1 and Mitofusin 2 (Ziviani 
et al., 2010; Gegg et al., 2010; Poole et al., 2010; Glauser et al., 2011), which are required 
for mitochondrial fusion. Selective degradation of the mitofusins may inhibit fusion of 
damaged mitochondria and hence stimulate mitophagy (Tanaka et al., 2010). 
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       A recent finding reports that Parkin can be modified with the ubiquitin-like protein 
NEDD8 (Um et al., 2012). The authors reported that neddylation enhances the binding of 
Parkin with UbcH8 and with the putative substrate, the p38 subunit of aminoacyl 
transferase, and consequently result in enhanced ubiquitin ligase activity (Um et al., 
2012). A subsequent finding also suggests stimulatory effect of neddylation on Parkin E3 
ligase activity (Choo et al., 2012). However, the physiological significance of Parkin 
neddylation remains to be fully elucidated. 
1.6 Cullin RING E3 Ubiquitin Ligases
             Cullin is an evolutionarily conserved gene family that was first identified in both 
C. elegans and budding yeast [cullin homolog Cdc53 (cell division control protein 53)] 
respectively, by two independent groups as a component involved in ubiquitin dependent 
proteolysis of cell cycle regulators (Kipreos et al. 1996; Mathias et al. 1996). The 
mammalian (Homo sapiens, Mus musculus and Rattus norvegicus) genomes encode 
seven different cullin homologs (Cul1 to Cul3, Cul4a, Cul4b, Cul5 and Cul7). There are
six cullins in C. elegans (cul-1 to cul-6) and five in Drosophila (Cul1 to Cul5). The 
Arabidopsis genome encodes five cullins (Cul1, Cul2, Cul3A, Cul4 and Cul5), and yeast 
has three cullin proteins [cul1, cul3, cul8 in Saccharomyces cerevisiae; cul1, cul3 and 
cul4 in Schizosaccharomyces pombe] (reviewed by Sarikas et al., 2011).
           Cullin RING ligases (CRLs) represent the largest family of E3 ubiquitin ligases
that catalyze the ubiquitination of cellular proteins in a multitude of biological processes 
such as cell cycle transition, signal transduction, transcriptional regulation, and 
development (reviewed by Petroski and Deshaies, 2005). The cullin homologs serve as a 
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scaffold that functions by binding the RING domain-containing protein, Roc1/Rbx1, via
its C-terminus (Kamura et al., 1999; Ohta et al., 1999; Seol et al., 1999). Rbx1 facilitates 
the recruitment of the E2 to the complex. The N-terminus of cullin proteins serves as a 
docking site for binding of different substrate recognition subunits, which only recognize
and recruit specific substrate proteins. This confers substrate specificity to individual 
ligases. Specific adaptor proteins are required to bridge the binding of the various 
substrate recognition subunits with the cullin homologs [except in the case of Cul3] 
(reviewed by Petroski and Deshaies, 2005 ; Bosu and Kipreos, 2008). For instance, the 
adaptor protein Skp1 links the N-terminus of Cul1 to various F-box domain containing
substrate recognition subunits, thus forming the SCF (Skp1–Cullin–F-box) ubiquitin 
ligase, whereas cullin 2 and cullin 5 bind to the substrate recognition subunit von Hippel–
Lindau (VHL) or to different suppressor of cytokine signalling (SOCS) proteins, 
respectively, via the adaptor proteins elongin B and C (Kamura et al., 2004). In CRL4A, 
the Damage-specific DNA Binding protein 1 (DDB1) serves as an adaptor protein to 
bridge a member of the DDB1 and Cul4 Associated Factor (DCAF) family which
recognizes different substrates (Angers et al., 2006). In contrast, Cul3 is known to bind 
directly to substrate recognition subunits via their bric-a-brac, tramtrack, broad complex
(BTB) domain (Pintard et al., 2004). In addition to the cullin homolog specific binding 
domains, all of the substrate recognition subunits contain specific substrate binding 
domains that are responsible for substrate recruitment, often in a manner that is
dependent on substrate posttranslational modifications, such as phosphorylation and 
hydroxylation. As a result, the cullin proteins bring substrate and ubiquitin-charged E2 
enzyme into close proximity, thus facilitating ubiquitin transfer from the E2 enzyme to a 
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side chain of a lysine residue in the substrate, forming an isopeptide bond. Reiteration of 
the substrate ubiquitination reaction results in the conjugation of the substrate with a 
polyubiquitin chain, which is necessary for recognition by the 26S proteasome. For 
instance, the SCFSkp2 CRL is known to catalyze the degradation of p27 substrate protein, 
in which p27 associates with Cul1 via the Skp2 substrate recognition subunit and the
adaptor protein Skp1 (Carrano et al., 1999; Tsvetkov et al., 1999). Covalent modification
of the ubiquitin-like protein Nedd8 (Neural precursor cell-Expressed Developmentally 
Down-regulated 8) to cullin proteins are essential for CRL functions. Likewise, CRLs are 
















































Figure 1.2 Schematic composition diagrams of CRL complexes. Each complex 
contains a characteristic cullin protein, an Rbx RING domain protein, adaptor protein, 
and one member of a family of substrate-binding proteins. Nedd8 is covalently attached 
to the cullin protein at the C-terminus on a conserved lysine residue. 
1.6.1 Structural characteristics of CRLs
          A structural model of a complete CRL1 complex, SCFSkp2-Rbx-complex, which 
was derived by superimposing the crystal structures of Cul1-Rbx1-Skp1-F box on the 
Skp1-Skp2 complex delineates our understanding of the structural properties and 
assembly of CRLs (Schulman et al., 2000; Zheng et al., 2002). The SCFSkp2 structural 
model provided insights into key structural features underlying its ubiquitin ligase 
functions. Of note, the central scaffold protein Cul1 have a long stalk-like amino-terminal 
domain (NTD), consisting of three cullin repeats (CR1 to CR3), and a globular carboxy-
terminal domain (CTD). Cul2 to Cul5 are thought to form the same structure based on
sequence homology. Cullin CTD is assembled from 4-helix bundle (4HB), α/β, and 
winged-helix B (WHB) subdomains. The 4HB interacts with the NTD. The cullin CTD 
binds to its RING subunit protein, RING box protein Rbx1 and Rbx2, respectively [also 
known as Regulator of cullins 1 (ROC1) or ROC2], which recruits the ubiquitin-charged 
E2 enzymes for catalysis. The Cul1-Rbx1 association is established mainly by interaction 
between the cullin α/β subdomain and Rbx1 N-terminal strand. The RING domain of 
Rbx1, which is thought to bind E2s (Zheng et al., 2000), is connected to Rbx1’s N-strand 
via a 6-residue linker. For CRLs not modified with Nedd8, the WHB subdomain interacts 
with Rbx1’s RING domain. The cullin-RING interaction forms the catalytic core that
defines CRLs.
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            The N-terminal helices H2 and H5 of CR1 in Cul1 to Cul5 are involved in 
anchoring their cognate adaptors. These helices are well conserved between cullin 
orthologues and mutation of specific conserved residues disrupts binding to the 
corresponding adaptor. This is evident as mutations of H2 and H5 of Cul3 abolish its 
binding to BTB proteins. There are two distinct types of recognition fold in the adaptor. 
For SCF, CRL2, CRL3 and CRL5 E3s, different adaptors (Skp1, Elongin C or BTB) 
share a similar structural motif termed the Skp1/BTB/Pox virus and zinc finger (POZ)
fold to interact with the cullin N-terminus. On the other hand, the DDB1 adaptor of 
CRL4 lacks the Skp1/BTB/POZ fold and instead uses its BPB (β-propeller) domain to 
bind with the Cul4A H2 and H5 helices at its N-terminal extension.
          As revealed by structural and biochemical studies, additional substrate recognition
subunit-cullin interactions further complement the functional assembly of complete CRLs.
For instance although Cul1 mediates interactions to Skp1 adaptor protein through the
Skp1/BTB/POZ fold, the F-box domain of Skp2 also binds to Cul1, thus contributing to 
the assembly of the SCFSkp2 complex (Zheng et al., 2002). A recent structural 
characterization of the Cul3-SPOP complex by Schulman and colleagues showed that 
Cul3 binds to a conserved helical structure carboxy-terminal of the SPOP BTB domain, 
which was named ‘3-box’ for Cul3-interacting box, in addition to the Skp1/BTB/POZ 
fold mediated Cul3-BTB proteins interactions. The Cul3-3-box association strengthens 
the Cul3-BTB protein interactions (Zhuang et al., 2009). Cul2 and Cul5 share the 
identical adaptor protein, Elongin C to direct the assembly of individually distinct E3 
complexes, i.e. CRL2 with VHL or related BC box proteins, and CRL5 with SOCS-box 
containing proteins. 
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We are yet to understand in atomic details the determinants of substrate 
recognition subunits in mediating CRL complexes assembly. Future structural and 
biochemical characterization, using a larger set of substrates will bridge the gap in our 
understanding of the complete CRLs assembly. Structural determination of Cul2 and 
Cul5, in particular the N-terminus is critical to understand the differential ability of Cul2 
and Cul5 to organize CRL2 and CRL5, respectively. 
1.7 Diverse functions of CRLs and its implications in diseases
Genetic ablation experiments in a variety of organisms, including mouse, C. 
elegans and Drosophila have revealed the major physiological functions of the cullin 
family proteins that are associated with numerous cellular processes, including cell-cycle 
control, signal transduction and development. In Arabidopsis, CRLs regulate hormonal 
perception, light responses, circadian rhythms and photomorphogenesis. 
1.7.1 CRL1
           Cul1 is the most extensively studied member of the cullin family. Cul1 mouse 
knockout experiment resulted in early embryonic lethality, indicating its roles in cell 
cycle regulation and early embryonic development (Dealy et al, 1999; Wang et al., 1999).
siRNA silencing of Cul1 in C. elegans has demonstrated the requirement of Cul1 for cell 
cycle progression (Kipreos et al., 1996). The human genome encodes 69 F-box proteins,
thus human cells potentially assemble 69 distinct SCF to catalyze ubiquitin-dependent 
proteolysis in regulating a multitude of biological processes (Jin et al., 2004). The Cul1-
based SCF containing the F-box protein Skp2 mediates the ubiquitin-dependent 
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degradation of the cyclin-dependent kinases inhibitors p27 and p21, thereby regulating
the mammalian cell cycle through activation of the cyclin-dependent kinases 
(Guardavaccaro and Pagano 2006). β-TrCP is another well characterized F-box protein. 
SCFβ-TrCP recognizes substrates that contain the conserved DSGXXS destruction motif 
(Yaron et al. 1997; Winston et al. 1999). SCFβTrCP–dependent degradation of IκBα 
mediates the activation of NF-κB signaling and promotes cell cycle progression and 
survival (Tan et al., 1999). Recently, three independent groups have identified SCFβTrCP
to be the E3 ubiquitin ligase that catalyzes the degradation of DEPTOR, an inhibitor of 
the mammalian target of rapamycin (mTOR). DEPTOR is downregulated in many tumors, 
which is consistent with the activation of mTOR in many tumors, suggesting that 
DEPTOR acts as a tumor suppressor. These groups showed that DEPTOR 
phosphorylation by mTOR kinase in response to growth signals, and in collaboration 
with casein kinase I (CKI), generates a phosphodegron that binds β-TrCP, with 
subsequent proteasomal degradation of DEPTOR (Zhao et al, 2011; Duan et al, 2011; 
Gao et al, 2011).
1.7.2 CRL2 and CRL5
          To date, knock out mouse models for either Cul2 or Cul5 have not been published.
In C. elegans, RNA interference knockdown of Cul2 revealed that Cul2 is an essential 
gene for mitotic germline proliferation and meiotic division II following fertilization,
(Feng et al., 1999; Liu et al., 2004) while Cul5 is not essential for growth or development 
(reviewed by Lee and Zhou, 2010). The best characterized Cul2 substrate receptor is the 
von Hippel-Lindau (VHL) tumor suppressor, which targets the oxygen-sensing 
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transcription factor HIF-1α for ubiquitin-dependent degradation (Maxwell et al., 1999).
Mutations of the VHL tumor suppressor gene are causal for the familial von Hippel-
Lindau disease, which is characterized by tumors of the kidney, pancreas, eye, brain, 
spinal cord, and adrenal glands. Under normoxic conditions, hydroxylation of specific 
proline residues on HIF-1α by prolyl hydroxylases facilitates binding of HIF-1α to VHL 
thus catalyzing ubiquitination and proteasome-mediated degradation of HIF-1α (Ivan et 
al., 2001; Jaakkola et al., 2001). Under hypoxic conditions, prolyl hydroxylases are 
inhibited and the accumulated HIF-1α activates the expression of proangiogenic genes 
such as VEGF and PDGF, leading to increased oxygen delivery by stimulating
angiogenesis.
           Both CRL2 and CRL5 utilize Elongin B/C as adaptors for substrate recruitment, in 
addition to recruiting distinct SOCS-box proteins as substrate recognition subunits. A 
number of viral proteins were found to serve as substrate recognition subunits for CRL5.
The best characterized factor is the HIV-1 viral infectivity factor (Vif). Vif contains a 
SOCS-box and assembles a Cul5-based ubiquitin ligase that mediates ubiquitination of 
the host antiviral factor APOBEC3G (Yu et al., 2003).
1.7.3 CRL3
             Mammalian Cul3 has been implicated in the turnover of cyclin E, and Cul3
deficient mice die at about embryonic day 6.5 (Singer et al., 1999). In C. elegans, loss of 
cul-3 leads to defects in spindle positioning in single-cell embryos, resulting in failed 
cytokinesis (Kurz et al., 2002). To identify Cul3 substrate adaptor modules, Xu et al. 
screened C. elegans two-hybrid complementary DNA libraries and the ORFEOME 
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library for Cul-3-interacting proteins (Xu et al, 2003). This led to the identification of 11 
different gene products that could mediate a two-hybrid interaction with Cul-3 but not 
with Cul-4. The authors later found that these gene products encode proteins that 
contained a conserved BTB/POZ domain. In the same study, biochemical assays using 
the BTB protein MEL-26 and its genetic target MEI-1 further indicate that BTB proteins 
integrate the functions of both adaptors and substrate receptors into a single polypeptide.
Simultaneously, BTB/POZ domain proteins were also identified by a number of other 
groups as substrate receptors of Cul-3 based E3 ligases (Pintard et al., 2003; Furukawa et 
al., 2003).
             The most intensely studied Cul3 substrate receptor is Keap1, which targets the 
Nrf2 transcription factor for ubiquitination and degradation. Under basal cellular 
conditions, Nrf2 is constitutively ubiquitinated by the Cul3–Keap1 ubiquitin ligase and 
degraded via the 26S proteasomes. Upon exposure to electrophilic and oxidative insults, 
reactive cysteine residues in Keap1 are modified; leading to inactivation of the E3 ligase 
activity. Consequently, Nrf2 is stabilized and activates the transcription of antioxidant 
genes and phase II detoxifying enzymes (Venugopal and Jaiswal, 1998). Expression of 
Nrf2-dependent cytoprotective gene products is critical to ameliorate the effects of 
carcinogens, and maintain cellular redox homeostasis. 
           Keap1 and Nrf2 have been found to be mutated in tumors of lung cancer patients.
There is also accumulating evidence that Nrf2 and its downstream genes are 
overexpressed in human cancer tissues and many cancer cell lines, conferring a survival 
and growth advantage (reviewed by Hayes and McMahon, 2009). Moreover, Nrf2 is
postulated to confer chemoresistance in cancer cells since upregulation of Nrf2 was 
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detected in cancer cells (Wang et al., 2008). In view of these, targeted inhibition of the 
Nrf2 pathway may serve as an effective mode in chemotherapy. 
           In addition to Keap1, Cul3 recruits the BTB protein, speckle-type POZ domain 
protein (SPOP) as another substrate receptor to potentially exert its tumor suppressor role
through the degradation of Daxx, a transcriptional repressor of p53 (Kwon et al., 2006). 
CUL3-SPOP also catalyzes the ubiquitination of the Ci/Gli family of transcription factors 
in the regulation of Hedgehog signaling. Dysregulation of Hedgehog signaling and Ci/Gli
turnover have been frequently observed in basal cell carcinomas (reviewed by Yang et
al.), implying that SPOP-mediated regulation of Ci/Gli ubiquitination plays a role in the
control of this critical signaling pathway.
1.7.4 CRL4
              Cul4 deletion studies in C. elegans have established a significant role for Cul4 in 
DNA replication. CRL4 associates with the DCAF protein Cdt2 as substrate recognition 
subunit to target the replication licensing factor Cdt1 for degradation, thereby regulating 
DNA re-replication (Zhong et al., 2003). Another well characterized substrate recognition 
subunit is the damaged DNA binding protein 2 (DDB2), which constitutes part of the 
DDB1-DDB2-Cul4-Rbx1 E3 ligase complex (CRL4DDB2) (Scrima et al., 2011). 
Following ultraviolet light (UV) damage, genomic DNA is susceptible to the formation 
of covalent crosslinks between neighboring pyrimidine nucleotides. If left unrepaired, 
these pyrimidine dimers result in stalled transcription by RNA polymerase II (RNAPII). 
Recruitment of the core Nucleotide Excision Repair (NER) machinery to the DNA 
damage site by the XPC-RAD23-Centrin2 complex is facilitated by DDB2-associated 
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CRL4 (Volker et al., 2001; Nishi et al., 2009). Fischer et al. (2011) recently uncovered 
the molecular basis for CRL4DDB2 recruitment to cyclobutane pyrimidine dimer (CPD) 
lesions in chromatin and provided detailed insights on how DNA damage recognition 
results in ubiquitin ligase activation, a process mediated by CSN. The authors proposed 
that in the absence of DNA damage, the CSN bound CRL4DDB2 is in an inactivate state. 
Following UV irradiation, CRL4DDB2-CSN is recruited to recognize CPDs. Binding of 
DDB2 to the DNA damage site results in displacement of CSN from CRL4DDB2 and 
ligase activation. Active CRL4DDB2 targets histones and XPC for ubiquitination. In 
addition, CSN displacement allows CRL4DDB2-mediated DDB2 autoubiquitination. This 
results in degradation of DDB2 and may function to regulate CRL4DDB2 activity 
following UV damage. In the similar study, crystal structure determination of the related 
CRL4DCAF, DDB1-CSA complex revealed an overall structural similarity to the DDB1-
DDB2 complex, indicating a general mechanism of ligase activation, which is induced by 
CSN dissociation from CRL4DCAF following substrate binding to the DCAF (Fischer et al.
2011).
         Several familial mutations in the Cul4B gene were associated with X-linked mental 
retardation syndrome (XLMR) (Tarpey et al., 2007). The authors reported three 
truncating, two splice-site and three missense variants at conserved amino acids in the 
Cul4B gene on Xq24 in 8 of 250 families with XLMR. During adolescence of these 
affected subjects, a syndrome emerges with delayed puberty, hypogonadism, growth 
retardation, foot abnormalities, relative macrocephaly, central obesity, aggressive 
outbursts and fine intention tremor. 
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1.7.5 CRL7
Mutations in the Cul7 gene cause the 3-M syndrome, an autosomal-recessive 
disorder characterized by pre- and postnatal growth retardation, facial dysmorphism, 
large head circumference, normal intelligence, and skeletal anomalies that include long 
slender tubular bones and tall vertebral bodies (Huber et al., 2005; 2009). Direct 
sequencing of the Cul7 gene in individuals with 3-M syndrome from 29 families by 
Huber et al. detected 25 distinct mutations, indicating that Cul7 as the major disease gene 
of 3-M syndrome. The mutations were located throughout the Cul7 gene and most are 
predicted to cause premature termination of translation. Together, studies with 3-M
syndrome combined with vascular defects observed in Cul7 knockout mice, have
suggested a prominent role for Cul7 in regulating cell growth (reviewed by Sarikas et al., 
2008).
1.8 Deubiquitinating enzymes (DUBs): Cellular function and implication in 
disease
             It is now evident that conjugation of substrate proteins with ubiquitin plays an 
important role in regulating a plethora of cellular processes depending on the ubiquitin 
modification involved. The fates of ubiquitin-conjugated proteins can range from 
proteasomal degradation for K48-linked or K11-linked polyubiquitinated substrates, 
activation of nuclear factorκ B (NF-κB) signaling pathway through K63-linked 
polyubiquitin-mediated recruitment of signaling intermediates, to transcriptional 
regulation and DNA damage response for monoubiquitination of histones and chromatin 
associated proteins (MacKay et al. 2010). Importantly, ubiquitination is a reversible 
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process and the deconjugation of ubiquitin potentially plays a fundamental role in the 
regulation of these proteins and processes. Recently, bioinformatics-based studies have 
unveiled an increasing number of known DUBs (Nijman et al., 2005) and studies 
determining interacting proteins of DUBs (Sowa et al., 2009) have led us to better 
understand of their cellular function and regulation.
      By removing ubiquitin from either a target substrate or another ubiquitin molecule 
onto which they have been conjugated, DUBs play many roles within the cell. These 
include recycling free ubiquitin, rescue of a substrate protein from either proteasomal or 
lysosomal degradation, altered cellular trafficking of a protein within the cell, or the 
activation/deactivation of intermediates in particular signaling pathways (reviewed by 
Komander et al., 2009).  
       The regulation of receptor trafficking by DUBs is apparent with the identification of 
AMSH (associated molecule with the Src homology 3 domain of STAM [signal-
transducing adapter molecule]) and USP8 in regulating the endocytic trafficking of 
epidermal growth factor receptor (EGFR) (reviewed by Clague and Urbe, 2006). Upon 
activation, EGFR is ubiquitinated (Levkowitz et al., 1998), internalised and incorporated 
in early endosomes before being trafficked to the lysosome for degradation (Urbe et al., 
2003). By deubiquitining EGFR, AMSH apparently promotes recycling of the receptor 
back to the plasma membrane. In contrast, deconjugating of ubiquitin by USP8 is 
required for lysosomal targeting and eventual degradation of EGFR (Row et al., 2006; 
Bowers et al., 2006; Mizuno et al., 2006). 
        In the regulation of cell cycle progression, the ubiquitin C-terminal hydrolase, 
UCHL1, associates during M-phase as a dimer with the mitotic spindle, and thus has been 
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implicated in the control of the mitotic spindle checkpoint. The role of the UCHL1 dimer 
in this checkpoint has been attributed to its proposed function as an E3 ligase by 
catalyzing tubulin ubiquitination and probably regulating tubulin polymerisation (Bheda 
et al., 2010). Mutations of UCH-L1 have been identified in one family with a history of 
Parkinson’s disease (PD) (Lincoln et al., 1999) and a particular polymorphism in UCH-
L1 has been linked with reduced susceptibility to PD (Zhang et al., 2000). However, the
role of UCHL1 in PD is currently unclear. 
         CYLD, a member of the Ubiquitin Specific Protease (USP) family, was originally 
identified as a tumour suppressor gene mutated in cylindromatosis syndrome (Bignell et 
al., 2005), and was subsequently implicated in NF-kappaB regulation. CYLD acts by 
deconjugating K63 linked polyubiquitin chains from numerous signalling intermediates 
including TRAF2, TRAF6, RIP1 and NEMO (Burnett et al., 2003; Trompouki et al., 
2003; Brummelkamp et al., 2003) and thus blocks the activation of NF-kappaB. CYLD 
has also been shown to be mutated in Brooke-Spiegler syndrome (BSS) and multiple 
familial trichoepithelioma (MFT) (Bowen et al., 2005), which represent tumours of skin 
appendages. In spite of regulating NF-kappaB signaling, it has now become evident that 
CYLD also functions during the cell cycle progression through G1/S and during 
cytokinesis (Massoumi et al., 2006). During G1/S transition, peri-nuclear localized 
CYLD associates with Bcl-3 and delays G1/S progression (Massoumi et al., 2006). 
CYLD also appears to bind with histone deacetylase 6 (HDAC6) during cytokinesis and 
as a result regulates the rate of cell division (Massoumi et al., 2006). It is now believed 
that the role of CYLD in cancer may be more related to its regulation of the cell cycle 
through Bcl-3 and HDAC6 (Massoumi et al., 2006). 
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         A20 is another DUB implicated in the regulation of NF-kappaB signaling. A20 was 
originally identified due to its up-regulation following Tumour Necrosis Factor alpha 
(TNF-alpha) treatment (Lee et al., 2000). A20 was reported to inhibit NF-kappaB 
activation by TNF-alpha by deconjugating K63-linked polyubiquitin chains from RIP1 
kinase (Shi and Kehrl, 2003). Other targets such as TRAF6, RIP2 and NEMO have also 
been shown to be deubiquitinated by A20. As a result, A20 has been implicated in the 
regulation of NF-kappaB activation through the Tumour Necrosis Factor receptor 
(TNFR), Interleukin 1 (IL-1)/Toll-like receptor (TLR) and T-cell receptor (TCR) 
pathways (Boone et al., 2004; Mauro et al., 2006). The potential role of A20 as a tumor 
suppressor is substantiated by the absence of A20 expression in some cases of non-
hodgkins lymphoma including cases of diffuse large B-cell lymphoma, Burkitt’s 
lymphoma and T-cell lymphomas such as anaplastic large cell lymphoma (Honma et al., 
2009). Moreover, a number of inactivating mutations of A20 have been found in 
marginal zone lymphomas (Novak et al., 2009).   
        
1.9 Regulation of CRLs by the ubiquitin-like protein Nedd8
             Despite considerable diversity, each of the classes of CRL complexes is subject 
to a well orchestrated set of regulatory mechanisms. Specifically, all cullin based 
ubiquitin ligases are post-translationally modified with the ubiquitin-like protein Nedd8. 
Nedd8 was originally identified within a set of genes that are developmentally down-
regulated (Kumar et al. 1992). Cloning of Nedd8 showed it to be 60% identical and 80% 
similar to ubiquitin (Kamitani et al. 1997). Covalent modification of cullins with Nedd8
(neddylation) is essential for all organisms, with the exception of budding yeast. 
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Neddylation occurs in a process analogous to ubiquitination. In this regard, in an ATP-
dependent manner, Nedd8 is first activated by the Nedd8 E1 APPBP1-Uba3 
heterodimeric enzyme, followed by the transfer of the activated Nedd8 to the Nedd8 E2 
conjugating enzyme (Ubc12 / UBE2M or UBE2F) (Gong and Yeh, 1999), and with the 
aid of Rbx1 / Rbx2 as well as the activator Dcn1 (Kurz et al., 2008), the Nedd8 
polypeptide is attached to a conserved lysine residue at the cullin C-terminus. Nedd8-
conjugation is required for CRL activity in vivo and for preventing the CRL inhibitor 
CAND1 from binding to the cullin scaffold. Kawakami et al., (2001) proposed that 
neddylation stimulates CRLs by promoting E2 ubiquitin conjugating enzyme recruitment 
to the ligase complex and thus polyubiquitin chain assembly.
In an effort to model the ubiquitin-charged E2 docked-Rbx1 RING domain, a
~50-Ǻ distance was predicted between the active site cysteine of E2 and the acceptor 
lysine in the target substrate. Based on this, it is unclear how CRLs catalyze ubiquitin
transfer to target proteins. Moreover, the geometry between E2 catalytic site and substrate 
is postulated to vary during polyubiquitination. Recent biochemical and structural studies 
have indicated that Nedd8 modification of cullin proteins is important to facilitate 
ubiquitin transfer. Using in vitro reconstituted system, Saha and Deshaies (2008) 
performed a detailed enzymatic analysis of the SCF complex and reported that Nedd8 
conjugation stimulates SCF activity by bridging the 50-Ǻ gap between substrate and 
ubiquitin-charged E2 bound to Rbx1. In addition, crystal structure elucidation of the 
Nedd8-conjugated Cul5/Rbx1 complex by Duda et al. demonstrated that neddylation 
induces a drastic conformational change in the C-terminal WHB domain of Cul5 and 
eliminates the CRL inhibitor CAND1 binding site (Duda et al., 2008). Consequently, the 
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Rbx1 RING domain partially dissociates from Cul5 and is free to adopt multiple 
conformations, thus conferring favorable catalytic geometries for ubiquitin transfer. In 
vitro findings by Yamoah et al. further substantiated this mechanism. In this study, Pan
and colleagues showed that deletion of the Cul1 WHB domain render partial dissociation 
and, hence, flexibility of Rbx1. The Cul1 C-terminally truncated ligase was shown to be 
active in the absence of neddylation in vitro (Yamoah et al., 2008). Our studies further 
substantiate the proposed neddylation-induced conformational rearrangement regulate 
CRL activity in vivo. In the present study, we show that the cullin extreme C-terminal 
domain (ECTD) deletion mutants (equivalent to WHB deletion) also have the ability to 
rescue CRL substrate ubiquitination in a cellular context with inhibited cellular 
neddylation pathway, suggesting that cullin WHB domain deletion leads to liberation of 
the RING domain of Rbx1 and bridging of the gap for ubiquitin transfer onto the 
substrate (Boh et al., 2011a).
1.10 Regulation of CRLs by the Cop9 Signalosome
          The Cop9 Signalosome (CSN) is an evolutionarily conserved eight-subunit protein 
complex with similarity to the lid of the 26S proteasome regulatory particle (Wei et al., 
2008). The COP9 (constitutive photomorphogenic 9) complex was first identified in 
Arabidopsis thaliana, where it is required for the repression of photomorphogenesis.
Photomorphogenesis is the developmental process that occurs in response to the dark ⁄ 
light environment. Indeed, Wei and Deng (1992) have demonstrated that the COP9 
complex modulates gene expression dependent on light. In 1998, the same protein 
complex was rediscovered during the course of the purification of proteasomes from the 
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lysate of mammalian red blood cells (designated as the Jab1-containing signalosome) as 
well as purified from pig spleen (reviewed by Kato and Yoneda-Kato, 2009)). The COP9 
complex was eventually given the nomenclature as COP9 Signalosome (CSN) complex. 
Each subunit was designated as CSN1 to CSN8. Since its discovery in plants and 
mammals, the CSN has been identified in a variety of different eukaryotic organisms 
ranging from yeast, Aspergillus, C. elegans to Drosophila. CSN has been implicated in a 
wide range of biological processes including yeast mating pathways, signal transduction, 
oocyte maturation, autophagy, T-cell development, circadian rhythm, the regulation of 
DNA repair, and cell cycle regulation. Loss of COP9 function as a result of deletion of 
different CSN subunits causes a constitutive photomorphogenic phenotype in plants and 
sterility in Caenorhabditis elegans and is lethal in Drosphila and mice (Chamovitz et al., 
1996; Freilich et al., 1999; Orsborn et al., 2007; Dohmann et al., 2008). Recently, 
Yoshida et al. provided evidence that Cre recombinase–dependent knockout of CSN5 in 
mouse embryonic fibroblasts results in multiple cell cycle defects and cell death (Yoshida 
et al., 2010), further substantiating the essential role of CSN. Similarly, Dohmann et al.
(2008) demonstrated that CSN is essential for G2-phase progression and genomic 
stability in Arabidopsis.         
     The primary molecular function of CSN is the deneddylation of cullin proteins.
Nedd8 conjugates are removed from cullins (deneddylation) by the isopeptidase activity 
of the metalloprotease CSN5/Jab1 subunit of CSN. Loss of function of CSN elevates the 
levels of Nedd8-conjugated cullins in vivo. CSN-mediated cullin deneddylation leads to 
inhibition of CRL activity in vitro. Contrary to the negative role of CSN in the regulation 
of CRL activity in vitro, it is well documented that CSN is required for CRL functions in 
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vivo (reviewed by Bosu and Kipreos, 2008; Wei et al., 2008). Thus CSN inactivation 
leads to accumulation of CRL substrates and inhibition of CRLs in vivo. Several groups 
have proposed a number of mechanisms for the roles of CSN as a positive regulator in 
regulating CRL activity. CSN has been reported to prevent the autoubiquitination of 
several cullin substrate recognition subunits (Bosu and Kipreos, 2008; Schmidt et al., 
2009). This is likely due to CSN-mediated cullin deneddylation and subsequent CRL
inhibition in the absence of a bound substrate or recruiting of the CSN-associated 
deubiquitinase Ubp12/Usp15 to the CRL complex. Several groups have demonstrated 
that Ubp12/Usp15 functions to reverse substrate-receptor autoubiquitination (Zhou et al., 
2003; Hetfeld et al., 2005). Since both neddylation and deneddylation are essential for 
CRL activation, it has also been proposed that in vivo CRLs undergo rapid cycles of 
Nedd8 conjugation and deconjugation (Cope and Deshaies, 2003) (Figure 1.3). 
According to the proposed model, a CRL activation cycle operates in which substrate 
binding to the CRL complex induces cullin neddylation, thus leading to CRL activation. 
Upon substrate ubiquitination and dissociation, the activation cycle completes with CSN-
mediated deneddylation, this cycle resumes when a new substrate binds.
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Figure 1.3 Neddylation and deneddylation reactions in CRL regulation and 
substrate ubiquitination. 1). The neddylated forms of CRLs are in the active state to 
catalyze substrate ubiquitination. 2). The COP9 Signalosome (CSN) complex recognizes 
and binds the neddylated form of cullins. 3). CSN catalyzes Nedd8 removal from cullins 
(deneddylation), the non-neddylated CRLs are inactive in catalyzing substrate 
ubiquitination. 4 and 5). In an unknown sequential manner, CAND1 probably binds to 
deneddylated CRLs, resulting in the likely dissociation of adaptors and substrate 
receptors or their exchange from deneddylated CRLs. 6). In the presence of the 
neddylation machinery and the adaptor substrate receptor module, CAND1 dissociates
from CRLs through an incompletely elucidated mechanism. 7). CAND1-free CRLs 
reassemble to active neddylated CRL complexes. 8). By recruiting ubiquitin-
thioesterified E2 enzyme, neddylated CRLs catalyze substrate ubiquitination.
       
     Likewise, CSN may function to regulate the interaction of CAND1, a major cullin 
interacting protein (Cope and Deshaies, 2003; Bosu and Kipreos, 2008). CAND1 
interacts exclusively with cullin proteins that are non-neddylated and without bound 
substrate recognition subunits. Therefore, CSN-mediated deneddylation of cullin proteins
may promote CAND1 recruitment and thus facilitate the exchange of substrate 
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recognition subunits (Lo and Hannink, 2006; Schmidt et al., 2009). Otherwise, CSN may 
compete with CAND1 for binding to cullin and subsequently prevent CAND1-mediated 
CRL disassembly. In addition, it also has been reported that CSN executes its regulatory
function by promoting the dissociation of polyubiquitinated proteins from the CRL 
complex (Miyauchi et al., 2008).
      In our recent findings on the characterization of the roles of CSN in regulating CRL 
activity, we provide evidence that CSN-mediated cullin deneddylation is not intrinsically 
coupled to substrate polyubiquitination as part of the CRL activation cycle (Choo et. al., 
2010). We further demonstrated that inhibiting substrate-receptor autoubiquitination is 
unlikely to account for the major mechanism through which CSN regulates CRL activity. 
CSN also did not affect recruitment of the substrate-receptor SPOP to Cul3, suggesting it 
may not function to facilitate the exchange of Cul3 substrate receptors.
        Despite extensive efforts to characterize the roles of CSN in regulating CRL activity, 
the mechanism through which CSN functions as a positive regulator of CRL functions in 
vivo is not completely elucidated at present. Several major questions remain regarding the 
roles of CSN in regulating CRLs such as: I. What promotes the association and 
disassociation of CSN complex with CRLs, and how does this regulate CRL activity? II. 
What are the roles of the CSN-associated proteins in regulating CRLs, for instance the 
CSN-associated kinases? III. Is CSN the sole deneddylating enzyme to mediate CRLs 
Nedd8 deconjugation? IV. Is there a crosstalk between CSN and CAND1 in regulating 
CRL activity in vivo? Future in vitro and in vivo studies will be necessary to investigate
these potential mechanisms and to understand how CSN regulates CRLs.
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1.11 Regulation of CRLs by CAND1/TIP120A
In an initial attempt to identify potential regulators of SCF, two independent 
groups found that the majority of Cul1 was specifically associated with a protein with an 
apparent molecular weight of 120kDa (p120) in the immunoaffinity chromatography of 
Cul1 complex (Zheng et al., 2002; Liu et al., 2002). p120 was isolated and subjected to 
protein sequencing. The amino acid sequence of the peptide was found to match the 
protein sequences of rat and human TIP120A [TBP(TATA binding protein)-Interacting 
Protein 120A]. As its name implies, TIP120A was previously identified to interact 
directly with TBP in vitro and also to be associated with TBP in nuclear extracts 
(Yogosawa et al. 1996). TIP120A is thought to be a unique global transcription factor 
that can interact with TBP and can stimulate all classes of eukaryotic transcription. Since 
p120 is a major cullin interacting protein, it was renamed as CAND1 for Cullin-
Associated Neddylation Dissociated 1. Crystal structure elucidation of the human 
CAND1 bound to a Cul1-Rbx1 complex reveals that CAND1 is a nearly all helical-
solenoid protein, consisting of 27 tandem HEAT (huntingtin-elongation-A subunit-TOR)
repeats. CAND1 wraps around the cullin, with the CAND1 N-terminus bound to the 
cullin C-terminus and the CAND1 C-terminus bound to the cullin N-terminus 
(Goldenberg et al., 2004). At Cul1 N-terminus, CAND1 β hairpin protrusion partially 
occupies the adaptor binding site on Cul1, inhibiting Cul1 interactions with the Skp1 
adaptor and the substrate-recognition subunit F box proteins. At the C-terminal of Cul1, 
two CAND1 HEAT repeats pack against a conserved Cul1 surface cleft and bury a Cul1 
lysine residue, rendering it inaccessible for Nedd8 conjugation. CAND1 is capable of 
binding to all cullins in human cells (Zheng et al., 2002; Liu et al., 2002). In human 
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HEK293T and HeLa cells, CAND1 associates with Cul1, Cul2, Cul3 and Cul4a, but 
weakly with Cul5. In C. elegans, CAND1 binds at high level to Cul2, but does not appear
to bind Cul3 (reviewed by Bosu and Kipreos, 2008). CAND1 binding to cullin-Rbx is 
incompatible with neddylation. Conversely, Nedd8-modification hinders CAND1 binding 
to CRLs. Crystal structure determination of the Nedd8-conjugated Cul5/Rbx1 complex 
by Duda et al. (2008) demonstrated that neddylation induces a drastic conformational 
change in the Cul5 C-terminal WHB domain and eliminates a binding site for CAND1, 
suggesting that CAND1 binds to cullin-Rbx only after CSN has removed Nedd8 (Zheng 
et al., 2002; Liu et al., 2002). CAND1 can dissociate the adaptor Skp1 from unneddylated 
Cul1 in vitro, suggesting that once Nedd8 has been removed, CAND1 is capable of 
stripping off the adaptor and binding the cullin (Liu et al., 2002). 
             Although the binding mode of CAND1 suggests that it inhibits CRL assembly 
and activity, loss of function studies in Arabidopsis have demonstrated that CAND1 is 
essential for CRL function in vivo (Chuang et al., 2004; Feng et al., 2004; Cheng et al., 
2004). The Arabidopsis cand1-1 null mutant displays distinct phenotypes, including late 
flowering, floral organ defects, low fertility, dwarfism and altered responses to multiple 
plant hormones. In parallel, Chuang et al. provided evidence that CAND1 positively 
regulates SCFTIR1 because Aux/IAA protein stability is significantly increased in CAND1
mutants, indicating that CAND1 is required for CRL optimal activity. Recently, using C. 
elegans as a model organism, Bosu et al. (2010) provided evidence that CAND1 is 
required for the activity of a subset of CRL complexes. cand-1 mutants exhibit 
phenotypes such as developmental arrest, morphological defects of the vulva and tail, and 
reduced fecundity.
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            The exact role of CAND1 in the regulation of CRL activity is not well established. 
It has been hypothesized that by binding mutual exclusively with substrate receptors to 
cullin proteins, CAND1 prevents substrate receptor autoubiquitination in the absence of 
bound E3 ligase substrate (reviewed by Petroski and Deshaies, 2005 ; Bosu and Kipreos, 
2008). In support of this, siRNA knockdown of CAND1 leads to decreased cellular 
concentrations of the substrate receptor protein Skp2 (Zheng et al., 2002; Chew et al., 
2007). Alternatively, it has been proposed that cycles of CAND1 binding to and 
dissociation from cullins promote substrate receptor exchange and binding of substrate 
receptor subunits with lower affinity to Cul1 (Lo and Hannink, 2006; Schmidt et al., 
2009). In order to evaluate existing CRL dynamicity models, Bennett et al. (2010)
performed a systematic analysis of the occupancies of individual components and 
complexes within the CRL network upon acute perturbation of the CRL neddylation 
pathway. This study suggests an alternative model of CRL control where the abundance 
of adaptor modules, rather than cycles of neddylation and CAND1 binding, drives the 
dynamic organization of the CRL network. However, the exact mechanisms through 
which CAND1 regulates CRLs remain to be identified.
The regulation of the interaction between cullins and CAND1 remains a major 
unresolved question. Currently the mechanism through which CAND1 is dissociated 
from cullin-Rbx complex has not been completely resolved. Two potential mechanisms
have been tested to explain CAND1 dissociation, the first is neddylation, and the second 
is the binding of additional CRL components. Using immunoprecipitated endogenous 
human Cul1, neddylation was initially shown to dissociate CAND1 based on in vitro
experiments (Liu et al., 2002). However, studies using recombinant Cul1 showed that 
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CAND1 is not dissociated by neddylation and the neddylation site is completely 
inaccessible (Goldenberg et al., 2004; Hwang et al., 2003). The second mechanism for 
CAND1 dissociation is the binding of CRL components. Zheng et al. reported that 
addition of the Skp1 adaptor and ATP could trigger CAND1 dissociation from 
endogenous Cul1 (Zheng et al., 2002). However, Bornstein et al. demonstrated that
CAND1 could be dissociated from endogenous Cul1 by the addition of the Skp1-Skp2 
complex (but not Skp1 alone), and that ATP had no effect on the dissociation (Bornstein 
et al., 2006). Hitherto the discrepancy between the two findings has not been resolved. It 
is plausible to speculate that either the post-translational modification of endogenous 
Cul1 or an unknown cellular 'dissociation factor' mediates the dissociation of cullin-Rbx 
complex from CAND1. A recent study showed that COMMD1 (copper metabolism 
MURR1 domain-containing 1), a factor previously found to promote ubiquitination of 
various substrates, regulates CRL activation by displacing CAND1 from CRLs (Mao et 
al., 2011).
1.12 The potent and selective inhibitor of Nedd8 Activating Enzyme 1    
                 (NAE1), MLN4924
             Recently, MLN4924 (Millennium Pharmaceuticals Inc.) was reported as a potent 
and selective inhibitor of the Nedd8 E1 activating enzyme (NAE). MLN4924 (Fig. 1.4) 
resembles the structure of an adenosine sulfamate analog, (Soucy et al., 2009) in which
NAE catalyzes the formation of a covalent NEDD8-MLN4924 adduct. The NEDD8-
MLN4924 adduct resembles adenylated NEDD8, the first intermediate in the NAE 
reaction cycle, but cannot be utilized to form thioester in subsequent reactions. The 
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stability of the NEDD8-MLN4924 adduct within the NAE active site potentially inhibits
the NEDD8 pathway by locking the enzyme in an inactive state (Brownell et al., 2010).
            Loss of NAE activity following MLN4924 treatment in cultured cells and in 
human tumor xenografts leads to accumulation of numerous CRL substrates. Inhibition of 
tumor growth was also demonstrated with MLN4924 in lung tumor xenografts and in 
HCT-116 xenografts (Soucy et al., 2009). Despite blocking the turnover of multiple CRL 
substrates, the most apparent consequence of NAE inhibition observed in cells upon 
MLN4924 treatment was DNA rereplication. This observed phenotype is due to inhibited 
degradation of the DNA replication licensing factor, Cdt-1 (Soucy et al., 2009). 
Overexpression of Cdt-1 has been shown to result in DNA rereplication, DNA damage, 
and consequent apoptosis (Vaziri et al., 2003; Hu et al., 2004; Nishitani et al., 2006). In 
HCT-116 cells and other human tumor–derived cell lines, treatment of MLN4924 
resulted in S-phase-defective phenotypes (Soucy et al., 2009). Administration of
MLN4924 to acute myeloid leukemia cell lines and mouse xenograft models was shown 
to result in CRL substrate accumulation, DNA damage, reduced DNA binding activity of 
NF-κB–p65 and decreased expression of NF-κB downstream targets (Swords et al., 2010).
Recently, phase 1 clinical trial of MLN4924 in patients with relapsed and/or refractory 
multiple myeloma demonstrated the expected pharmacodynamic effects of NAE 
inhibition (reviewed by Soucy et al., 2010). Ongoing phase 1 studies are being conducted 
for MLN4924 in patients with melanoma and other non-hematological malignancies. 
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Figure 1.4 Chemical structure of MLN4924 ((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-
inden-1-ylamino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl 
sulphamate. (Soucy et al., 2009)
1.13 Inhibition of CRLs by Cycle Inhibiting Factor (Cif)
          To create favourable growth condition upon infection of host cells, pathogens often 
secrete proteins, termed effectors to interfere with host cellular signalling cascades. 
Ubiquitination is one major cellular pathways targeted by effector proteins since this 
allows the pathogen to rapidly manipulate immune defence signalling by altering host 
protein turnover or functions. Cycle inhibiting factor (Cif) is a type III secretion virulence 
effector that is present in enteropathogenic and enterohemorrhagic Escherichia coli as 
well as in Burkholderia pseudomallei and other pathogenic Gram-negative bacteria
(Jubelin et al., 2009; Yao et al., 2009). Upon injection into host cells, Cif induces a 
cytopathic effect characterized by cell cycle arrest in both G1/S and G2/M phase 
transitions, actin stress fiber formation, and cell enlargement (De Rycke et al., 1997; 
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Nougayrede et al., 2001; Marches et al., 2003). Stress fibers are nonmuscle cellular self-
assembling, high order structures of the cytoskeleton that are maintained through 
dynamic exchange of preformed filaments and cytoplasmic components. Stress fibers 
stabilize the cell structure and transduce mechanical signaling of the extracellular 
composition to modulate changes in extracellular matrix remodeling and cell shape
(reviewed by Geiger et. al., 2009). The Cif-induced cell cycle arrest eventually leads to 
delayed cell death by apoptosis (Samba Louaka et al., 2009). The inhibition of the cell 
cycle correlates with the accumulation of the cyclin-dependent kinase (CDK) inhibitors 
p21 and p27 (Samba Louaka et al., 2008), as a result from impaired protein turnover,
indicating that Cif perturbs the 26S proteasome-mediated degradation. Structural studies 
reveal that Cif and Cif homolog from Burkholderia pseudomallei (CHBP) adopt a
cysteine protease fold with a catalytic triad composed of Cys, His, Gln residues that is 
essential for the cytopathic effect (Jubelin et al., 2009; Yao et al., 2009; Crow et al., 
2009).
          Recent studies have shown that Cif has deamidating activity and functions to 
convert Gln40 in ubiquitin and in Nedd8 into Glu in vitro and during Burkholderia
infection (Cui et al., 2010). Formation of E1~Ub and E2~Ub thioester intermediates has 
been shown to be unaffected by CHBP-mediated ubiquitin deamidation, however Gln40-
deamidated ubiquitin severely impairs E3 ligase-catalyzed chain formation. Although 
deamidation of Nedd8 has no major effect on Nedd8 modification of cullin proteins, it 
dramatically inhibits cullin ligase activity, resulting in the stabilization of p27 and other 
CRL substrates including IκBα, Cdt1, β-catenin, RhoA and CyclinD1 (Jubelin et al., 2010). 
This is likely to account for the cell cycle inhibitory effect that Cif exerts upon secretion 
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into host cells. The ubiquitin or NEDD8 deamidase activity of Cif and CHBP represents a 
unique tool to study the regulation of ubiquitin proteasome system. Future structural 
elucidation of the NEDD8 Q40E-conjugated CRL complex will bridge the gap in our 
current understanding of the Cif-induced cytopathic effect through revelation of 
deamidated-Nedd8 inhibition of CRL activity.
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2. AIMS OF THE STUDY
In this study, we aim to address the global regulatory mechanisms that govern CRL 
activity.
I) Regulation of CRLs by CAND1 in vivo
The first aim of the study is to characterize the regulation of CRLs by CAND1 and to 
experimentally test the two proposed models: (i) CAND1 sequesters cullin proteins and 
thus prevents autoubiquitination of substrate receptors, and (ii) CAND1 is required to 
promote the exchange of bound substrate receptors.
II) Role of neddylation in regulating CRL activity in vivo
In vitro reconstituted experiments and structural studies have demonstrated that
neddylation stimulates CRL activity through conformational rearrangement of the cullin 
C-terminal WHB domain and Rbx1 RING subdomain from a closed architecture to an 
open and dynamic structure, thus promoting ubiquitin transfer onto the substrate. The 
second aim is to test whether the proposed mechanism of Nedd8-induced conformational
control operates in a cellular system and whether neddylation also regulates other 
members of the CRL family via a similar mechanism.
III) Inhibition of CRLs by Cycle Inhibiting Factor (Cif) 
Cycle Inhibiting Factors have been shown to deamidate Gln40 in Nedd8 into Glu and to 
dramatically inhibit CRL activity. The third aim of the study is to identify the mechanism
through which B. pseudomallei Cif (CHBP)-mediated Nedd8 deamidation inhibits CRL 
ligase activity.
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3. SUPPLEMENTARY EXPERIMENTAL METHODS
Generation of tetracycline-inducible FLAG-CAND1-HA expressing cell line
1μg of FLAG-CAND1-HA pcDNA4/TO was transfected into HEK293 cells in a well of 
a 12-wells plate. When the cells are confluent, they were trypsinized with 50μl trypsin 
and the trypsinized cells were added into a 60 mm plate. When cell colonies were formed 
after 1 to 2 days, 20μl of Zeocin were added into the 60 mm plate. New media was 
replaced every 3 to 4 days followed by addition of 20μl Zeocyn. When cell colonies were 
detectable on the plate by visual inspection (usually after two to three weeks), medium 
was aspirated and cell colonies were picked using a pipette and were added into 48 wells 
plates (each well contains 250 μl medium). Zeocin was added on the second day after 
cells were attached on the wells. When cells were confluent, they were trypsinized with 
50 μl of trypsin, and subsequently 450 μl of medium was added to the trypsinised cells. 
250μl of trypsinized cells were aspirated out twice and these cells were seeded into two 
individual wells on a 12-wells plate. The rest 100μl trypsinized cells were seeded into a 
well of a six well plate. The two individual wells of the 12 wells plate were treated with 
or without tetracycline and expression of the endogenous as well as the tetracycline-
inducible FLAG-CAND1-HA were verified from Western blotting analysis using anti-
CAND1 or anti-FLAG antibody. After verification of the tetracycline-induced expression 
of FLAG-CAND1-HA, the cells in the 6 wells plate were subcultured into a T25 flask 
when they are confluent. These cells were then frozen in liquid nitrogen for future usage.
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Expression of GST-CAND1 in E. coli
pGEX-CAND1 plasmid was a kind gift from Dr. Brenda Schulman (St. Jude Children 
Hospital, Tennessee, USA). pGEX-CAND1 was transformed into BL21 (DE3) strain. 
Desired transformants were selected by an Amp resistance LB agar plate. A freshly 
transformed single colony was inoculated in 5ml LB culture containing 1mg/ml 
ampicillin. The culture was grown overnight at 37°C with 250 rpm shaking.
Subsequently, the 5ml preculture was used to inoculate 200ml of LB medium. After
OD600 reached 0.8, the incubation temperature was decreased to 16°C. Following half an 
hour of cooling, isopropyl-β-D-thiogalactoside (IPTG) was added to a final concentration 
of 0.75 mM and induction was carried out overnight (about 16 h).
Purification of GST-CAND1
All of the purification steps were performed at 4°C or on ice. Cells were harvested by 
centrifugation at 4000 rpm for 15 min at 4°C. After centrifugation, cell pellets were 
resuspended in 8 ml lysis buffer [20 mM Tris-HCl, 200 mM NaCl, 5 mM dithiothreitol 
(DTT), pH 8.0] supplemented with a protease inhibitor cocktail [1 mM 
phenylmethylsulfonyl fluoride (PMSF), 1 μg/ml aprotinin, 1 μg/ml leupeptin, and 1 
μg/ml pepstatin]. The cells were then lysed by sonication and cell debris was removed by 
a 30 minutes centrifugation at 15,000 rpm. A gravity column of 1 ml glutathione-
Sepharose 4B (Amersham Biosciences) was equilibrated with 10 column volume (CV) 
lysis buffer. The cleared lysate was applied to the column and was mixed gently with 
glutathione-Sepharose beads for 2 hours to allow binding of GST-CAND1 to the beads. 
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The column was washed with 10 CV of lysis buffer after the lysate has passed through.
The protein was eluted with 500 μl of elution buffer (50 mM Tris-HCl, 200 mM NaCl, 20 
mM reduced glutathione, pH 8.0). GST-CAND1 protein concentration was determined
by the Bio-Rad protein assay and the purity of the eluted protein was checked by SDS–
PAGE. 
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4. GENERAL DISCUSSION AND CONCLUSIONS
        The multimodular CRLs are subject to a well orchestrated set of regulatory 
mechanisms to execute its ubiquitin ligating functions, thereby regulating a plethora of 
cellular processes. In this study, we aimed to characterize the role of individual cullin 
interacting proteins in the regulation of CRL activity. We first set out to study the role of 
CAND1 in regulating CRLs in vivo. Contrary to previously proposed models, findings 
from our studies suggest that CAND1 is unlikely to sequester all inactive, non substrate 
bound cullin proteins to prevent substrate receptor autoubiquitination. Importantly, the 
ratio of endogenous CAND1 and Cul1 protein, particularly in the nuclei is too low for 
CAND1 to sequester all cellular non-substrate bound cullin proteins. Our findings of a
weaker binding affinity of CAND1 to Cul1 compared to F-box substrate receptor proteins 
further support this conclusion. A further indication which disfavors the notion that 
CAND1 sequesters cullins to prevent substrate receptor autoubiquitination is the finding 
that inhibiting binding of adaptors and substrate receptors to Cul1 does not increase 
CAND1 binding. In agreement with Bennet et al. (2010), we found that even though 
increasing cullin neddylation led to a decrease in CAND1 bound Cul1, yet decreasing 
cullin neddylation did not result in elevated CAND1 binding to Cul1. Collectively, these 
results indicate that CAND1 binding to cullin proteins may be highly regulated via 
mechanisms that are independent of competition with adaptor and substrate receptor 
subunits for cullin proteins (refer to Figure 1.5).
We next sought to address the roles of neddylation in regulating CRLs in vivo. Based 
on previously reported in vitro and structural studies (Duda et. al., 2008; Yamoah et. al., 
2008), we hypothesized that upon impairing the intact cellular neddylation system, the 
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inhibited CRL activity can be rescued by introducing the neddylation-mimicking extreme 
C-terminal domain (ECTD) deletion of cullin mutants or flexible linker insertion Rbx1 
mutants. We indeed observed that, when cellular neddylation was inactivated by either 
treating cells with the NAE inhibitor, MLN4924 or tetracycline-induced expression of 
dnUBC12, expression of the mutant cullin and Rbx1 proteins, which confer Rbx1 RING 
domain flexibility in a neddylation-independent manner, resulted in rescue of substrate 
ubiquitination (Boh et. al., 2011a). Moreover, CSN was found to preferentially associate 
with these neddylation-mimicking, constitutively active CRLs (Choo et. al., 2010). It is 
therefore tempting to propose that these preferentially bound CSN complexes with 
associated binding proteins may then exert additional functions important for CRL
regulation (refer to Figure 1.5). Our studies therefore support the model that in vivo
neddylation generally induces a conformational rearrangement of the cullin winged-helix 
B (WHB) domain that partially dissociate RBX1 RING domain, thus conferring 
favorable catalytic geometry for CRLs to catalyze ubiquitin transfer onto substrates. 
   We subsequently investigated the inhibitory mechanism of CRLs by the bacterial type 
III effector, Cycle Inhibiting Factor (Cif). Recent studies have shown that Cif catalyzes 
the deamidation of Gln40 to Glu in ubiquitin and Nedd8 and thus inhibits CRL activity
(Cui et. al., 2010). Our results indicate that Burkholderia pseudomallei Cif (CHBP)-
mediated inhibition of CRLs is a consequence of the inability of deamidated Nedd8 to 
induce an open, active conformation of the Cul1 C-terminal domain-Rbx1 structure (Boh 
et. al., 2011b). This perturbation on the interaction between the Nedd8 hydrophobic patch 
and the cullin WHB subdomain consequently led to reduced CSN binding and impaired 
deneddylation in vivo. Notably, CHBP-dependent deamidation mimicking Q40E
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ubiquitin inhibits the interaction between the hydrophobic surface of ubiquitin and the 
ubiquitin-binding protein p62/SQSTM1. Conceptually this observation indicates that 
upon entering host cell, Cif may modulate cellular processes by selectively or broadly 
interfering with the association between ubiquitin and ubiquitin-binding proteins, which 
may be of importance in host–pathogen interactions.





















• Promotes exchange of
substrate receptor subunits
• CAND1-cullin interaction
may be regulated by post-
translational modification
on either CAND1/cullin.
• CAND1 may regulate CRLs
in a cell cycle dependent
manner
• Other regulatory proteins
may be required to
facilitate CAND1 in
regulating CRLs
• CSN associated proteins,
such as kinases may mediate
important functions in the
CRL activation cycle, such as
the exchange of substrate-
receptor subunits.
•The deneddylating activity of
CSN may be important for
promoting its own
dissociation to allow
progression through the CRL
activation cycle.
Figure 1.5 Putative functions of CAND1 and CSN in regulating CRLs.
   Despite extensive efforts to characterize multiple aspects of the global regulatory 
mechanism of CRLs, there are unresolved questions on the roles of different interacting 
proteins in regulating CRL activity. In particularly, it is still not well characterized why
CAND1 is required for CRL activity in vivo. The role of CAND1 to promote the 
exchange of substrate recognition modules from CRLs remains to be elucidated. It is 
technically challenging to address this hypothesis as a robust cellular system is 
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fundamental to acutely measure exchange of different substrate recognition modules. In 
view of this, a CAND1 knockout cell line would be instrumental to provide extensive 
insights into the role of CAND1 in the regulation of CRLs. Hitherto there is still lack of 
prevailing evidence of what regulates the interaction between CAND1 and cullins. 
CAND1 binding to cullin proteins may be regulated by posttranslational modifications in
either of the proteins or by other interacting proteins. CAND1 binding may also be 
directly coupled to substrate ubiquitination. Lately, it has been reported that COMMD1 
(copper metabolism MURR1 domain-containing 1), a factor previously found to promote 
ubiquitination of various substrates, regulates CRL activation by displacing CAND1 from 
CRLs (Mao et al., 2011). However, the physiological relevance of COMMD1 dependent 
CRL regulation is currently unknown.
       With regards to the mechanism of action of Cif, we are still yet to understand how 
Cif-mediated ubiquitin deamidation leads to inhibiton of UPS-dependent substrate
proteolysis. Questions remain on whether deamidated ubiquitin is impaired in 
polyubiquitin chain formation or recognition by the 26S proteasome. Future in vitro and 
in vivo studies will be necessary to investigate these potential mechanisms and to 
understand in details how bacterial effector proteins employ diverse and unique 
biochemical strategies to modulate eukaryotic biological pathways.
      Together, the findings in these studies unveil several aspects of the mechanism 
involved in CRL regulation and potentially contribute to the understanding of underlying 
mechanisms vital for the modulation of CRLs by small molecule inhibitors in future.
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Abstract
Cullin RING ligases are multi-subunit complexes consisting of a cullin protein which forms a scaffold onto which the RING
protein Rbx1/2 and substrate receptor subunits assemble. CAND1, which binds to cullins that are not conjugated with
Nedd8 and not associated with substrate receptors, has been shown to function as a positive regulator of Cullin ligases in
vivo. Two models have been proposed to explain this requirement: (i) CAND1 sequesters cullin proteins and thus prevents
autoubiquitination of substrate receptors, and (ii) CAND1 is required to promote the exchange of bound substrate
receptors. Using mammalian cells, we show that CAND1 is predominantly cytoplasmically localized and that cullins are the
major CAND1 interacting proteins. However, only small amounts of CAND1 bind to Cul1 in cells, despite low basal levels of
Cul1 neddylation and approximately equal cytoplasmic endogenous protein concentrations of CAND1 and Cul1. Compared
to F-box protein substrate receptors, binding of CAND1 to Cul1 in vivo is weak. Furthermore, preventing binding of F-box
substrate receptors to Cul1 does not increase CAND1 binding. In conclusion, our study suggests that CAND1 does not
function by sequestering cullins in vivo to prevent substrate receptor autoubiquitination and is likely to regulate cullin RING
ligase activity via alternative mechanisms.
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Introduction
Cullin RING ligases are the largest family of cellular E3
ubiquitin ligases and control the stability of numerous cellular
substrates involved in the regulation of the cell cycle, transcription
and cell signaling. Cullin RING ligases are composed of one of 7
cullin homologues (in humans) which form a scaffold onto which
the RING domain containing protein Rbx1/Rbx2 assembles at
the cullin C-terminus [1,2]. At the N-terminus, cullin proteins bind
substrate receptor subunits, usually via an adaptor protein. For
instance, Cullin1 (Cul1) forms SCF (Skp1-Cul1-F-box) complexes,
in which Cul1 binds substrate receptors with a conserved F-box
via the adaptor protein Skp1. All F-box proteins have different
substrate binding domains which recruit ubiquitin ligase sub-
strates, usually in a manner dependent on substrate phosphory-
lation or other posttranslational modifications. All cullin RING
ligases require the modification with the ubiquitin like protein
Nedd8 at a conserved lysine residue at the cullin C-terminus for
full activity. Cullin neddylation is mediated by the Nedd8 specific
APP-BP1/Uba3 E1 activating and Ubc12 E2 conjugating
enzymes and is reversible via the action of the COP9 signalosome
(CSN) [3,4].
CAND1 is a cullin binding protein that only interacts with
cullins that are unneddylated and are not associated with adaptor
and substrate receptor subunits [5–8]. CAND1 is therefore
believed to sequester cullin proteins in an inactive state [1,2].
Nevertheless, loss of function studies in Arabidopsis have shown that
CAND1 is required for cullin RING ligase function in vivo [9–11].
Thus, CAND1 mutant plants show distinct phenotypes and
accumulation of cullin RING ligase substrates. Furthermore, a
recent study in C. elegans provided evidence that CAND1 is
required for the activity of a subset of Cullin RING E3 ligase
complexes [12]. How CAND1 regulates cullin RING ligase
activity is not well established. It has been hypothesized that by
preventing binding of substrate receptors to cullin proteins,
CAND1 prevents substrate receptor autoubiquitination in the
absence of bound E3 ligase substrate [1,2]. In support of this,
CAND1 knockdown results in reduced cellular concentrations of
the substrate receptor protein Skp2 [6,13]. Alternatively, it has
been proposed that cycles of CAND1 binding to and dissociation
from cullins promote substrate receptor exchange and binding of
substrate receptor subunits with lower affinity to Cul1 [14,15].
However, the exact mechanisms through which CAND1 regulates
cullin RING ligases remain to be identified. In this study, we
investigated the role of CAND1 in vivo. Our results argue against
a role of CAND1 in sequestering cullin proteins and preventing
substrate receptor autoubiquitination in mammalian cells. Our
data also suggest that the CAND1-Cul1 interaction is likely to
be highly regulated via mechanisms that are independent of
cullin neddylation and adaptor and substrate receptor subunit
binding.
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Methods
Plasmid constructs, mutagenesis and transfection of
HEK293 cells
HEK293 cells were obtained from ATCC. Human CAND1
cDNA, a kind gift from Dr. Jong-Bok Yoon (Yonsei University,
Korea), was PCR amplified using oligonucleotides which con-
tained KpnI and XbaI sites at the 59 and 39ends, respectively, and
the sequence encoding for a V5 tag at the 39end and cloned into
pcDNA3. For doubly tagged CAND1 constructs we used the same
strategy and inserted the PCR products into modified pcDNA3.1
or pcDNA4/TO including a 59 FLAG tag. All other plasmids were
as previously described [13,16]. Mutagenesis to generate the
K472E/R473E mutant Cul1 was carried out using the Stratagene
site-directed mutagenesis kit.
The T-Rex system (Invitrogen) was used to generate cell lines
with tetracycline-inducible expression of FLAG-CAND1-HA and
dominant-negative Cul1-V5 (dnCul1) and dominant-negative
Ubc12-HA (dnUbc12) according to the manufacturer’s instruc-
tions, as previously described [13,16]. For DNA transfections, sub-
confluent T-Rex-293 cells (Invitrogen) were transfected using
Genejuice (Novagen) according to the manufacturer’s instructions.
For transfection of recombinant protein, TurboFect (Fermentas)
was used according to the manufacturer’s instructions. To validate
the method, we transfected cells with recombinant GST fusion
protein in the presence or absence of the protein transfection agent
for two hours, followed by immunofluorescence staining for GST.
It was observed that strong intracellular GST staining in
approximately 50% of the cells was detectable, while no signal
was present when no transfection agent was included.
siRNA-mediated gene silencing
For siRNA transfections, RNAi Max Lipofectamine (Invitrogen)
was used as transfection agent according to the manufacturer’s
instructions with the following annealed Silencer predesigned
siRNA duplexes (Ambion) at a final concentrations of 20 nM:
CAND1: siRNA ID 27001 (CAND1 siRNA#1), 140585 (CAND1
siRNA#2), 27093 (CAND1 siRNA#3); CSN5: 214069 (CSN5
siRNA#1); Negative controls: Silencer Negative Control siRNA
#2. Cells were lysed three days after siRNA transfections for
Western blot analysis.
Immunoblotting
For immunoblotting, cells were washed with ice-cold PBS and
then lysed in triton X-100 containing lysis buffer, as previously
described [17]. Lysates were pre-cleared by centrifugation before
use for Western blotting. Equal amounts of protein were loaded
for Western blot analysis. The following antibodies were used:
monoclonal anti-p27 (610241; BD Biosciences), monoclonal anti-
Skp1 (H-6) (sc5281; Santa Cruz Biotechnology), goat polyclonal
anti-Skp2 (N-19) (sc1567; Santa Cruz Biotechnology), rabbit
polyclonal anti-CSN5 (ab12323; Abcam Ltd.), rabbit polyclonal
anti-Cul1 (40990547; Zymed Laboratories), goat polyclonal anti-
CAND1 (A-13) (sc-10672; Santa Cruz Biotechnology), goat
polyclonal anti-GST (27-4577-01; GE Healthcare), rabbit poly-
clonal anti-PARP (9542, Cell Signaling Technology), monoclonal
anti-GAPDH (G8140-04; US Biological), monoclonal anti-a-
tubulin (236–10501; Molecular Probes), monoclonal anti-V5
(Serotec), monoclonal anti-FLAG M2 (Sigma), rat monoclonal
anti-HA (clone 3F10) (Roche).
Immunoprecipitation
10 ml of Anti-FLAG M2 agarose (Sigma) or 2.5 mg of V5
antibody, coupled to 10 ml of protein G-sepharose (Amersham
Biosciences) was used for immunoprecipitations. 500 ml pre-
cleared lysate from HEK293 cells transfected in 60 mm tissue
culture plates was added. The samples were tumbled at 4uC for
2 hours and the agarose or sepharose beads were then washed four
times in 1 ml of cold buffer containing 50 mM Tris (pH 7.5), 0.5%
NP40, 5% glycerol, 0.5 mM EDTA, 50 mM NaCl and once in
buffer containing 50 mM Tris (pH 7.5). The immunoprecipitated
proteins were then denatured in SDS-sample buffer and subjected
to SDS-PAGE and Western blotting.
Immunofluorescence staining
For immunocytochemistry, cells were fixed using paraformal-
dehyde and, after permeabilization of cells with 0.1% triton X-100
and blocking with 5% normal goat serum, incubated with FLAG
antibody and secondary TRITC-conjugated anti-mouse IgG.
Nuclei were labelled using DAPI.
Preparation of nuclear and cytoplasmic protein fractions
HEK293 cells were lysed in hypotonic lysis buffer (containing
10 mM Tris, pH 7.5, 10 mM KCl, 1 mM EDTA, 1 mM EGTA,
0.1% b-mercaptoethanol and protease inhibitor cocktail (Roche)).
After incubation on ice for 20 min, cell lysates were subjected to a
freeze-thaw cycle and then centrifuged at 3,000 rpm. The
supernatant was used as cytoplasmic fraction. The pellet was
washed three times in phosphate-buffered saline followed by
extraction of nuclear proteins in high salt buffer (containing
20 mM Tris, pH 7.5, 420 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 25% glycerol, 0.1% b-mercaptoethanol and protease
inhibitor cocktail (Roche)).
Results
Cullin proteins are the major CAND1 binding proteins
To identify CAND1 interacting proteins, we generated a
HEK293 cell line with stable expression of N-terminally FLAG-
tagged CAND1 under a tetracycline-inducible promoter. As
shown in Fig. 1a, the FLAG-CAND1 in maximally induced cells
was slightly less abundant than endogenous CAND1 and hence
expressed at physiological concentrations. Cell lysates from
induced and control cells were used for FLAG-immunoaffinity
purification. When using triton X-100 containing lysis buffer, no
interacting proteins could be detected in Coomassie Blue stained
or silver stained SDS gels (data not shown). We then used
hypotonic lysis buffer to break the cells and keep weaker protein-
protein interactions intact. Using this approach, we detected a
number of bands with a molecular weight of around 85 kDa that
were not present in the control. Mass spectrometric analysis of
these bands revealed their identity as Cul1, Cul2, Cul3, and Cul5.
In addition to the cullin proteins, no other bands were detected
that were specific for the FLAG-CAND1 induced cells. This
suggests that cullin proteins are the major CAND1 interacting
proteins. The absence of Cul4a and Cul4b is most likely related to
their nuclear localization and the use of hypotonic lysis buffer with
which nuclear proteins are not extracted. The results also suggest
that a significant amount of CAND1 (and cullin proteins) is
localized in the cytoplasm (see below).
We next used coimmunoprecipitation to compare the interac-
tion of CAND1 with the various cullin protein homologues. To
this end, cells were transfected with C-terminally V5-tagged cullins
or empty vector and cell lysates subjected to V5 immunoprecip-
itation. Analysis of the V5 immunoprecipitates with CAND1
antibody revealed specific binding of endogenous CAND1 to all
cullin proteins, although the interaction with Cul5 was somewhat
weaker and the interaction with Cul2 markedly reduced compared
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to Cul1, Cul3 and Cul4a (Fig. 1c). In our previous study we found
that CAND1 interacts primarily with Cul1 [16]. However, here
we used NP-40 containing buffer in contrast to triton X-100 buffer
(which was used in the previous study) to wash the immunopre-
cipitates and also detected significant interactions with other
cullins, as shown in Fig. 1c. In further experiments, we focused on
the interaction between Cul1 and CAND1 for which strong
binding was detected.
Cul1 neddylation regulates the interaction between Cul1
and CAND1 in vivo
CAND1 is known to bind to unneddylated cullin proteins
[5,6,18]. To confirm that neddylation indeed regulates binding of
CAND1 in vivo, we generated a hyperneddylation mutant of mouse
Cul1 by mutating both Lys-472 and Arg-473 to Glu [5,19–21].
K472E/R473E mutant Cul1 displayed a significantly increased
level of Nedd8 modification (Fig. 2a). We hypothesized that the
increased neddylation of K472E/R473E mutant Cul1 is due to
reduced binding of the deneddylating CSN complex. We therefore
measured the binding of wild type and K472E/R473E mutant
Cul1 to the CSN5 subunit of the COP9 signalosome (CSN). As
shown in Fig. 2b, in contrast to wild type Cul1, no interaction of
CSN5 with K472E/R473E Cul1 could be detected, suggesting
that the increased neddylation of the Cul1 mutant is due to
reduced binding of CSN.
The K472E/R473E mutant Cul1 was then used to measure
binding of CAND1 by coimmunoprecipitation. Binding of
endogenous CAND1 to mutant Cul1 was significantly reduced
compared to wild type Cul1 (Fig. 2c). This result suggests that
increased Cul1 neddylation in vivo results in decreased CAND1
binding. Although we found in Fig. 2b that the increased
neddylation of K472E/R473E mutant Cul1 is due to reduced
CSN binding, it would also be possible that the increased
neddylation of the mutant is a consequence of reduced CAND1
binding, possibly due to a conformational change in the Cul1
protein. To rule out this possibility, neddylation of wild type and
Figure 1. Cullin proteins are the major CAND1 binding proteins. (a) Western blot analysis of two different clones of HEK293 cells with stable
expression of N-terminally FLAG-tagged and C-terminally HA-tagged CAND1 under a tetracycline-inducible promoter. Western blotting with CAND1
antibody indicates that the stably transfected CAND1 is expressed at physiological concentrations. (b) Cells harboring the stably transfected CAND1
were induced with 1 mg/ml of tetracycline for 24 hours. Control HEK 293 cells and tetracycline-induced cells were harvested and lysed with hypotonic
lysis buffer consisting of 25 mM Tris, 2 mM EDTA, 2 mM EGTA and complete protease inhibitor cocktail tablet (Roche). Lysates were subjected to
immunoprecipitation using anti-FLAG antibody to immunoprecipitate FLAG-CAND1-HA, immunoprecipitates were washed four times with 1X
phosphate buffer saline (1X PBS) and analyzed by SDS-PAGE and Coomassie blue staining. A number of bands with a molecular weight of around
85 kDa were detected that were not present in the control. Mass spectrometric analysis of these bands revealed their identity as Cul1 (score:173; 12
detected peptides), Cul2 (score: 200; 17 detected peptides), Cul3 (score:63; 2 detected peptides), and Cul5 (score:47; 2 detected peptides). (c) HEK293
cells were transfected in 60-mm cell culture plates for two days with V5-tagged expression constructs for the cullin homologs indicated at the top of
each panel. The cells were lysed, and the lysates were subjected to V5 immunoprecipitation, as described under Methods. Immunoprecipitates and
aliquots of the cell lysates were analyzed by Western blotting with the indicated antibodies.
doi:10.1371/journal.pone.0016071.g001
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K472E/R473E mutant Cul1 was inhibited. This was achieved by
using a cell line which expresses a tetracycline inducible dominant
negative Ubc12-HA (dnUbc12) (Fig. 2d) [13,22]. Induction of
dnUbc12 led to markedly reduced neddylation (compare lanes 8
and 9 with lanes 6 and 7 in Fig. 2d), although some neddylation
was still observed in the immunoprecipitated wild type and mutant
Cul1. When neddylation was inhibited, CAND1 binding to the
mutant Cul1 was no longer reduced compared to wild type. This
suggests that the K472E/R473E mutation does not interfere with
CAND1 binding per se, but that increased neddylation in vivo
reduces the CAND1-Cul1 interaction.
In order to further confirm these immunoprecipitation results,
which measure steady state interactions between Cul1 and
CAND1 in vivo, we used transfection of recombinant GST-
CAND1 protein into cells and measured binding to Cul1 one hour
after transfection using immunoprecipitation of Cul1-V5. As
shown in Fig. 2e, recombinant GST-CAND1 protein was only
present in cell lysates and V5 immunoprecipitates when the
protein transfection agent was included. Within one hour of
protein transfection, markedly less GST-CAND1 bound to
K472E/R473E mutant Cul1 compared to wild type Cul1
(compare lanes 4 and 2), thus confirming that increased
neddylation of Cul1 inhibits CAND1 binding in vivo.
CAND1 is unlikely to function to sequester all inactive
cullin proteins
The majority of cellular Cul1 is normally in the unneddylated
form which may be due to sequestration by CAND1. However,
siRNA-mediated knockdown of CAND1, which led to more than
90% CAND1 protein reduction, caused only a marginal increase
Figure 2. Neddylation regulates the interaction between Cul1 and CAND1 in vivo. (a) HEK293 cells were transfected with wild type or
K472E/R473E mutant Cul1-V5, followed by Western blotting with V5 antibody. (b–d) Lysates from cells transfected with wild type or mutant (K472E/
R473E) Cul1-V5 were subjected to immunoprecipitation using V5 antibody followed by Western blotting of lysates and immunoprecipitates with the
indicated antibodies. In (d) dnUbc12 tet-on cells were used for transfection and induced with 1 mg/ml tetracycline for 24 hours prior to cell lysis in
order to block Cul1 neddylation. (e) Cells were transfected in 60 mm dishes with 1 mg wild type or K472E/R473E mutant Cul1-V5 and 1.5 mg dnCul1-
V5 or empty vector, as indicated. After two days, all plates were transfected with 10 mg of recombinant GST-CAND1 in the presence or absence of
TurboFect protein transfection reagent. One hour after protein transfection, cells were rinsed and lysed and cell lysates subjected to V5
immunoprecipitation. The immunoprecioitates were analyzed by Western blotting with GST and V5 antibodies. As expected, no GST-CAND1 was
observed in cell lysate and V5 immunoprecipitates when no protein transfection agent was included (see lanes 5 and 10). When GST was transfected
into cells as a negative control, no binding to Cul1 could be observed (not shown).
doi:10.1371/journal.pone.0016071.g002
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in Cul1 neddylation (Fig. 3). This result suggests that the low basal
neddylation of cullins is not due to sequestration by CAND1. It is
possible that an increase in neddylation cannot be observed
because of high deneddylating activity of CSN. We therefore also
knocked down CSN5, which resulted in a greater increase in Cul1
neddylation. When CAND1 siRNA was cotransfected with CSN5
siRNA, an additive effect on Cul1 neddylation was observed.
These results suggest that CAND1 may play a role in sequestering
a certain amount, although not the majority of cellular Cul1.
To further test the hypothesis that CAND1 functions by binding
and sequestering non-active cullin proteins, we determined if such
a role of CAND1 would be compatible with the ratio of the
endogenous cellular CAND1 and Cul1 proteins. To compare the
relative expression of endogenous CAND1 and Cul1, we first
transfected and immunoprecipitated the proteins from cell lysate
using V5 antibody. The immunoprecpitated proteins, whose
expression could be directly compared using detection of the V5
tag, served as protein standards in Western blots to normalize the
endogenous cellular CAND1 and Cul1 amounts. For instance, as
shown in the CAND1 and Cul1 Western blots in the upper panel
of Fig. 4a, the CAND1 protein amount in the total HEK293 cell
lysate (lane 3) was similar compared to the CAND1 protein
standard (lane 2), whereas the Cul1 amount in the lysate (lane 3)
was slightly less than the Cul1 protein standard (lane 1). Direct
comparison of the CAND1 and Cul1 protein standards by V5
Western blot revealed similar amounts (lower panel in Fig. 4a). It
therefore follows that the endogenous CAND1 concentration is
slightly higher compared to the Cul1 concentration. This
experiment was repeated four times in HEK293 cells and a ratio
of CAND1 to Cul1 in total lysate of 1.33:1 was determined after
densitometry analysis (Fig. 4b). CAND1 and Cul1 were expressed
at somewhat similar ratios in HCT116 cells (1.99:1) and in HeLa
cells (0.74:1) (n = 2). We also separated HEK293 cells into nuclear
and cytoplasmic fractions and the purity of these fractions was
confirmed by Western blotting with PARP (nuclear marker) and
GAPDH (cytoplasmic marker) antibodies (Fig. 4c). The measured
ratios of CAND1 to Cul1 in the nucleus and cytoplasm were
0.32:1 and 1.25:1, respectively (Fig. 4a and b). Our results indicate
that the endogenous concentrations of CAND1 and Cul1 in the
cytoplasm are similar, while in the nucleus there is significantly less
CAND1 compared to Cul1. Given that CAND1 interacts with
various cullin homologues, it therefore appears unlikely that
CAND1 can function to sequester and inactivate all free cullin
proteins.
CAND1 is predominantly a cytoplasmic protein in
HEK293 cells
The experiments in Fig. 4 indicate a threefold lower ratio of the
CAND1 to Cul1 protein concentrations in the nucleus compared to
that in the cytoplasm. The different ratios are mainly due to a 2.9
fold lower concentration of CAND1 in the nucleus compared to the
cytoplasm [ratio of nuclear to cytoplasmic CAND1 =0.34:160.09
(n= 3)] (Fig. 5a). In contrast, the nuclear and cytoplasmic
concentration of Cul1 is approximately equal [ratio of nuclear to
cytoplasmic = 1.32:160.33 (n= 3)]. We also observed by Western
blotting that transiently transfected FLAG-CAND1-HA was almost
exclusively localized in the cytoplasm in HEK293 cells (Fig. 5a).
Consistent with higher expression of CAND1 in the cytoplasm,
stably transfected FLAG-CAND1-HA, stained with FLAG anti-
body, showed predominant cytoplasmic staining with very little
staining in the nucleus (Fig. 5b). The immunofluorescence results
with the transfected FLAG-CAND1-HA therefore substantiate the
Western blot results for endogenous CAND1. The predominant
presence of CAND1 in the cytoplasm suggests that the protein may
regulate Cullin Ring ligases differentially dependent on their
localization. It is also possible that the CAND1 subcellular
localization is subject to regulatory events.
Cul1 binds preferentially to substrate receptors
Cul1 can bind to Skp1 adaptor and substrate receptor subunits
and to CAND1 in a mutually exclusive manner [5–8]. To
determine with which interaction partner Cul1 associates
preferentially in vivo, we transfected cells with a plasmid encoding
Cul1 carrying an N-terminal FLAG and a C-terminal V5 tag. The
cells were co-transfected with V5-tagged CAND1 and b-TrCP or
Skp2 substrate receptors. FLAG antibody was then used to
immunoprecipiate Cul1 protein complexes. The FLAG-Cul1-V5
immunoprecipitates were analyzed in Western blots with V5
antibody to directly compare the amounts of Cul1, CAND1, b-
TrCP and Skp2 in the Cul1 complex. Although CAND1 and b-
TrCP were expressed at approximately equal amounts in the cell
lysate, much more binding of b-TrCP to Cul1 was observed
compared to CAND1 (see lane 4 of the total cell lysates and lane 4
of the FLAG immunoprecipitates in Fig. 6). Transfected Skp2 was
expressed at higher concentrations. When comparing the ratio of
Skp2 in the FLAG-immunopreciptates to that in the lysate, a
marked enrichment of Skp2 protein was seen in the immunopre-
cipitates compared to CAND1 (compare the rations of Skp2 and
CAND1 between lane 2 of the FLAG immunoprecipitates and
lane 3 of the lysates). The enrichment of Skp2 in the
Figure 3. Effect of CAND1 and CSN5 knockdown on Cul1
neddylation. Cells were transfected with siRNA targeting CAND1 or
CSN5 for three days, as described under Methods. In lanes 2 to 4, 20 nM
of individual siRNA was transfected. In lane 5, 10 nM of each CAND1
and CSN5 siRNA and in lane 6, 20 nM of both siRNAs was used. Cul1
neddylation was assessed by Western blotting with Cul1 antibody.
Densitometry analysis of the ratio of neddylated to unneddylated Cul1
is presented in the lower panel which is derived from two independent
experiments which showed very similar trends.
doi:10.1371/journal.pone.0016071.g003
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immunoprecipiates compared to lysate was smaller than that
observed for b-TrCP, which is likely due to the higher basal
expression of Skp2 and saturation of Cul1 binding sites. When
CAND1, b-TrCP and Skp2 were transfected in the absence of
Cul1, none of the proteins was detected in the FLAG
immunoprecipitates, confirming the specificity of the assay (see
lane 2 of the lysates and lane 3 of the FLAG immunoprecipitates).
Given the predominant localization of CAND1 in the cytoplasm,
we also performed analogous experiments using cytoplasmic
cellular fractions. Similarly to the total cell lysate, strong binding
of both b-TrCP and Skp2 to Cul1 was observed while specific
binding of CAND1 to Cul1 was low or undetectable (data not
shown). Taken together, the results in Fig. 6 suggest that under in
vivo conditions the substrate receptor proteins bind much stronger
to Cul1 compared to CAND1. Our results are consistent with data
published by Bornstein et al. [23], who showed that Skp2–Skp1
promotes the dissociation of CAND1 from Cul1 in vitro.
Inhibiting binding of adaptor and substrate receptor
subunits to Cul1 fails to increase CAND1 binding
If CAND1 were to function by sequestering inactive cullin
proteins, it would be expected that CAND1 association with Cul1
increases when binding of Skp1 and substrate receptor proteins is
prevented. To test this prediction, we used a stably transfected cell
line with tetracycline inducible expression of dominant-negative
Cul1 (dnCul1) [16]. dnCul1 lacks the C-terminus and is therefore
unable to interact with CAND1. When induced, dnCul1 competes
with full length Cul1 for binding to Skp1 and substrate receptor
subunits. Thus, as shown in Fig. 7a, binding of endogenous Skp1
and Skp2 to full length Cul1 is abolished after addition of
tetracycline to cells for 24 hours. Because substrate binding is a
requirement for efficient cullin neddylation [16,23], full length
Cul1 also exhibits markedly reduced conjugation with Nedd8.
Despite dissociation of Skp1 adaptor and substrate receptor from
full length Cul1 and reduced neddylation, CAND1 binding to full
length Cul1 did not increase, but actually exhibited a slight
decrease. We also ruled out that the effect of dnCul1 is due to
direct interaction with CAND1. As shown in Fig. 7b, only full
length Cul1, but not dnCul1, interacted with CAND1. Similarly to
the in vivo experiment in Fig. 7a, when using transfection of
recombinant GST-CAND1 protein for one hour, reduced binding
of CAND1 was observed in the presence of dnCul1 to inhibit
binding of substrate receptor subunits (Fig. 2e).
As an alternative approach to decrease Skp1 and substrate
receptor subunit binding to Cul1, we used siRNA silencing to
knock down Skp1. As shown in Fig. 7c, Skp1 in the cell lysate was
undetectable in cells transfected with Skp1 siRNA, but not with
negative control siRNA. Some Skp1 protein was still bound to
Cul1 in the immunoprecipitates, although much less compared to
untransfected or negative control siRNA transfected cells.
Knockdown of Skp1 also did not increase CAND1 binding to
Cul1 (Fig. 7c). Thus, taken together, these results provide further
evidence that CAND1 does not function by binding and
sequestering inactive cullin proteins, but suggests that CAND1
binding to cullin proteins in vivo is regulated via other mechanisms.
Discussion
CAND1 is an important regulator of cullin RING ligases.
Although the interaction of CAND1 with cullin proteins, in
particular with Cul1, and its consequences have been well
characterized in structural and in vitro studies [18], the exact role
of CAND1 in regulating E3 ligase activity in vivo is still unknown
[1,2]. According to one proposed model, CAND1 functions by
binding to and inactivating of cullin proteins in the absence of
ubiquitination substrates. This is believed to prevent autoubiqui-
tination of substrate receptor subunits. In a different model,
dynamic association and dissociation cycles of CAND1 with cullin
proteins promote the exchange of substrate receptor subunits. In
this study, we present a number of findings which suggest that
CAND1 is unlikely to sequester all inactive, non-substrate bound
cullin proteins. Thus, the ratio of endogenous CAND1 and Cul1
protein is likely to be too low, especially in the nucleus, for
Figure 4. Cellular ratio of endogenous CAND1 and Cul1
proteins. (a,b) To compare cellular CAND1 and Cul1 protein
expression, transfected and immunoprecipitated Cul1-V5 (lane 1 and
CAND1-V5 (lane 2) were used as protein standards. Endogenous
amounts of CAND1 and Cul1 protein in total lysate, nuclear and
cytoplasmic fractions was measured in Western blots and compared to
the respective protein standards by densitometry. Direct comparison of
the two protein standards by Western blotting with V5 antibody (lower
panel in (a)) allowed for calculation of the ratios of endogenous CAND1
to Cul1. Densitometry measurements from four independent experi-
ments gave the means and S.E.M. values presented in (b). (c) The purity
of the nuclear and cytoplasmic fractions, which were prepared as
described under Methods, was confirmed by Western blotting with
PARP and GAPDH antibodies.
doi:10.1371/journal.pone.0016071.g004
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CAND1 to associate with all cellular non-substrate bound cullin
proteins. Furthermore, CAND1 binding to Cul1 in vivo is much
weaker compared to binding of substrate receptors. It should be
noted that one alternative explanation is also that the different
apparent binding affinities of CAND1 and substrate receptors for
Cul1 are a consequence of other factors, such as different cellular
Figure 5. Nuclear and cytoplasmic distribution of CAND1. (a) In the left panel, untransfected HEK293 cells were fractionated into nuclear and
cytoplasmic fractions as described under Methods. Equal amounts of total, nuclear and cytoplasmic proteins were loaded onto SDS gels and analyzed
by Western blotting using CAND1 and Cul1 antibodies. The results shown are representative of three independent experiments. To quantify the ratio
of nuclear versus cytoplasmic proteins, densitometry analysis was carried out and the results are mentioned in the text. In the right panel, cells were
transiently transfected with FLAG-CAND1-HA, followed by preparation of nuclear and cytoplasmic fractions and Western blotting using the indicated
antibodies. (b) Immunofluorescence staining of transfected HEK293 cells was carried out using FLAG antibody, as described under Methods.
doi:10.1371/journal.pone.0016071.g005
Figure 6. Cul1 binds preferentially to substrate receptors. HEK293 cells were cotransfected with the indicated plasmids. Cell lysates were used
for immunoprecipitation with FLAG antibody followed by Western blotting.
doi:10.1371/journal.pone.0016071.g006
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localization of CAND1 and substrate receptor subunits or binding
to and sequestration by other proteins. Finally, we found that
preventing binding of adaptor and substrate receptor subunits to
Cul1 (by overexpressing dominant negative Cul1 or silencing
Skp1) does not increase CAND1 binding. These results suggest
that CAND1 binding to cullin proteins may be highly regulated
via mechanisms that are different from competition with adaptor
and substrate receptor subunits for cullin proteins.
Given that CAND1 binds only non-Nedd8 conjugated cullin
proteins, cullin neddylation could be an important regulator of
CAND1 binding. Indeed, we observed that increased neddylation
of Cul1 in vivo in the K472E/R473E Cul1 mutant results in
decreased CAND1 binding (see Fig. 2). The increased neddylation
in the K472E/R473E Cul1 mutant, which leads to the disruption
of a buried salt bridge in the four-helix bundle domain of Cul1
[24], is likely a result of reduced binding of the deneddylating CSN
Figure 7. Inhibiting binding of substrate receptors fails to increase CAND1 binding. (a) dnCul1 tet-on cells were transfected with full
length Cul1-FLAG as indicated and dnCul1-V5 expression was induced by adding 1 mg/ml tetracycline during the last 24 hours before cell lysis. Cell
lysates were subjected to FLAG immunoprecipitation and Western blotting with the indicated antibodies. (b) Cells were transfected with full length
Cul1-V5 or dnCul1-V5, as indicated, followed by V5 immunoprecipitation and Western blotting of immunoprecipitates and cell lysates with CAND1
and V5 antibodies. (c) Cells were transfected for three days with negative control or Skp1 siRNA (20 nM) and for the last two days with Cul1-FLAG
plasmid as indicated. FLAG immunoprecpitation was then carried out followed by Western blotting with the indicated antibodies. The band labeled
with NS in the CAND1 blot corresponds to a non-specific band.
doi:10.1371/journal.pone.0016071.g007
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complex (see Fig. 2b). Indeed, the four-helix bundle has been
reported to be required for binding of CSN to Cul1 [25]. Our
results in Fig. 2d indicate that the K472E/R473E mutation per se
does not inhibit CAND1 binding, but that decreased CAND1
binding is due to the increased neddylation levels. On the other
hand, normal neddylation levels of all cullin proteins are relatively
low, and yet, binding of CAND1 to Cul1 under basal conditions is
weak. Furthermore, inhibiting neddylation by expressing a
dominant negative form of Ubc12 does not increase CAND1
binding (data not shown). Thus, factors other than neddylation are
important in the regulation of the CAND1-Cul1 interaction.
Given the limited role of substrate receptor binding and
neddylation in regulating the CAND1-Cul1 association in vivo, it
is likely that the interaction between the two proteins is regulated
by other mechanisms. For instance, CAND1 binding to cullin
proteins may be regulated by posttranslational modifications in
either of the proteins or by other interacting proteins. CAND1
binding may also be directly coupled to substrate ubiquitination.
Future in vitro and in vivo studies will be necessary to investigate
these potential mechanisms and to understand how CAND1
regulates cullin RING E3 ligases.
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Cullin RING ligases (CRLs) constitute the largest family of ubiquitin ligases
with diverse cellular functions. Conjugation of the ubiquitin-like molecule
Nedd8 to a conserved lysine residue on the cullin scaffold is essential for the
activity of CRLs. Using structural studies and in vitro assays, it has been
demonstrated that neddylation stimulates CRL activity through conforma-
tional rearrangement of the cullin C-terminal winged-helix B domain and
Rbx1 RING subdomain from a closed architecture to an open and dynamic
structure, thus promoting ubiquitin transfer onto the substrate. Here, we
tested whether the proposed mechanism operates in vivo in intact cells and
applies to other CRL family members. To inhibit cellular neddylation, we
used a cell line with tetracycline-inducible expression of a dominant-
negative form of the Nedd8 E2 enzyme or treatment of cells with the
Nedd8 E1 inhibitor MLN4924. Using these cellular systems, we show that
different mutants of Cul2 and Cul3 and of Rbx1 that confer increased Rbx1
flexibility mimic neddylation and rescue CRL activity in intact cells. Our
findings indicate that in vivo neddylation functions by inducing
conformational changes in the C-terminal domain of Cul2 and Cul3 that
free the RING domain of Rbx1 and bridge the gap for ubiquitin transfer
onto the substrate.
© 2011 Elsevier Ltd. All rights reserved.
Introduction
The cullin really interesting new gene (RING)
ubiquitin E3 ligases [cullin RING ligases (CRLs)]
constitute the largest family of E3 ubiquitin ligases
that mediate the ubiquitination of cellular proteins in
diverse biological processes including cell cycle
transition, signaling and transcriptional regulation.
These RING domain-containing ligases function by
binding the substrate through a protein–protein
interaction domain and the E2 enzyme through the
RING motif, thus playing an important role in
bridging the ubiquitin-charged E2 and substrates
into close proximity to facilitate the transfer of
ubiquitin from E2 to the substrate. The mammalian
genome encodes for six distinct cullin homologs (i.e.,
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Cul1, Cul2, Cul3, Cul4a, Cul4b and Cul5). CRLs are
composed of several subunits. The cullin homologs
serve as a scaffold that functions by binding the
RING domain-containing protein, Roc1/Rbx1, via
its C-terminus. Rbx1 facilitates the recruitment of the
E2 to the complex. The N-terminus of cullin proteins
serves as a docking site for binding of different
substrate recognition subunits, which only recognize
and recruit specific substrate proteins. This confers
substrate specificity to individual ligases. Specific
adaptor proteins are required to bridge the binding
of the various substrate recognition subunits with
the cullin homologs (except in the case of Cul3).1,2
For instance, the adaptor protein Skp1 links the N-
terminus of Cul1 to various F-box domain containing
substrate recognition subunits, thus forming the SCF
(Skp1–Cullin–F-box) ubiquitin ligase, whereas cullin
2 and cullin 5 bind to the substrate recognition
subunit von Hippel–Lindau (VHL) or to different
suppressor of cytokine signaling proteins, respec-
tively, via the adaptor proteins elongin B and C. In
contrast, Cul3 is known to bind directly to substrate
recognition subunits via their bric-a-brac, tramtrack,
broad complex domain. In addition to the cullin
homolog specific binding domains, all of the
substrate recognition subunits contain specific sub-
strate binding domains that are responsible for
substrate recruitment, often in a manner that is
dependent on substrate posttranslational modifica-
tions, such as phosphorylation.
Despite their considerable diversity, each of the
classes of CRL complexes is subject to similar
regulatory mechanisms. In particular, all cullin-
based ubiquitin ligases are covalently modified
with the ubiquitin-like protein Nedd8. Nedd8
conjugation (neddylation) occurs in a fashion anal-
ogous to ubiquitination in which Nedd8 is first
activated in an ATP-dependent manner by the
Nedd8 E1 APPBP1-Uba3 heterodimeric enzyme,
followed by the transfer of the activated Nedd8 to
the Nedd8 E2 conjugating enzyme Ubc12,3 which in
turns attaches the Nedd8 polypeptide to a conserved
lysine residue at the cullin C-terminus. Neddylation
is required for CRL activity in vivo and for prevent-
ing the CRL inhibitor cullin-associated neddylation-
dissociated 1 (CAND1) from binding to the E3
scaffold. It has been suggested that Nedd8 stimu-
lates CRLs by recruiting E2 ubiquitin conjugating
enzyme to the ligase complex and stimulating
polyubiquitin chain assembly.4
In a model of ubiquitin-charged E2 docked to
the Rbx1 RING domain, an approximately 50-Ǻ
gap was predicted between the E2 enzyme
catalytic site cysteine residue and the acceptor
lysine in the target substrate. This raised the
question of how ubiquitin is transferred to target
proteins. Furthermore, the distance between E2
catalytic site and substrate is expected to vary
during polyubiquitin chain elongation. Recent
biochemical and structural studies have provided
evidence for an important role of Nedd8 conjuga-
tion of cullins to facilitate ubiquitin transfer. Saha
and Deshaies performed a detailed enzymatic
study of the SCF complex in a reconstituted
system and found that neddylation stimulates
SCF activity by bridging the 50-Ǻ gap between
substrate and ubiquitin-charged E2 bound to
Rbx1.5 In addition, crystal structure determination
of the Nedd8-conjugated Cul5/Rbx1 complex by
Duda et al. demonstrated that neddylation induces
a drastic conformational change in the Cul5
C-terminal winged-helix B (WHB) domain and
eliminates a binding site for the CRL inhibitor
CAND1.6 As a consequence, the RING domain of
Rbx1 partially dissociates from Cul5 and is free to
adopt multiple conformations, thus conferring
favorable catalytic geometries for ubiquitin trans-
fer. This mechanism is further substantiated by an
in vitro study by Yamoah et al.7 These authors
deleted the WHB domain from Cul1, thus inducing
partial dissociation and, hence, flexibility of Rbx1.
The Cul1 C-terminally truncated ligase was shown
to be active in the absence of neddylation in vitro.
However, it is currently unknown whether this
mechanism also operates in a cellular system and
applies to other CRLs.
In the present study, we tested whether the
proposed mechanism of Nedd8-induced conforma-
tional control operates in a cellular system. In
addition, we determined whether neddylation also
regulates other members of the CRL family via a
similar mechanism.
Fig. 1. Cul2 and Cul3 with ECTD deletions form CRL complexes in vivo. (a) Sequence alignment of the deleted ECTD of
human Cul1, Cul2, Cul3, Cul4a, Cul4b and Cul5 using the ClustalW program (⁎, identical; :, conserved; ., semi-
conserved). The deleted sequences of human Cul1, Cul2, Cu3, Cu4a, Cu4b and Cu5 ECTDs are highlighted in green. (b
and c) The stably expressed dnUbc12 (dnUbc12-HA) cells under control of a tetracycline-inducible promoter were
cotransfected with Cul2-V5 and Cul3-V5 for 24 h, followed by either 1 μg/ml tetracycline treatment for 18 h or treatment
of the cells with 3 μM MLN4924 for 4 h, where indicated, to inhibit intact cellular neddylation. (d) HEK293T cells were
transfected in 60-mm cell culture plates for 2 days with expression constructs for the proteins indicated at the top of each
panel. The cells were lysed, and the lysates were subjected to V5 immunoprecipitation (IP), as described under Materials
and Methods. Immunoprecipitates and aliquots of the cell lysates were analyzed by Western blotting with the indicated
antibodies. Both the Cul2 and Cul3 ECTD deletion mutants bind to their substrate adaptors, VHL and Keap1,
respectively, to the same extent as WT Cul2 and Cul3.
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Results
Deletion of the Cul2 and Cul3 extreme C-terminal
domains rescues substrate ubiquitination in a
cellular system with inhibited cellular
neddylation pathway
To characterize the mechanistic features of
neddylation-induced conformational control of
CRL activity in an intact cellular system, we carried
out experiments under conditions in which the
cellular neddylation pathway has been inactivated.
We performed a sequence alignment of human
Cul1, Cul2, Cul3, Cul4a, Cul4b and Cul5 (Fig. 1a)
and deleted the extreme C-terminal domains
(ECTDs) of Cul2 and Cul3 at an analogous position
as described for Cul1.7 Into this system, we intro-
duced ECTD deletion mutants that confer increased
Rbx1 flexibility and determined their ability to
overcome the requirement of Nedd8 modification
for CRLs activity.7 To inhibit neddylation,we utilized
a human embryonic kidney (HEK)293 cell line that
expresses a tetracycline-inducible, dominant-
negative form of the Nedd8 E2 Ubc12-HA [domi-
nant-negative Ubc12 (dnUbc12)].8 The dnUbc12 that
harbors a point mutation of the active-site cysteine
residue (C111S) has been reported to exert a
dominant-negative effect on the neddylation conju-
gation cascade, leading to inhibition of CRL-mediated
substrate ubiquitination.9 To confirm that the induc-
tion of dnUbc12 can efficiently inhibit cullin neddyla-
tion, we induced the expression of dnUbc12 with
tetracycline for 18 h, and the expression of unconju-
gated as well as covalently Nedd8-conjugated C111S
Ubc12-HA8,9 was observed.As shown in Fig. 1b and c
(lane 3), this resulted in a dramatic decrease of the
Nedd8-conjugated Cul2 and Cul3.
Using this system, we then determined the ability
of the ECTD deletion mutants to rescue the
neddylation defect. Prior to this, we first set out to
verify that these neddylation-mimicking ECTD
deletion mutants still retain the ability to form
CRL complexes. To this end, HEK293T cells were
cotransfected with the corresponding expression
constructs, followed by immunoprecipitation using
an anti-V5 antibody. As shown in Fig. 1d, VHL and
Keap1 coimmunoprecipitated with both wild-type
(WT) and ECTD deletions of Cul2 and Cul3 [Cul2(1–
697 aa) and Cul3(1–720 aa)], respectively. The RING
domain-containing protein Rbx1 was also found to
Fig. 2. Deletion of the Cul2 and Cul3 ECTDs rescues
cellular substrate ubiquitination with inhibited neddyla-
tion pathway. (a and b) Cells with stable expression of
dnUbc12 under control of a tetracycline-inducible pro-
moter were transfected for 2 days with expression
constructs for the proteins indicated at the top of each
panel, followed by 1 μg/ml tetracycline treatment for 18 h,
where indicated. Equal amounts of cell lysates were
subjected to SDS-PAGE and analyzed byWestern blotting
with the indicated antibodies. [MG132 (20 μM) was
administered to cells for 4 h to reverse the effect of cullin
ECTD deletion-mediated decrease in steady-state level of
substrates in subsequent experiments as indicated, unless
otherwise stated.] Both endogenous and transfected WT
and ECTD mutant Cul3 could be detected in the Cul3 blot
in (b). This enabled us to compare the expression levels by
densitometry, as described in the text.
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interact with the WT and ECTD deletions of Cul2
and Cul3 to the same extent (data not shown),
indicating that truncation of the ECTDs of Cul2 and
Cul3 does not interfere with the ability of cullins as
scaffold proteins to form CRL complexes.
Subsequently, we transfected dnUbc12 cells with
either empty vector, WT Cul2 and Cul3 or the
neddylation-mimicking ECTD deletion mutants of
Cul2 and Cul3 [Cul2(1–697 aa) and Cul3(1–720 aa)].
Twenty-four hours posttransfection, dnUbc12 ex-
pression was induced with tetracycline for a further
24 h. As expected, addition of tetracycline resulted
in the expression of unconjugated as well as
covalently Nedd8-conjugated C111S Ubc12-HA
(Fig. 2a and b).8,9 Induced dnUbc12 was highly
effective in increasing the steady-state concentra-
tions of endogenous Cul2 and Cul3 substrates,
hypoxia-inducible factor-1 α (HIF-1α) and nuclear
factor erythroid 2-related factor 2 (Nrf2), respective-
ly, as shown in lane 2 in Fig. 2a and b. Transfection
of WT Cul2 and Cul3 failed to rescue HIF-1α and
Nrf2 ubiquitination (lane 4, Fig. 2a and b). This
result was expected as WT cullin containing CRLs
are inactive if neddylation is inhibited. In contrast,
introducing the neddylation-mimicking ECTD de-
letion mutants of Cul2 and Cul3 resulted in rescue of
substrates ubiquitination under conditions where
the neddylation pathway is inactive. This is dem-
onstrated by decreased steady-state concentrations
of HIF-1α and Nrf2 when Cul2(1–697 aa) and Cul3
(1–720 aa) were transfected into cells (lane 5, Fig. 2a
and b). The decreased steady-state concentrations of
HIF-1α and Nrf2 mediated by ECTD deletions of
Cul2 and Cul3 were reversible by addition of the
proteasome inhibitor MG132 (lane 6, Fig. 2a and b).
This suggests that the effects of the Cul2 and Cul3
ECTD deletion mutants were indeed due to the
induction of substrate ubiquitination and degrada-
tion. In contrast to Nrf2 concentrations, HIF-1α
steady-state levels were shown to remain
unchanged upon transfection of the Cul3 ECTD
mutant, confirming that the observed effects are
specific. The expression of endogenous, as well as
WT, and ECTD deletion of Cul3 (as detected with
anti-Cul3 antibody, see Cul3 blot in Fig. 2b) was
quantified using densitometry and ImageJ software.
Transfected WT and Cul3(1–720 aa) were found to
be expressed 2.0-fold and 2.1-fold, respectively,
higher compared to endogenous Cul3, suggesting
that significant overexpression of ECTD mutants
was achieved to overcome the effect of inhibi-
tion of Cul3 neddylation. To evaluate the efficiency
of transient transfection in these experiments,
we cotransfected plasmid encoding eGFP into
HEK293T cells and found transfection efficiency to
be 70–80% by immunofluorescence microscopy
(data not shown). In summary, in agreement with
previous structural and in vitro findings, these
results suggest that deletions of Cul2 and Cul3
ECTDs resulted in conformational rearrangement
of the cullin scaffold, thus conferring multiple
catalytic geometries for the ligases to overcome
inhibition of the neddylation pathway by facilitat-
ing ubiquitin transfer to its bound substrates.
ECTD deletions of Cul2 and Cul3 overcome the
inhibitory effect of Nedd8-activating enzyme
inhibitor, MLN4924
To further substantiate whether the proposed
neddylation-induced conformational regulation of
CRLs activity operates in vivo, the cellular neddyla-
tion pathway was inhibited by administration of the
potent and selective NAE inhibitor, MLN4924. This
compound has been shown previously to inhibit
NAE pathway function in cells and to disrupt CRL-
mediated protein turnover, which results in apo-
ptotic death in human tumor cells via the deregu-
lation of the prereplication complex.10 As shown in
Fig. 1b and c, lane 4, the treatment of HEK293T
cells with 3 μM MLN4924 for 4 h efficiently inhibits
cullin neddylation. HEK293T cells were transfected
with either empty vector, WT Cul2 and Cul3 or Cul2
(1–697 aa) and Cul3(1–720 aa). Twenty-four hours
posttransfection, cells were treated with MLN4924
at 3 μM for 4 h to inhibit neddylation. As shown in
Fig. 2a and b, treatment of cells withMLN4924 led to
the protein accumulation of Cul2 and Cul3 sub-
strates, HIF-1α and Nrf2, respectively (lanes 2, 4 and
6 in Fig. 3a and b). This suggests that, at the
administrated dose, MLN4924 inhibits the neddyla-
tion conjugation pathway, leading to prevention of
CRL-induced turnover of its target proteins. Over-
expression of WT Cul2 and Cul3 in MLN4924-
treated cells did not result in decreased abundance
of HIF-1α and Nrf2 substrate proteins compared to
cells transfected with empty vector (compare lane
4 with lane 2 in Fig. 3a and b), indicating that WT
cullins failed to overcome the inhibitory effect on the
neddylation cascade byMLN4924. In contrast toWT
cullins, when ECTD deletions of Cul2 and Cul3 were
overexpressed in MLN4924-treated cells, these
neddylation-mimicking cullin mutants were able to
overcome the inhibitory effect of MLN4924. The
steady-state concentration of HIF-1α was reduced
compared to that of WT Cul2-overexpressing cells
(lane 5 in Fig. 3a), and this observation was rever-
sible upon addition of MG132. A similar result was
also observed for Nrf2 in Cul3(1–720 aa)-expressing
cells. The steady-state concentration of Nrf2 in cells
treated with MLN4924 was reduced to a level
similar to that in untreated cells (lane 5 in Fig. 3b).
These results indicate that ECTD deletion of cullins
confers favorable catalytic activity for the ligases to
catalyze ubiquitination reaction in vivo, leading to
degradation of their target substrates even when the
neddylation pathway has been inactivated. There-
fore, our findings suggest that neddylation-induced
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conformation regulation of CRLs activity indeed
operates in intact cells and applies to other CRL
family members.
The inability of WT cullins to overcome the
inhibitory effect of Nedd8-conjugation
pathway inactivation is independent of
cullin–CAND1 binding
An important factor regulating CRL function is
CAND1. In the crystal structure of the CAND1–
Cul1–Rbx1 ternary complex, CAND1 was shown to
bind Cul1 in a head-to-tail fashion. The N-terminus
of CAND1 binds to the Cul1 C-terminus, preventing
access of Nedd8 to the conserved lysine residue on
Cul1, whereas the C-terminus of CAND1 binds to
Cul1 N-terminus, precluding binding of the adaptor
Skp1 and substrate recognition subunits.11 Hence,
CAND1 binding to cullin leads to inhibition of
substrate ubiquitination. Therefore, it is possible
that the observed ability of the mutant, but not of the
WT cullins, to induce substrate ubiquitination is due
to the lack of CAND1 binding of the ECTD mutant
cullin. Using immunoprecipitation of transfected
WT and ECTD deletion mutants of Cul2 and Cul3,
we indeed found that only WT, but not the
truncations of Cul2 and Cul3, interacts with
CAND1 (Fig. 4a). Thus, the differential effects of
WT cullins and ECTD deletion mutants to rescue
substrate ubiquitination might be due to differences
in CAND1 binding. To address this possibility, we
used small interfering RNA (siRNA)-mediated gene
silencing to knock down cellular CAND1. The cells
were then transfected with empty vector, WT cullins
and ECTD deletion mutants of cullins, followed by
inhibition of the neddylation cascade by MLN4924
as in previous experiments. It can be observed that
even upon siRNA-mediated knockdown of CAND1,
which led to more than 90% CAND1 protein
reduction, only the ECTD deletion mutants of Cul2
and Cul3, but not the WT proteins, were able to
overcome the inhibitory effect of MLN4924 on HIF-
1α and Nrf2 ubiquitination, respectively (compare
lane 7 with lane 5; Fig. 4b and c).
Rbx1 linker flexibility is sufficient to overcome the
inactivation of the Nedd8-conjugation pathway
Cullin neddylation can induce flexible positioning
of the Rbx1 RING domain, thus contributing to
multiple catalytic geometries for CRL catalysis of
ubiquitin transfer and chain elongation. Based on
modeling catalytic complexes, Duda et al. designed
deletions and insertions at Rbx1 Val38–Val39 to
probe roles of linker positioning and flexibility.6
These authors showed that introducing Val inser-
tion mutations had deleterious effects on substrate
polyubiquitination, whereas Gly insertions would
accommodate rotation of the RING domain into a
range of conformations. Based on the reported
structural and in vitro studies, it was hypothesized
that, upon introduction of the flexible linker inser-
tion, the RING domain of Rbx1 can adopt flexible
geometries that would mimic the neddylation-
induced conformational rearrangement to promote
substrate ubiquitination. This has been confirmed
experimentally using an in vitro system.6 We
sought to examine whether, under conditions in
which the intact cellular Nedd8-conjugation path-
way has been inactivated, a flexible RING domain
Fig. 3. ECTD deletions of Cul2 and Cul3 overcome the
inhibitory effect of MLN4924. HEK293T cells were
transfected with (a) WT Cul2-V5, Cul2(1–697 aa)-V5 and
empty vector; (b) WT Cul3-V5, Cul3(1–720 aa)-V5 and
empty vector for 24 h. Prior to lysis, cells were treated with
dimethyl sulfoxide (DMSO) as vehicle control or with
3 μM MLN4924 for 4 h to inhibit the intact cellular
neddylation pathway, where indicated. Equal amounts of
cell lysates were then prepared and subjected to Western
blot analysis with the indicated antibodies.
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mutant of Rbx1 would act to overcome the
inhibition of the neddylation cascade. We therefore
generated a triple Gly insertion mutant of Rbx1
after residue Val39 of the linker (Rbx1+3G). As
shown in Fig. 4a and b, tetracycline-induced expres-
sion of dnUbc12 or treatment of cells with 3 μM
Fig. 4. The inability of WT cullins to overcome the Nedd8-conjugation pathway inactivation is independent of cullin–
CAND1 binding. (a) HEK293 cells were transfected with Cul2-V5, Cul2(1–740 aa)-V5, Cul2(1–697 aa)-V5, Cul3-V5, Cul3
(1–763 aa)-V5 or Cul3(1–720 aa)-V5, as indicated, followed by immunoprecipitation (IP) of cell lysates with V5 antibody,
as described under Materials and Methods. Immunoprecipitates were then analyzed for coimmunoprecipitating
endogenous CAND1 by Western blotting (WB). Both the Cul2 and Cul3 ECTD deletion mutants showed markedly
reduced CAND1 binding. Given the high conservation of the last five C-terminal residues among all cullin orthologs and
paralogs, we also determined their role in CAND1 binding. Similar to the ECTD mutants, truncations of Cul2 and Cul3
lacking the last five amino acids were also deficient in CAND1 binding, suggesting that these residues are important for
CAND1 interaction or for conformational control of the cullin protein. (b) HEK293T cells were transfected with 25 nM
MDM2 siRNA as negative control or CAND1 siRNA for 3 days and cotransfected with expression constructs for WT
Cul2-V5, Cul2(1–697 aa)-V5 and empty vector; (c) WT Cul3-V5, Cul3(1–720 aa)-V5 and empty vector as indicated for the
last 2 days. To inhibit cellular neddylation, cells were treated with DMSO as vehicle control or with 3 μMMLN4924 for 4 h
prior to lysis. The cell lysates were used for Western blotting with the indicated antibodies. An asterisk (⁎) indicates a
nonspecific band associated with anti-Nrf2.
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MLN4924 for 4 h was used to inhibit the intact
neddylation cascade. Accumulation of cullin sub-
strates such as HIF-1α or Nrf2 was evident upon
inhibition of the neddylation pathway. BothWT and
Gly insertion mutant of Rbx1 (Rbx1+3G) were
overexpressed to determine if the neddylation
inhibitory effect can be rescued. However, only
overexpression of Rbx1+3G, but not of WT Rbx1,
exhibited a marked decrease in the steady-state level
ofHIF-1α andNrf2, respectively (compare lane 4 and
5 in Fig. 5a and b). The decrease in steady-state
concentrations of HIF-1α and Nrf2 was reversible by
addition of MG132. The steady-state concentrations
of Cul1 substrates such as p21 and p27 were also
determined in the same experiments. Even though,
in overall, we observed a decrease in steady-state
levels of both p21 and p27 when Rbx1+3G was
introduced in cells with neddylation pathway
inhibited, the decrease of both of the substrates was
inconsistent. Together, this suggests that the Gly
insertion mutant of Rbx1, which potentially adopts
multiple catalytic geometries, can overcome inacti-
vation of the Nedd8-conjugation pathway and can
promote ubiquitin transfer onto substrates.
Discussion
The majority of the mechanistic studies on Nedd8-
induced activation of SCF E3 ligase complexes were
performed using in vitro purified components.
Hitherto, there is no evidence of cellular studies to
substantiate the recently suggested mechanism of
neddylation-induced conformational control of CRL
activity in vivo, possibly due to the lack of a robust
cellular system to inhibit Nedd8 conjugation and
mimic the proposed neddylation-induced confor-
mational rearrangement of the cullin and Rbx1
complex in vivo. In addition, only the SCF ubiquitin
ligase was chosen as a model CRL in previous in
vitro studies6,7 due to its well-characterized complex
structure and well-defined assayed activities. The
cullin ECTD was previously defined to be a highly
conserved region, in the case of Cul1 spanning
residues 727–776, comprising α-helices H30 and
H31 and β-strands S10 and S11 within the Cul1
WHB domain. Based on the crystal structure of the
Cul1–Rbx1–Skp1–F-box–Skp2 ligase complex,
Zheng et al. showed that the human Cul1 ECTD
forms extensive contacts with the Rbx1 RING finger
protein.12 Recently, the solved crystal structure of
Nedd8–Cul5C-terminal–Rbx1 complex exhibited a
major conformational rearrangement of the cullin
C-terminal WHB domain in contrast to its non-
neddylated counterpart, thereby eliminating the
binding surface for CAND1, which only binds to
cullins in the absence of Nedd8 and substrate
adaptors. The conformational changes that result
from Nedd8 conjugation on cullin also partially
dissociate the RING domain of Rbx1 from the cullin
C-terminus, allowing more flexible catalytic geom-
etry of the Rbx1 RING domain to catalyze ubiquitin
transfer from the E2 to the bound substrates.6
Hence, it would be tempting to ask whether this
Fig. 5. Rbx1 linker flexibility is sufficient to overcome
the inactivation of the Nedd8-conjugation pathway. (a)
Cells were transfected with WT V5-Rbx1, V5-Rbx1+3G or
empty vector for 2 days. dnUbc12-HA expression was
induced by treating the cells with 1 μg/ml tetracycline for
the last 24 h. (b) HEK293T cells were transfected with WT
V5-Rbx1, V5-Rbx1+3G or empty vector for 2 days. Cells
were treated with DMSO or with 3 μM MLN4924 for 4 h
prior to lysis. Cell lysates were subjected to Western blot
analysis with the indicated antibodies.
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mechanism also operates in vivo in intact cells and
whether this mechanism could be generalized for
other members of the CRL family. To address these
questions, we hypothesized that upon impairing the
intact cellular neddylation system, the inhibited
CRLs activity can be rescued by introducing the
neddylation-mimicking ECTD deletion of cullin
mutants or flexible linker insertion Rbx1 mutants.
To test this hypothesis in a cellular system, the intact
neddylation pathway was inactivated by two
approaches: (i) by inducing the expression of a
dominant-negative Nedd8 conjugating E2 enzyme
(dnUBC12) and (ii) by treating transfected cells with
the potent and selective NAE E1 inhibitorMLN4924.
The inhibition of the Nedd8 conjugation cascade
was evident from a marked increase in the steady-
state concentrations of cullin substrates such as HIF-
1α and Nrf2. As predicted based on the previous in
vitro studies,6,7 expression of the mutant cullin and
Rbx1 proteins, which confer Rbx1 RING domain
flexibility in a neddylation-independent manner,
resulted in rescue of substrate ubiquitination under
conditions where neddylation was inhibited. When
either Cul1 ECTD deletion or Rbx1 Gly insertion
mutant was overexpressed under impaired neddy-
lation conditions, the inconsistency observed with
regard to the steady-state levels of Cul1 substrates
p21 and p27 may be due to the regulation of both
cyclin-dependent kinase inhibitory proteins via
different degradation pathways. For instance, it
has been reported that the degradation of p27 in
early G1 occurs in the cytoplasm via the ubiquitin
ligase Kip1 ubiquitinylation-promoting complex,13
whereas its degradation at the G1/S transition and
in the G2 phase before mitosis occurs in the nucleus
via the SCFSkp2 ubiquitin ligase complex.14,15 A
recent finding also provides evidence that p27
undergoes endolysosomal degradation through its
interaction with the endosomal protein sorting
nexin 6.16 Similarly, a number of different ubiqui-
tin-dependent and ubiquitin-independent degrada-
tion pathways have been reported for p21.17–19
In summary, our studies suggest that the pro-
posed mechanism of Nedd8-dependent CRL activa-
tion operates under in vivo conditions. Given that
our studies employed Cul2- and Cul3-based E3
ubiquitin ligases, we suggest that Nedd8-induced
conformational control is a general mechanism
common to all CRLs.
Materials and Methods
Plasmid constructs and mutagenesis
Human Cul2 and Cul3 amplified from cDNA Image
clones were purchased from Geneservice Ltd. (Image
identifiers 4104375 and 6168545, respectively) and
inserted into pcDNA3 including a C-terminal V5-tag
(Cul2 and Cul3 constructs). The ECTD deletion cullin
constructs Cul2(1–697 aa) and Cul3(1–720 aa), respective-
ly, Cul2(1–740 aa) and Cul3(1–763 aa) were made using
the same approach. Rbx1 was purchased from Addgene
(plasmid no. 20717) and subcloned into pcDNA3.1/Zeo
including an N-terminal V5-tag. To generate the
N-terminally V5-tagged Rbx1 with three Glycine insertion
mutant after residue Val39 (V5-Rbx1+3G), we amplified
Rbx1 by PCR from WT V5-Rbx1 with the following
primers: 5′ GC GGT ACC ATG GCG GCA GCG ATG
GAT 3′ (forward) and 5′ GC CTG CAG AT GGC ACA
GTT ATC TCC GCC TCC AAC CAC AAT ATC 3′
(reverse), and resulting DNA fragment was inserted into
the expression vector via KpnI and PstI sites (V5-N-
terminal Rbx1+3G). The remaining 3′ half of Rbx1 was
digested from WT V5-Rbx1 pcDNA3.1 and religated into
V5-N-terminal Rbx1+3G via PstI and XhoI sites, resulting
in the mutant V5-Rbx1+3G.
The T-REx system (Invitrogen) was used to generate cell
lines with tetracycline-inducible expression of dnUbc12-
HA (dnUbc12) according to the manufacturer's instruc-
tions, as previously described.8 ForDNA transfections, sub-
confluent T-REx-293 cells were transfected using GeneJuice
(Novagen) according to the manufacturer's instructions.
siRNA-mediated gene silencing
For siRNA transfections, RNAi Max Lipofectamine
(Invitrogen) was used as transfection agent according to
the manufacturer's instructions with the following
annealed Silencer predesigned siRNA duplexes (Ambion)
at a final concentrations of 25 nM: CAND1, siRNA ID
140584 and negative controls, Silencer negative control
siRNA no. 2 or Mdm2 siRNA 122297. Cells were lysed
3 days after siRNA transfections for Western blot analysis.
Immunoblotting
For immunoblotting, the cells were washed with ice-
cold phosphate-buffered saline and then lysed in Triton X-
100-containing lysis buffer, as previously described.20
Lysates were precleared by centrifugation before use for
Western blotting. Equal amounts of protein were loaded
for Western blot analysis. The following antibodies were
used: rabbit polyclonal anti-Cul2 (51–1800; Zymed Labo-
ratories), rabbit polyclonal anti-Cul3 (34–2200; Zymed
Laboratories), goat polyclonal anti-CAND1 (A-13) (sc-
10672; Santa Cruz Biotechnology), rabbit polyclonal anti-
Nrf2 (C-20) (sc-722; Santa Cruz Biotechnology), monoclo-
nal anti-α-tubulin (236–10501; Molecular Probes), mono-
clonal anti HIF-1α (610959; BD Biosciences), monoclonal
anti-V5 (Serotec) and monoclonal anti-FLAG M2 (Sigma).
All of the Western blots shown are representative of three
independent experiments.
Immunoprecipitation
V5 antibody (2.5 μg), coupled with 20 μl of protein G-
Sepharose (Amersham Biosciences), was used for immu-
noprecipitations. Five-hundred microliters of precleared
lysate from HEK293T cells transfected in 60-mm tissue
culture plateswas added. The sampleswere tumbled at 4 °C
for 2 h, and the Sepharose beads were then washed four
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times in 1 ml of NP40 cold lysis buffer [containing 50 mM
NaCl, 0.5% NP40, 5% glycerol, 0.5 mM ethylenediaminete-
traacetic acid, 50mMTris (pH 7.5) and 1mMdithiothreitol]
and once in buffer containing 50 mM Tris (pH 7.5). The
immunoprecipitated proteins were then denatured in SDS
sample buffer and subjected to SDS-PAGE and Western
blotting. The immunoprecipitation experiment shown is
representative of three independent experiments.
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Cycle inhibiting factor (Cif) is produced by pathogenic intracellular bacteria
and injected into the host cells via a type III secretion system. Cif is known to
interfere with the eukaryotic cell cycle by inhibiting the function of cullin
RING E3 ubiquitin ligases (CRLs). Cullin proteins form the scaffold protein
of CRLs and are modified with the ubiquitin-like protein Nedd8, which
exerts important conformational control required for CRL activity. Cif has
recently been shown to catalyze the deamidation of Gln40 in Nedd8 to Glu.
Here, we addressed how Nedd8 deamidation inhibits CRL activity. Our
results indicate that Burkholderia pseudomallei Cif (also known as CHBP)
inhibits the deconjugation of Nedd8 in vivo by inhibiting binding of the
deneddylating COP9 signalosome (CSN) complex. We provide evidence
that the reduced binding of CSN and the inhibition of CRL activity by Cif
are due to interference with Nedd8-induced conformational control, which
is dependent on the interaction between the Nedd8 hydrophobic patch and
the cullin winged-helix B subdomain. Of note, mutation of Gln40 to Glu in
ubiquitin, an additional target of Cif, inhibits the interaction between the
hydrophobic surface of ubiquitin and the ubiquitin-binding protein p62/
SQSTM1, showing conceptually that Cif activity can impair ubiquitin/
ubiquitin-like protein non-covalent interactions. Our results also suggest
that Cif may exert additional cellular effects by interfering with the
association between ubiquitin and ubiquitin-binding proteins.
© 2011 Elsevier Ltd. All rights reserved.
Introduction
Cycle inhibiting factor (Cif) is a virulence factor
that is present in enteropathogenic and enterohe-
morrhagic Escherichia coli as well as in Burkholderia
pseudomallei and other pathogenic Gram-negative
bacteria.1,2 Cif is injected into the host cells and is
known to inhibit cell cycle progression at both G1/S
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Abbreviations used: Cif, cycle inhibiting factor; CRL,
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hypoxia-inducible factor-1 α; ECTD, extreme C-terminal
domain; DEN1, deneddylase 1; GST, glutathione S-
transferase; UBA, ubiquitin associated.
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and G2/M transitions. Recent studies have shown
that this is at least partially due to protein
stabilization of the p27Kip1 cell cycle inhibitor.3–6
p27 protein concentrations are normally tightly
controlled via ubiquitination by the cullin RING
E3 ligase SCFSkp2 [Skp1 (S-phase kinase-associated
protein 1)–Cullin1–F-box-Skp2 (S-phase kinase-asso-
ciated protein 2)], which targets p27 for proteasome-
dependent degradation.7–9 Cullin RING E3 ubiqui-
tin ligases (CRLs) are multisubunit complexes
consisting of one of six different cullin homologs in
mammalian cells, forming scaffold onto which the
E3 ligase complex assembles.10,11 Via their C-
terminus, cullin proteins bind the RING protein
RING box protein 1 (Rbx1), which functions to
recruit the ubiquitin-charged E2 ubiquitin conjugat-
ing enzyme. Via their N-terminus, cullin proteins
can associate with a total of approximately 300
different substrate receptor subunits that function to
recruit specific substrate proteins. As a result, the
cullin proteins bring substrate and ubiquitin-
charged E2 enzyme into close proximity, thus
facilitating ubiquitin transfer from the E2 enzyme
to a side chain of a lysine residue in the substrate,
forming an isopeptide bond. Reiteration of the
substrate ubiquitination reaction results in the
conjugation of the substrate with a polyubiquitin
chain, which is necessary for recognition by the 26S
proteasome. For instance, p27 is known to bind to
the SCFSkp2 CRL, in which p27 is recruited to Cul1
via the Skp2 substrate receptor protein and the
adaptor protein Skp1.
CRLs require modification of the cullin protein
with the ubiquitin-like protein Nedd8 for
activity.10,11 Nedd8 is conjugated onto a lysine
residue that is conserved in all cullin proteins via
the action of a Nedd8 E1 activating enzyme, Uba3/
APP-BP1, and a Nedd8 E2 conjugating enzyme,
Ubc12. Nedd8 conjugation of cullin proteins is
reversible via the action of the COP9 signalosome
(CSN).12–14 CSN is a complex composed of eight
subunits of which CSN5 has metalloprotease activ-
ity and can cleave the isopeptide bond between the
Nedd8 C-terminal glycine and the side chain of the
conserved lysine in cullin proteins. Cullin neddyla-
tion induces a major conformational change in the
cullin C-terminal domain–Rbx1 structure, which
allows for greater flexibility of the Rbx1 RING
domain.15–17 In the unneddylated state, the Rbx1
RING domain contacts the cullin C-terminal
winged-helix B (WHB) subdomain, thus forming a
closed architecture. Neddylation induces a change
in this structure to an open architecture in which
Rbx1 remains only anchored to cullins via its N-
terminus.15 This open conformation confers greater
flexibility to the RING domain and bridges the gap
between the binding site for the ubiquitin-charged
E2 in the RING domain and the substrate ubiquiti-
nation site.
Recent studies have shown that Cif has deamidat-
ing activity and functions to convert Gln40 in
ubiquitin and Nedd8 into Glu in vitro and during
Burkholderia infection.4 Although deamidation of
Nedd8 has no major effect on Nedd8 modification of
cullin proteins, it dramatically inhibits cullin ligase
activity, resulting in the stabilization of p27 and
other CRL substrates. This is likely to account for the
cell cycle inhibitory effect that Cif exerts upon
secretion into host cells.
In the present study, we address the mecha-
nism through which the Cif homolog from B.
pseudomallei (CHBP)-mediated Nedd8 deamida-
tion inhibits CRL ligase activity. Our results
strongly suggest that deamidation prevents
Nedd8 from inducing a conformational change
in the cullin C-terminus. Furthermore, we show
that deamidation of ubiquitin inhibits its interac-
tion with the ubiquitin-binding protein p62/
SQSTM1, which is mediated via the ubiquitin
hydrophobic patch.18 Our results suggest that the
cellular effects of Cif may be a consequence of
interference with intermolecular protein–protein
interactions involving the hydrophobic surfaces of
ubiquitin and Nedd8.
Results and Discussion
Cif expression in mammalian cells increases
CRL substrate abundance
We initially confirmed that B. pseudomallei Cif
inhibits CRL function in mammalian cells. Full-
length Cif or Cif lacking the N-terminal type III
secretion signal sequence was transfected into
HEK293 T cells. Two days after transfection, a
marked increase in the cellular abundance of the
SCFSkp2 substrate p27 was observed compared to
cells transfected with empty vector (Fig. 1a).
Similarly, the Elongin BC/Cul2/Vhl substrate hyp-
oxia-inducible factor-1 α (HIF-1α) was undetectable
in control cells and markedly induced upon Cif
transfection. There was no significant change in the
steady-state levels of cullin neddylation observable
(as detected by the slightly slower migrating band in
the Cul1 Western blot) despite the marked accumu-
lation of CRL substrates. We also did not detect a
change in endogenous unconjugated Nedd8 con-
centrations in Cif-transfected cells (data not shown),
suggesting that Cif does not affect maturation of
Nedd8 precursor. Because full-length Cif and Cif
lacking the secretion signal sequence had similar
cellular effects, we used the full-length form in
further experiments.
We also tested the effect of transfecting wild-type
or Q40E mutant FLAG-Nedd8 into cells (Fig. 1b).
The Q40E mutant form corresponds to the
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deamidated Nedd8 protein. Transfection of Q40E
FLAG-Nedd8 even at high plasmid DNA concen-
trations did not increase p27 concentrations com-
pared to wild-type FLAG-Nedd8. We noted that the
Q40E mutant was less efficiently conjugated to
cullin and non-cullin substrates, as apparent in the
Cul1 and FLAG Western blots in Fig. 1b. Thus,
despite similar abundance of monomeric FLAG-
Nedd8, higher-molecular-weight FLAG-Nedd8-
conjugated proteins were less abundant with the
Q40E mutant compared to wild-type Nedd8. In
contrast to our findings, Cui et al. found no
difference in the conjugation of wild type and
Q40E Nedd8 conjugation to Cul3 in vitro.4 It is
possible that the different results are due to high
substrate and/or enzyme concentrations under in
vitro conditions. Because Cif expression did not
reduce basal Cul1 neddylation levels, this suggests
that in vivo Cif acts predominantly on Nedd8 after
its conjugation to cullin proteins.
Cif inhibits the rate of Cul1 deneddylation in vivo
Our results in Fig. 1a show that Cif inhibits CRL
activity without reducing basal levels of neddyla-
tion. Similarly, previous studies have reported that
infection of cells with Cif-expressing bacteria does
not decrease but actually increases cellular cullin
neddylation levels.5,6 We therefore considered
alternative explanations. One possibility is that Cif
affects the assembly of the CRL ligase complex.
However, we did not observe any change in binding
of Cul1 to Skp1 upon expression of Cif (data not
shown). Alternatively, CRL substrate accumulation
may be due to interference with the degradation of
polyubiquitinated proteins, for example, as a result
of deamidation of ubiquitin. However, when stead-
y-state levels of ubiquitin–proteasome substrates
whose ubiquitination is not mediated by CRLs were
measured, including cyclin B and geminin, no
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Fig. 1. Cif expression increases
CRL substrate abundance. (a)
HEK293T cells were transfected
with the indicated expression plas-
mids for 2 days followed by West-
ern blotting of cell lysates with the
antibodies shown. (b) Cells were
transfected with equal amounts of
wild-type or Q40E mutant FLAG-
Nedd8 for 2 days. Cell lysates were
analyzed by Western blotting with
the indicated antibodies. (c)
HEK293T cells were transfected
with 0.4 and 0.8 μg of empty vector
or FLAG-Cif for 2 days followed by
Western blotting of cell lysates with
the antibodies shown.
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pseudomallei Cif in HEK293 T cells (Fig. 1c). This
suggests that Cif-dependent CRL inhibition is a
direct consequence of Nedd8 deamidation.4
It is known that CRL complexes in vivo undergo
relatively rapid cycles of neddylation and deneddy-
lation, and this is believed to be important for CRL
activity.10,11,19 We therefore tested the effect of Cif
on the rate with which Cul1 is deneddylated in
intact cells. To this end, cells transfected with Cif or
empty vector were treated with the Nedd8 E1
enzyme inhibitor MLN4924, which inhibits new
neddylation of cullin proteins, and the kinetics of
deneddylation were determined by lysing cells at
different time points after drug addition. As shown
in Fig. 2a, in cells transfected with empty vector,
Cul1 neddylation was almost completely reversed
after 10 min of drug treatment. In contrast, cells
expressing Cif had a markedly reduced deneddyla-
tion rate.
We also compared the deneddylation rate of wild-
type and Q40E FLAG-Nedd8 using the same
approach. To achieve similar basal cullin neddyla-
tion levels, we transfected more Q40E FLAG-Nedd8
plasmid DNA in this experiment. The Cul1 blot in
Fig. 2b shows one slower migrating band for
untransfected cells (corresponding to Cul1 conju-
gated with endogenous Nedd8) and an additional
slower migrating band in FLAG-Nedd8-transfected
cells (corresponding to Cul1 conjugated with FLAG-
Nedd8). Upon MLN4924 addition, the rate of
deneddylation of Q40E FLAG-Nedd8 is markedly
reduced compared to wild-type FLAG-Nedd8. We
therefore conclude that Cif-mediated Nedd8 deami-
dation inhibits Cul1 deneddylation in vivo.
Cif reduces binding of CSN to Cul1 by preventing
the Nedd8-induced conformational change in the
cullin C-terminal domain–Rbx1 structure
The highly conserved CSN complex is known to
be the major protease that functions to catalyze the
deconjugation of Nedd8 moiety on cullin
proteins.12–14 In addition, the human deneddylase
1 (DEN1),20 also known as Nedd8-specific protease
(NEDP1),21 has been identified as a protease that
specifically cleaves neddylated cullin in vitro and
when overexpressed in intact cells. However, in
Drosophila DEN1 null mutant, there is no elevation
of endogenous neddylated Cul1 and Cul3, suggest-
ing that DEN1 is not a major deneddylating enzyme
in vivo, at least in this organism.22 We therefore
examined whether the slower rate of Cul1 dened-
dylation in the presence of Cif is a consequence of
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Fig. 2. Cif inhibits the in vivo rate
of Cul1 deneddyla t ion . (a )
HEK293T cells were transfected
with empty vector or FLAG-Cif for
2 days. To measure the rate of cullin
deneddylation, we added the
Nedd8 E1 inhibitor MLN4924
(2 μM) at time zero. Cells were
lysed at the indicated time points.
The kinetics of deneddylation were
determined by observing the de-
crease in the slower migrating,
neddylated band in the Cul1 West-
ern blot over time. (b) Cells were
transfected with wild-type or Q40E
mutant FLAG-Nedd8 for 2 days.
The rate of FLAG-Nedd8 deconju-
gation was measured as in (a) by
observing the time-dependent dis-
appearance of the slowest migrat-
ing form of Cul1 corresponding to
FLAG-Nedd8–Cul1.
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co-transfected with Cul1-FLAG and V5-Cif or empty
vector, followed by FLAG immunoprecipitation of
cell lysates. As apparent in Fig. 3a, binding of CSN2
and CSN5 to Cul1 was markedly reduced when Cif
was coexpressed.
One possible explanation for reduced CSN bind-
ing is that Cif competes with CSN for association
with Cul1. However, this appears unlikely given
that we only detected very weak specific binding of
Cif to Cul1 despite very high expression levels
under conditions where binding of endogenous
CSN2 and CSN5 was easily detectable (Fig. 3a, see
asterisk for specifically bound V5-Cif in the longer
exposure of the V5 blot). This result suggests that the
interaction of Cif with neddylated Cul1 is very
transient.
An alternative mechanism for reduced CSN
interaction with Cul1 in the presence of Cif is that
Cif deamidation of Nedd8 directly interferes with
CSN recruitment to the Cul1 E3 ligase complex.
However, our recent results indicate that Nedd8
modification is not necessary for CSN binding to
cullin proteins (Choo et al., manuscript submitted).
Thus, cullin extreme C-terminal domain (ECTD)
deletion mutants that cannot be neddylated show
increased CSN binding. These ECTD deletion
mutants have been shown to have a constitutive
active conformation and E3 ligase activity in the
absence of Nedd8 modification.15,16
We have recently shown that the cullin ECTD
deletion mutants also have the ability to rescue CRL
substrate ubiquitination in a cellular context with
inhibited cellular neddylation pathway.23 We there-
fore tested whether these mutants with a constitu-
tively active conformation in the absence of
neddylation are able to rescue Cif-induced CRL
inhibition. Indeed, as shown in Fig. 3b and c, the Cif-
dependent inhibition of p27 and HIF-1α ubiquitina-
tion and degradation was reversed by ECTD
deletion mutants of Cul1 and Cul2, respectively.
This suggests that Nedd8 deamidation prevents the
Nedd8-induced conformational change in the cullin
C-terminal domain–Rbx1 structure, thus leading to
inhibition of CRL activity and substrate accumula-
tion. Nedd8 interacts with cullin proteins via two
binding sites. The C-terminal glycine of Nedd8 is
covalently bound to the conserved cullin acceptor
lysine side chain. In addition, the Nedd8 binding
surface (Leu8/Ile44/His68/Val70) interacts non-
covalently with the cullin WHB subdomain, leading
to freeing of the Rbx1 RING domain and, conse-
quently, CRL activation. Thus, mutation of hydro-
phobic patch residues Leu8 and Ile44, as well as
Lys48, has been shown to inhibit CRL ligase
activity.24,25 We hypothesize that Nedd8 deamida-
tion of Gln40, which is localised within adjacent to
the hydrophobic surface of Nedd8, interferes with
the non-covalent interaction between Nedd8 and the



















































































Fig. 3. Cif reduces binding of CSN to Cul1. (a)
HEK293T cells were transfected with the indicated
expression plasmids for 2 days followed by FLAG
immunoprecipitation as described under Materials and
Methods and Western blotting with the indicated anti-
bodies. The specifically bound V5-Cif in the longer
exposure of the V5 blot is indicated by an asterisk. (b
and c) Cells were co-transfected with V5-Cif and wild type
or ECTD deletion constructs of Cul2 (a) or Cul1 (b). The
effects on the ubiquitination and degradation of the Cul2
and Cul1 substrates HIF-1α and p27, respectively, were
determined by Western blotting.
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induced conformational activation of cullin C-
terminal domain–Rbx1. Our recent findings suggest
that CSN binding to the CRL complex is promoted
by an active, Nedd8-induced conformation (Choo
et al., manuscript submitted). This suggests that
reduced CSN binding and inhibition of Cul1
deneddylation are also a consequence of the
inability of deamidated Nedd8 to induce the
open, active conformation of the Cul1 C-terminal
domain–Rbx1 structure.
Ubiquitin deamidation inhibits the interaction
between the ubiquitin hydrophobic patch and
the p62 ubiquitin-associated domain
The interaction between the Nedd8 hydrophobic
patch and the cullin C-terminus is likely of low
affinity and facilitated by the covalent linkage of the
Nedd8 C-terminus to cullins. We therefore turned to
the higher-affinity interaction between the hydro-
phobic patch of ubiquitin and the ubiquitin-binding
ubiquitin-associated (UBA) domain of the p62
protein18 as a model for the effects of the Q40E
change in Nedd8 on its non-covalent interaction
with cullin. Gln40 is conserved in both ubiquitin and
Nedd8, and similarly to Nedd8, Gln40 in ubiquitin
has been reported to become deamidated by Cif.4
We therefore performed in vitro pull-down experi-
ments with immobilized wild-type and Q40E
ubiquitins and the recombinant p62 protein. As
shown in Fig. 4a, mutation of Gln40 to Glu of
ubiquitin markedly reduced the non-covalent bind-
ing of glutathione S-transferase (GST)-p62. These
results are consistent with our previous structural
studies in which we have mapped the p62 UBA
binding surface of ubiquitin using NMR chemical
shift perturbation methods. In particular, we see
significant perturbations in the side chains of Gln40,
Gln41 and Gln49 between the free and the bound
states of ubiquitin (Fig. 4b), which suggest structural
changes or involvement in hydrogen-bonding in-
teractions at the ubiquitin–UBA interface. In the
structural model of ubiquitin (Fig. 4c), the polar side
chains of both Gln40 and Gln49, but also Arg72, all
Fig. 4. The Q40E change impairs the p62/ubiquitin (Ub) non-covalent interaction. (a) Top, in vitro binding of GST-p62
to an excess of glutathione-Sepharose (equivalent to input), control-Sepharose (no protein), wild-type (WT) or Q40E
mutant ubiquitin-Sepharose beads (Ub at 10 mg/ml) was performed as previously described26 and detected by Western
blotting with GST antibody. Bottom, Coomassie staining of equivalent gels run in parallel confirmed equal loading of
ubiquitin. (b) Chemical shift perturbations (CSPs in ppm) for each of the two side-chain NH resonances of Gln and Asn
residues of ubiquitin (inset structure) between free ubiquitin and UBA-bound ubiquitin. Notable perturbations are
observed for Gln40, Gln41 and Gln49, suggesting direct involvement in UBA binding. In contrast, other residues show
little difference and are remote from the binding interface. (c) Structure of ubiquitin showing the key residues that form
the hydrophobic patch (Ile44 and Val70), together with a cluster of polar residues (Gln40, Gln49 and Arg72) that lie
adjacent to this patch. All of the residues are perturbed when the p62 UBA binds to ubiquitin.
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of which are perturbed by binding the UBA domain
of p62, are situated adjacent to the hydrophobic
binding patch formed by Ile44 and Val70. By
analogy, we anticipate that Gln40 also plays a role
in non-covalent interactions between Nedd8 and
Nedd8-binding proteins. These findings also pro-
vide support for the hypothesis that Nedd8 deami-
dation interferes with the non-covalent interaction
between Nedd8 and the cullin C-terminus, thus
inhibiting E3 ligase activity. Finally, our results
suggest that Cif may exert additional cellular effects
by selectively or broadly interfering with the
association between ubiquitin and ubiquitin-bind-




B. pseudomallei Cif was PCR amplified using the
following PCR primers: 5′AGGGTACCATGTTGGAG-
CACGGCGTCAT [forward primer for full-length Cif
(amino acids 1–328) including a KpnI site], 5′AGGGTAC-
CATGATAACGCCGATCATTTC [forward primer for Cif
lacking the type III secretion signal sequence (amino acids
67–328) including a KpnI site] and 5′ATTCTAGATTAGC-
CAAGGCCGGCGACGTA (reverse primer including an
XbaI site). The PCR product digested with KpnI and XbaI
restriction enzymes was inserted into modified
pcDNA3.1, which includes an N-terminal 2× FLAG or
V5 epitope tag sequence. All other plasmids were
previously described.23,27,28
Immunoblotting
For immunoblotting, the cells were washed with ice-
cold phosphate-buffered saline and then lysed in lysis
buffer containing Triton X-100, as previously described.29
Lysates were precleared by centrifugation before use for
Western blotting. Equal amounts of protein were loaded
for Western blot analysis. The following antibodies were
used: monoclonal anti-p27 (610241; BD Biosciences), rabbit
polyclonal anti-Cul1 (40990547; Zymed Laboratories
and RB-1481-P0; NeoMarkers), monoclonal anti-HIF-1α
(610959; BD Biosciences), monoclonal anti-α-tubulin
(236–10501; Molecular Probes), rabbit polyclonal anti-
JAB1/CSN5 (ab12323-50; Abcam), mouse anti-CSN2/
hAlien (612492; BD Bioscience) monoclonal anti-V5
(Serotec) and monoclonal anti-FLAG M2 (Sigma). All
of the Western blots shown are representative of at least
two independent experiments.
Immunoprecipitation
Anti-FLAG M2 agarose (10 μl; Sigma) was used for
immunoprecipitations. Precleared lysate (500 μl) from
HEK293T cells transfected in 60-mm tissue culture plates
was added. The samples were tumbled at 4 °C for 2 h, and
the beads were then washed four times in 1 ml of NP40
cold lysis buffer [containing 50 mMNaCl, 0.5% NP-40, 5%
glycerol, 0.5 mM ethylenediaminetetraacetic acid, 50 mM
Tris (pH 7.5) and 1 mM dithiothreitol] and once in buffer
containing 50 mM Tris, pH 7.5. The immunoprecipitated
proteins were then denatured in SDS sample buffer and
subjected to SDS-PAGE and Western blotting.
Ubiquitin/GST-p62 interaction
To carry out the ubiquitin/GST-p62 pull-down assay,
we incubated an excess of immobilized (on CNBr-
activated Sepharose) wild-type or Q40E mutant ubiquitin
(purified recombinant protein, human sequence, 10 mg/
ml), control-Sepharose (no protein) or glutathione-Sephar-
ose with bacterial lysate containing GST-p62 protein,
essentially as described previously26 but using 10 mM
Tris, 50 mMNaCl and 0.1% Triton X-100 (vol/vol), pH 7.5,
as binding buffer. Captured GST-p62 proteins were
detected by Western blotting with GST antibody. Prior
to Immunodetection, membranes were stained with
Coomassie. The NMR methodology used in mapping
the binding surface of ubiquitin in its complex with the
UBA domain of p62 has previously been described.30
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ABSTRACT Cullin RING ligases (CRLs) are the largest family of cellular E3 ubiquitin ligases 
and mediate polyubiquitination of a number of cellular substrates. CRLs are activated via the 
covalent modification of the cullin protein with the ubiquitin-like protein Nedd8. This results 
in a conformational change in the cullin carboxy terminus that facilitates the ubiquitin transfer 
onto the substrate. COP9 signalosome (CSN)-mediated cullin deneddylation is essential for 
CRL activity in vivo. However, the mechanism through which CSN promotes CRL activity in 
vivo is currently unclear. In this paper, we provide evidence that cullin deneddylation is not 
intrinsically coupled to substrate polyubiquitination as part of the CRL activation cycle. Fur-
thermore, inhibiting substrate-receptor autoubiquitination is unlikely to account for the ma-
jor mechanism through which CSN regulates CRL activity. CSN also did not affect recruitment 
of the substrate-receptor SPOP to Cul3, suggesting it may not function to facilitate the ex-
change of Cul3 substrate receptors. Our results indicate that CSN binds preferentially to CRLs 
in the neddylation-induced, active conformation. Binding of the CSN complex to active CRLs 
may recruit CSN-associated proteins important for CRL regulation. The deneddylating activ-
ity of CSN would subsequently promote its own dissociation to allow progression through 
the CRL activation cycle.
INTRODUCTION
The COP9 signalosome (CSN) is an evolutionarily conserved com-
plex consisting of eight subunits with similarity to the lid of the 26S 
proteasome regulatory particle (Cope and Deshaies, 2003; Wolf 
et al., 2003; Schwechheimer, 2004; Bosu and Kipreos, 2008; Wei 
et al., 2008). Loss of CSN activity as a result of deletion of different 
CSN subunits causes a constitutive photomorphogenic phenotype 
in plants and sterility in Caenorhabditis elegans and is lethal in 
Drosphila and mice (Chamovitz et al., 1996; Freilich et al., 1999; Yan 
et al., 2003; Orsborn et al., 2007; Dohmann et al., 2008). Lethality of 
CSN inactivation in mice is due to cell cycle defects. It has recently 
been shown that Cre recombinase–dependent knockout of CSN5 in 
mouse embryonic fibroblasts leads to multiple cell cycle defects and 
cell death (Yoshida et al., 2010), further emphasizing the essential 
role of CSN. Similarly, in Arabidopsis, CSN is essential for G2-phase 
progression and genomic stability (Dohmann et al., 2008).
The major function of CSN is the proteolytic cleavage of 
the isopeptide bond between the ubiquitin-like protein Nedd8 
and cullin proteins (Lyapina et al., 2001; Cope et al., 2002; 
Schwechheimer, 2004). Cullins function as scaffold proteins for 
the assembly of cullin RING E3 ubiquitin ligases (CRLs) and con-
stitute the largest family of cellular E3 ubiquitin ligases. All of the 
six well-characterized cullin proteins in mammalian cells (Cul1, 
Cul2, Cul3, Cul4a, Cul4b, and Cul5) bind via their C-termini to 
the small RING domain protein Rbx1 or Rbx2, which functions to 
recruit the ubiquitin-charged E2-conjugating enzyme. The cullin 
N-terminus interacts with cullin-specific substrate-receptor sub-
units, usually via adaptor proteins that mediate the interaction 
between cullin and substrate-receptor subunits (Petroski and 
Deshaies, 2005; Bosu and Kipreos, 2008).
Monitoring Editor
Jonathan Chernoff
Fox Chase Cancer Center
Received: Mar 24, 2011
Revised: Oct 3, 2011
Accepted: Oct 13, 2011
Volume 22 December 15, 2011 Role of CSN in regulating CRL activity | 4707 
CRLs require the covalent modification of a conserved C-termi-
nal lysine residue with Nedd8. Neddylation activates CRLs by induc-
ing a conformational change in the cullin C-terminus that results in 
increased flexibility of the Rbx1 RING domain, thus imparting mul-
tiple catalytic geometries to the E2-conjugating enzyme and pro-
moting ubiquitin transfer onto the substrate (Duda et al., 2008; Saha 
and Deshaies, 2008; Yamoah et al., 2008). In addition, it has also 
been shown that cullin neddylation promotes the recruitment of 
ubiquitin-charged E2 enzyme (Kawakami et al., 2001; Sakata et al., 
2007). Consequently, CSN-mediated cullin deneddylation leads to 
inhibition of CRL activity in vitro. In contrast to the negative regula-
tion of CRL activity in vitro, there is clear evidence that CSN func-
tions as a positive regulator of CRLs in vivo (Bosu and Kipreos, 2008; 
Wei et al., 2008). Thus loss of function of CSN leads to accumula-
tion of CRL substrates and inhibition CRLs in vivo. A number of 
mechanisms for the positive role of CSN in regulating CRL activity 
have been proposed. It has been shown that CSN prevents the 
autoubiquitination of a number of cullin substrate-receptor subunits 
(Bosu and Kipreos, 2008; Schmidt et al., 2009; and references 
therein). This may be a consequence of cullin deneddylation and 
subsequent inactivation of CRLs in the absence of a bound sub-
strate or of recruiting the CSN-associated deubiquitinating enzyme 
Ubp12/Usp15 to the CRL complex. Ubp12/Usp15 has been shown 
to function to reverse substrate-receptor autoubiquitination (Zhou 
et al., 2003; Hetfeld et al., 2005). Because both Nedd8 conjugation 
and deconjugation are required for CRL function, it has also been 
suggested that in vivo CRLs undergo rapid neddylation and dened-
dylation cycles (Cope and Deshaies, 2003). Based on this, a CRL 
activation cycle has been proposed in which substrate binding to 
the CRL complex induces cullin neddylation, thus leading to CRL 
activation. Upon substrate ubiquitination and dissociation, CSN-
mediated deneddylation completes the activation cycle, which re-
sumes when a new substrate binds.
In addition, CSN may function to regulate the binding of CAND1, 
a protein that interacts with all cullin homologues (Cope and 
Deshaies, 2003; Bosu and Kipreos, 2008). CAND1 interacts exclu-
sively with unneddylated cullin proteins. Binding of CAND1 to cull-
ins is mutually exclusive with the binding of substrate-receptor sub-
units. Thus, by deneddylating cullin proteins, CSN may function to 
promote CAND1 binding and consequently facilitate the exchange 
of substrate-receptor subunits (Lo and Hannink, 2006; Schmidt 
et al., 2009). Alternatively, CSN may compete with CAND1 for bind-
ing to cullin and thus prevent CAND1-mediated CRL disassembly. 
Finally, CSN has also been reported to play a regulatory role by 
promoting the dissociation of polyubiquitinated proteins from the 
CRL complex (Miyauchi et al., 2008).
In this study, we used a mammalian cellular system to investigate 
the importance of the various mechanisms of CSN-dependent CRL 
regulation. We also utilized MLN4924, a mechanism-based inhibitor 
of the Nedd8 E1-activating enzyme (Soucy et al., 2008; Brownell 
et al., 2010). On the basis of our findings, we propose a new model, 
in which CSN binding to CRLs and deneddylation are part of the 
neddylation cycle and regulate CRL activity.
RESULTS AND DISCUSSION
Determinants of substrate-receptor autoubiquitination
It has been suggested that CSN-mediated deneddylation is re-
quired to prevent the autoubiquitination of substrate receptors in 
the absence of a bound substrate. However, not all substrate recep-
tors are subject to autoubiquitination. For the F-box protein family 
of Cul1 substrate receptors in fission yeast, it has recently been sug-
gested that the presence of a proline residue in the N-terminal part 
of the F-box domain determines the affinity of the substrate recep-
tor for Skp1 and Cul1 and the likelihood for CRL-mediated autou-
biquitination (Schmidt et al., 2009). To determine the importance of 
the conserved proline residue in a mammalian system, we substi-
tuted the respective proline with alanine residues in a number of F-
box proteins. As shown in Figure 1A, P101A Skp2 and P63A Fbxo4 
showed markedly reduced Cul1 binding compared with the wild-
type proteins. However, for Skp2, we observed no increase in the 
half-life of the P101A mutant compared with the wild-type protein 
under basal conditions (Figure 1B), suggesting that APCCdh1-medi-
ated Skp2 ubiquitination but not autoubiquitination is normally the 
major mechanism through which Skp2 protein stability is regulated 
(Bashir et al., 2004; Wei et al., 2004). Even when CSN5 was knocked 
down, which is expected to increase autoubiquitination, the de-
crease in Skp2 protein expression after 8 h treatment with the pro-
tein synthesis inhibitor cycloheximide was similar for wild-type and 
P101A mutant Skp2 (Figure 1C). In contrast to Skp2, the proline 
mutant of Fbxo4 was degraded slightly faster under both basal and 
CSN5 knockdown conditions compared with the wild-type protein, 
which was relatively stable (Figure 1C). Indeed, when we treated 
cells with proteasome inhibitor MG-132, we noted the accumulation 
of polyubiquitinated mutant but not wild-type Fbxo4 (Supplemental 
Figure S1A). Given the markedly reduced binding of P63A Fbxo4 to 
Cul1, this ubiquitination is likely to be independent of the Cul1 CRL. 
Indeed, it was not significantly inhibited upon knockdown of Cul1 
CRL adaptor protein Skp1, upon treatment with the Nedd8-activat-
ing enzyme (NAE) inhibitor MLN4924 (Soucy et al., 2008), and upon 
transfection of dominant-negative Cul1 (Figure S1, B and C).
We also determined the significance of the corresponding pro-
line residue in the F-box protein β-TrCP. β-TrCP was subject to 
autoubiquitination under basal conditions based on an increase in 
protein expression upon MLN4924 treatment, while there was a 
smaller increase for Skp2 and no effect for Fbxo4 (Figure S2A). 
Alignment of the N-terminal part of the F-box domain for Skp2, 
Fbxw7α, Fbxo4, and β-TrCP (Figure S2B, according to Schmidt 
et al., 2009) shows the conserved proline residue in position 2 and 
indicates that, unlike other F-box proteins, β-TrCP contains four ad-
ditional amino acids between the conserved LPx and EψxxxIxxxL 
sequences (where ψ corresponds to hydrophobic amino acids). The 
F-box–domain proline in position 2 in Skp2 (and presumably in other 
F-box proteins) is localized at the beginning of α-helix H1 in Skp2 
and makes contact with Cul1 (Schulman et al., 2000; Zheng et al., 
2002). In contrast, in the structure of the Skp1-β-TrCP complex, the 
proline residue is positioned in α-helix H0 and therefore presumably 
does not interact with Cul1 (Wu et al., 2002). Indeed, mutation of 
the proline to alanine (P185A β-TrCP) had no effect on the interac-
tion of β-TrCP and Cul1 (Figure S2C). Based on the structure of the 
Skp1-β-TrCP complex, a likely more accurate alignment would place 
Leu189 and not Leu184 into the position of the conserved leucine 
residue in position 1 of the F-box domain (Figure S2C). To test for 
the importance of the two different leucine residues for binding to 
Cul1, we mutated both amino acids separately to lysine. However, 
both the L184K and L189K mutations in β-TrCP were without sig-
nificant effect on the interaction between the two proteins (Figure 
S2C). In addition to the proline, the negatively charged residue in 
position 4 of the F-box is involved in the interaction with Cul1 (Zheng 
et al., 2002). However, this residue is absent in β-TrCP and is re-
placed by a histidine. We therefore tested whether the aspartate 
that precedes the histidine is involved in the binding of β-TrCP to 
Cul1. However, we observed that the D190A β-TrCP mutant also did 
not show reduced binding. Our results thus suggest that the N-ter-
minal part of α-helix H1 in β-TrCP is not critically involved in the 
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FIGURE 1: Role of the conserved proline residue in determining F-box protein binding to Cul1 and F-box protein 
stability. (A) HEK293T cells were transfected with the wild-type or proline mutant V5-Skp2 or V5-Fbxo4. Cell lysates 
were subjected to V5 immunoprecipitation and immunoprecipitates were analyzed by Western blotting with Cul1 and 
V5 antibodies. An asterisk (*) denotes a nonspecific band (heavy chain). (B) Cells were transfected with wild-type or 
P101A V5-Skp2 and subjected to chase analysis with 40 μM cycloheximide in which cells were lysed at the indicated 
time points after addition of the protein synthesis inhibitor. The relative amounts of wild-type and P101A V5-Skp2, 
determined by densitometry, are shown in the graph at the right. (C) Cells were transfected with negative control or 
CSN5 siRNA for 3 d and with wild-type or mutant V5-Skp2 or V5-Fbxo4 for the last 2 d. Cycloheximide (40 μM) was 
added where indicated 8 h before cell lysis and cells lysates were analyzed by Western blotting with the indicated 
antibodies. Bottom, quantification of the V5-Skp2 and V5-Fbxo4 abundance by densitometry. The results represent the 
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interaction of this F-box protein with Cul1 and that indirect contacts 
via Skp1 are likely sufficient to mediate Cul1 binding.
In conclusion, our results suggest that although the conserved 
F-box proline residue is important for binding of the F-box proteins 
Skp2 and Fbxo4 to Cul1, it is not the sole determinant of binding 
affinity and also does not appear to determine the rate of substrate-
receptor autoubiquitination in mammalian cells. Based on our re-
sults and various other studies, it is evident that not all substrate 
receptors are subject to autoubiquitination. On the contrary, a num-
ber of substrate receptors, such as the Cul2 substrate receptor von 
Hippel-Lindau (VHL) protein and the Cul5 substrate receptor SOCS3, 
are stabilized upon incorporation into CRL complexes (Schoenfeld 
et al., 2000; Kamura et al., 2002; Haan et al., 2003), and this may 
also be true for Fbxo4 (see Figures 1C and S1). Interestingly, even 
though the VHL protein is not subject to Cul2 CRL-mediated autou-
biquitination, knockdown of CSN2 or CSN5 in mammalian cells 
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delays the CRL2VHL-dependent HIF-1α polyubiquitination and deg-
radation (Miyauchi et al., 2008), suggesting that CSN is required for 
functions other than preventing autoubiquitination of substrate-re-
ceptor proteins. Two recent studies in Arabidopsis and Drosophila 
provide further support for this (Djagaeva and Doronkin, 2009; 
Spoel et al., 2009). In these studies, it was shown that the BTB 
(Broad-Complex, Tramtrack, and Bric a brac) proteins NPR1 and 
Kelch, respectively, bind to Cul3 and are subject to autoubiquitina-
tion. Importantly, lack of CSN activity in both Arabidopsis and Dros-
ophila resulted in stabilization and elevation of the protein levels of 
the BTB substrate receptors (Djagaeva and Doronkin, 2009; Spoel 
et al., 2009), suggesting CSN does not inhibit autoubiquitination, 
but functions to promote CRL activity. In our further work, we there-
fore tested a number of hypotheses for a role of CSN in promoting 
CRL activity that is independent of substrate-receptor autoubiquit-
ination prevention.
Hypothesis 1: CSN promotes CRL activity by mediating 
cycles of neddylation and deneddylation
In vivo, both neddylation and deneddylation are required for effi-
cient substrate ubiquitination. Based on this, it has been suggested 
that in vivo CRLs undergo rapid cycles of neddylation and dened-
dylation (Cope and Deshaies, 2003; Bosu and Kipreos, 2008; Wei 
et al., 2008). With the development of the specific inhibitor of cullin 
neddylation MLN4924, it has become possible to determine the in 
vivo deneddylation rates. As shown in Figure 2A, the deneddylation 
rates of endogenous Cul1 and Cul2 in HCT116 cells were relatively 
fast, demonstrating a marked decrease at 5 min after drug addition 
for Cul1 and at 15 min for Cul2, thus confirming results in the study 
by Soucy et al. (2009). The deneddylation rate of Cul1 in other cell 
lines was slightly slower (see Figure 2D), which is likely unrelated to 
the CSN expression level (Figure 2E). Given that it has been sug-
gested that the CAND1 protein promotes cullin deneddylation (Min 
et al., 2005; Chew et al., 2007), we also determined the effect of 
small interfering RNA (siRNA)-mediated silencing of CAND1 on the 
deneddylation rate in HEK293 cells. As shown in Figure 2B, CAND1 
silencing resulted in an increased basal Cul1 neddylation level, indi-
cating that the knockdown of the CAND1 protein was functional. 
However, silencing of CAND1 was without effect on the rate of Cul1 
deneddylation, even when the initial deneddylation rate was moni-
tored during the first minutes after addition of MLN4924 (see Figure 
2B, bottom). This suggests that CAND1 may not function to pro-
mote cullin deneddylation in vivo, possibly due to limiting expres-
sion levels relative to Cul1 (Chua et al., 2011).
In its simplest form, the CRL activation cycle proposes that cull-
ins are neddylated in the presence of a bound substrate and dened-
dylated after polyubiquitination and dissociation of the substrate 
(Cope and Deshaies, 2003; Bosu and Kipreos, 2008). Thus, if such 
CRL activation cycles operate in vivo, then it can be predicted that 
cullin deneddylation only occurs after the substrate has been poly-
ubiquitinated. Hence, if substrate ubiquitination is inhibited, the 
rate of cullin deneddylation should be delayed. To test the hypoth-
esis that cullin deneddylation is coupled to substrate ubiquitina-
tion, it was necessary to acutely inhibit ubiquitination. The only 
commercially available ubiquitination inhibitor, PYR-41, proved to 
be inefficient (unpublished data). As an alternative approach, we 
cotreated cells with the glycolysis inhibitor iodoacetate and the mi-
tochondrial electron transport chain inhibitor myxothiazol to rapidly 
deplete the cellular ATP required for ubiquitination at the step of 
ubiquitin activation by the E1 enzyme. As shown in Figure 2B, com-
bined treatment with iodoacetate and myxothiazol caused a rapid 
decline in the cellular free-ATP concentration, reaching virtually 
zero after 10 min. As expected, the treatment severely compro-
mised cell viability and cells started to detach after about 1 h of 
treatment. However, since deneddylation occurs over a much 
shorter time course, we utilized this approach to determine whether 
substrate ubiquitination is a requirement for CSN-mediated cullin 
deneddylation. Thus we carried out experiments in which we com-
pared the rate of Cul1 deneddylation in the presence of the specific 
neddylation inhibitor MLN4924 with that upon rapid ATP deple-
tion, which leads to the inhibition of both neddylation and ubiquit-
ination (which are both ATP dependent). We did not observe a sig-
nificant difference in the deneddylation rate between the two 
different conditions in all tested cell lines (Figure 2D). Even when 
we preincubated the cells with iodoacetate and myxothiazol for 
5 min prior to the addition of MLN4924 to ensure more ATP deple-
tion during the deneddylation chase period, there was no decrease 
in the deneddylation rate in ATP-depleted cells (Figure S3). To fur-
ther assess any role of substrate ubiquitination in regulating Cul1 
deneddylation, we measured the deneddylation rate upon addi-
tion of MLN4924 in the presence of MG-132 to inhibit the degrada-
tion of polyubiquitinated proteins and under conditions of overex-
pression of the CRL E2-conjugating enzyme cdc34. However, none 
of these manipulations caused a change in the Cul1 deneddylation 
rate (Figure S4, A and B).
Taken together, our results suggest that cullin deneddylation is 
constitutive and not dependent on and coupled to substrate ubiq-
uitination. While various reports have provided evidence that 
substrate binding induces cullin neddylation (Read et al., 2000; 
Bornstein et al., 2006; Sufan and Ohh, 2006; Chew and Hagen, 
2007), our experiments suggest that cullin deneddylation is not 
linked to substrate ubiquitination in the CRL activation cycle. It is 
possible that an activation cycle involving only a smaller subpopula-
tion of active CRL complexes exists in vivo. However, even when 
measuring the rate of deneddylation of Skp2-bound Cul1, which is 
presumably part of an active E3 ligase complex, no difference in the 
deneddylation rates when comparing ATP depletion and specific 
Nedd8 E1 inhibition was observed (unpublished data). We conclude 
that cullin neddylation is highly dynamic in vivo. Furthermore, 
deneddylation appears to be constitutive and independent of 
whether substrates are being polyubiquitinated. This suggests that 
there may be no direct link between substrate polyubiquitination 
and CRL activation cycles.
Hypothesis 2: CSN-mediated cullin deneddylation facilitates 
substrate-receptor exchange
It has been proposed that CSN-mediated cullin deneddylation is 
necessary for efficient exchange of substrate-receptor modules 
(Lo and Hannink, 2006; Schmidt et al., 2009). According to this 
model, deneddylation promotes the binding of CAND1 to cullin 
proteins. CAND1 is known to interact only with unneddylated cul-
lins. Furthermore, binding of substrate receptors and CAND1 to 
cullins is mutually exclusive. Thus binding of CAND1 would lead to 
the release of the substrate receptor. Subsequently, upon CAND1 
dissociation, a new substrate-receptor module can be recruited to 
the cullin protein. This hypothesis has thus far been challenging to 
test due to the difficulty in measuring dynamic rates of substrate-
receptor binding to and dissociation from cullins. We therefore 
planned to use a strategy based on rapidly introducing new sub-
strate-receptor proteins into cells and measuring their rate of as-
sociation with cullin proteins. However, various approaches, in-
cluding transfection of recombinant substrate-receptor proteins 
and transduction using protein transduction domains, did not re-
sult in significant binding of the substrate-receptor proteins to 
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FIGURE 2: In vivo cullin deneddylation rates in the presence and absence of ongoing substrate ubiquitination. 
(A) HEK293 cells were grown in 12-well plates and 3 μM MLN4924 was added at time zero. Cells were lysed at the 
indicated time points and cell lysates were analyzed by Western blotting with Cul1 and Cul2 antibodies. (B) Cells were 
transfected with negative control or CAND1 siRNA for 3 d. The Cul1 deneddylation rate was determined as in (A). NS, 
nonspecific band that served as a loading control. (C) Cells were cotreated with 1 μM myxothiazol and 2.5 mM 
iodoacetate to rapidly deplete cellular ATP concentrations. ATP concentrations were measured as described in Materials 
and Methods. (D) To measure the Cul1 deneddylation rate in the presence and absence of ongoing substrate 
ubiquitination, HEK293, HCT116, and HeLa cells were treated with either MLN-4924 (3 μM) or myxothiazol (1 μM) and 
iodoacetate (2.5 mM) at time zero. Cells were lysed at the indicated time points and cell lysates were analyzed by 
Western blotting with Cul1 antibody. The Western blots shown are representative of at least three independent 
experiments in each cell line and did not show any consistent difference in the rate at which neddylation occurs. (E) The 
relative expression levels of CSN and Cul1 in HEK293, HCT116, and HeLa cells was compared by Western blotting of 
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cullins in cells. We therefore used a strategy based on induction of 
a substrate-receptor protein using a tetracycline-inducible expres-
sion system. Thus a plasmid encoding for the Cul3 substrate-re-
ceptor SPOP under control of a tetracycline-inducible promoter 
was transfected into HEK293 cells. SPOP expression was induced 
by addition of tetracycline and binding of the substrate receptors 
to Cul3 was determined by coimmunoprecipitation. As shown in 
Figure 3, the SPOP protein was induced upon tetracycline addition 
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in a time-dependent manner and an obvious association between 
SPOP and Cul3 was observed after 2 h, as detected by Cul3-V5 
immunoprecipitation. However, knockdown of CAND1 (Figure 3A) 
or CSN5 (Figure 3B) had no effect on the apparent rate with which 
SPOP bound to Cul3. This suggests that CAND1 binding to Cul3 
upon CSN-mediated deneddylation is not required for the ex-
change of Cul3-bound substrate receptors with SPOP.
Hypothesis 3: CSN prevents CAND1-mediated 
CRL disassembly
In contrast to the mechanism in hypothesis 2, in which CSN-mediated 
deneddylation promotes the binding of CAND1, it is also possible 
that the interaction of CSN with cullins prevents CAND1 binding and, 
subsequently, CAND1-mediated disassembly of the CRL complex. 
To test this hypothesis, we used siRNA to knock down the expression 
FIGURE 3: Role of CSN-mediated cullin deneddylation in facilitating substrate-receptor exchange. Cells grown in 
60-mm dishes were transfected with negative control or CAND1 siRNA, which was followed after 1 d by transfection of 
Cul3-V5 and FLAG-SPOP (in a tetracycline-inducible plasmid). Three days after siRNA transfection, 1 μg/ml tetracycline 
was added at time zero and cells were lysed at the indicated times; this was followed by V5 immunoprecipitation and 
Western blotting of immunoprecipitates and cell lysates with the indicated antibodies. (B) The experiment was 
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of CSN5 and measured the effect on the interaction between Cul1 
and CAND1. As shown in Figure 4, silencing of CSN5 had no effect 
on the amount of CAND1 bound to Cul1. This suggests that CSN 
does not function to prevent binding of CAND1 to cullin proteins.
CSN binds preferentially to active CRLs
We finally considered the possibility that CSN binds to CRLs upon 
their activation by Nedd8. This may be a mechanism to recruit CSN-
associated proteins that are important for CRL function. CSN-de-
pendent cullin deneddylation may then terminate this process by 
causing the dissociation of the CSN complex from the CRL. To test 
this hypothesis, we determined whether cullin neddylation regulates 
CSN binding to cullin proteins in vivo. As shown in Figure 5A, inhib-
iting CRL neddylation with MLN4924 resulted in reduced CSN5 
binding. Similarly, rapid depletion of cellular ATP (by cotreating cells 
with iodoacetate and myxothiazol, as described under Hypothesis 1) 
resulted in markedly reduced CSN5 binding to Cul1 (Figure 5B), 
consistent with reduced affinity of CSN for unneddylated Cul1. Fur-
thermore, when we used the neddylation site mutant of Cul1 
(K720R), basal binding of CSN5 was reduced (Figure 5B). Impor-
tantly, when using the K720R mutant there was no further decrease 
in CSN5 binding upon ATP depletion, indicating that the decrease 
in CSN5 binding to wild-type Cul1 is not due to nonspecific effects 
of the ATP depletion. We have previously reported that preventing 
binding of substrate receptors and substrates to Cul3 by using the 
S53A/F54A/E55A Cul3 mutant (which is unable to bind to BTB sub-
strate-receptor proteins) causes a marked reduction in the neddyla-
tion level (Chew and Hagen, 2007). Consistent with our other results, 
reduced CSN5 binding to the mutant Cul3 was observed, compared 
with wild-type Cul3 (see Figure 6B).
To confirm the preferential binding of CSN to neddylated cullins 
in our cellular system, FLAG-tagged CSN5 was immunoprecipitated 
from HEK293T cell lysates and binding of endogenous Cul1 was 
determined by Western blotting of immunoprecipitates (Figure 5C). 
Only unneddylated Cul1 was detected with wild-type CSN5. In con-
trast, a CSN mutant lacking deneddylation activity (D151N CSN5) 
coimmunoprecipitated approximately equal amounts of neddylated 
and unneddylated Cul1. Given that the neddylated form of Cul1 is 
far less abundant in the cell lysate, it can be concluded that CSN5 
has a preference for binding to neddylated Cul1. The absence of 
neddylated Cul1 in wild-type CSN5 immunoprecipitates is likely due 
to deneddylating activity of CSN. These results are consistent with 
the hypothesis that cullin neddylation promotes binding of CSN.
We next wanted to determine whether the CSN binding is di-
rectly dependent on Nedd8 conjugation of cullins or whether it is an 
indirect consequence of the Nedd8-induced conformational change 
in the CRL C-terminus (Duda et al., 2008). To this end, we used ex-
treme C-terminal deletion mutants of Cul2 and Cul3, which have 
previously been shown to not undergo neddylation and to harbor a 
constitutively active conformation able to support efficient substrate 
polyubiquitination, even in the absence of neddylation in vitro and 
in vivo (Duda et al., 2008; Yamoah et al., 2008; Boh et al., 2011). We 
observed that, compared with the full-length proteins, both C-ter-
minally truncated Cul2 and Cul3 bound more CSN2 and CSN5, 
even though they lacked the modification with Nedd8 (Figure 6A). 
This suggests that it is not the conjugation with Nedd8 itself, but the 
Nedd8-induced conformational change in the CRL complex that 
may be important for CSN binding. To confirm the specificity of the 
increased binding of CSN2 and CSN5 to C-terminally truncated cul-
lins, we mutated the conserved Lys441 and Arg442 residues in the 
four-helix bundle of Cul2 to prevent CSN binding to full-length cullin 
(Chua et al., 2011). Similarly, the K441E/R442E extreme C-terminal 
deletion mutant of Cul2 was unable to bind both CSN2 and CSN5 
(Figure S5A) and lacked activity toward the Cul2 polyubiquitination 
target protein HIF-1α (Figure S5B).
It has been suggested that substrate polyubiquitination pro-
motes CSN recruitment to the CRL complex (Miyauchi et al., 2008). 
Thus it is also possible that the observed preferential binding of the 
CSN complex to active CRLs is a consequence of increased amounts 
of bound polyubiquitinated substrates. To rule out this possibility, 
we introduced the S53A/F54A/E55A mutations into the extreme C-
terminal deletion mutant of Cul3. These mutations in the interaction 
face of Cul3 with BTB proteins have been shown to prevent binding 
of substrate receptors and substrates to Cul3 (Chew and Hagen, 
2007). As shown in Figure 6B, the S53A/F54A/E55A mutations in 
full-length Cul3 caused reduced CSN5 binding, which, as men-
tioned above, is likely due to reduced neddylation levels. In con-
trast, the Cul3 extreme C-terminal deletion mutant showed higher 
basal CSN5 binding that was not reduced upon introduction of the 
S53A/F54A/E55A mutations. Thus CSN binding to Cul3 is not di-
rectly dependent on substrate recruitment and polyubiquitination. 
We therefore conclude that the CSN complex preferentially binds to 
active CRL complexes.
Conclusion: role of CSN and CSN-mediated cullin 
deneddylation in the regulation of CRL activity
The mechanism through which CSN functions as a positive regulator 
of CRL activity in vivo is currently unclear. In this study, we provide 
evidence that CSN-mediated cullin deneddylation is not intrinsically 
coupled to substrate polyubiquitination in the CRL activation cycle. 
It has been proposed that CSN promotes CRL function indirectly by 
inhibiting substrate-receptor autoubiquitination and facilitating 
CAND1-mediated exchange of substrate-receptor subunits. Our re-
sults suggest that these may not be the exclusive functions of CSN. 
As an alternative function, CSN has been reported to promote the 
dissociation of polyubiquitinated substrates from the CRL complex 
in a manner that does not require deneddylation activity (Miyauchi 
et al., 2008). However, it was recently demonstrated by Yoshida 
et al., (2010) that the essential role of CSN in promoting cell cycle 
progression and cell survival is critically dependent on its deneddy-
lation activity. This suggests that the dissociation of polyubiquit-
inated substrates is also unlikely to be the major function of CSN.
Our results indicate that CSN associates preferentially with active 
CRL complexes. This preferred binding may be due to a conforma-
tional change induced by the Nedd8 modification of the cullin 
FIGURE 4: Role of CSN in preventing CAND1-mediated CRL 
disassembly. Cells were transfected with negative control or CSN5 
siRNA, which was followed after 1 d by transfection of Cul1-V5. Cells 
were lysed 3 d after siRNA transfection, and cell lysates were 
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All plasmids used were previously described (Chew et al., 2007; 
Chew and Hagen, 2007; Boh et al., 2011), with the exception of the 
mammalian expression plasmid FLAG-SPOP and the retroviral 
expression plasmid for FLAG-CSN5. Both SPOP and CSN5 were 
protein. The recruited CSN complex may then exert functions im-
portant for CRL regulation. For instance, CSN may play a role in re-
cruiting critical binding proteins to the CRL complex. CSN has been 
reported to associate with different protein kinases (Uhle et al., 
2003) that may mediate important functions in the CRL activation 
cycle, such as the exchange of substrate-receptor subunits. The 
deneddylating activity of CSN may be important for promoting its 
own dissociation to allow progression through the CRL activation 
cycle. Thus studies on the role of CSN-binding proteins may be 
FIGURE 5: Preferential binding of CSN5 to neddylated Cul1. (A) Cells with stable expression of FLAG-CSN5 were 
transfected with Cul1-V5 and treated with 3 μM MLN-4924 for 3 h, as indicated. Cell lysates were used for V5 
immunoprecipitation, which was followed by Western blotting. (B) Cells with stable expression of FLAG-CSN5 were 
transfected with wild-type or K720R mutant Cul1-V5 and subjected to 30 min of myxothiazol (1 μM) and iodoacetate 
(2.5 mM) treatment, indicated as ATP depletion, prior to cell lysis. Each condition in this experiment was performed in 
duplicate to ensure consistency of the results. (C) Cells were transfected with wild-type or D151N mutant FLAG-CSN5, 
which was followed by FLAG immunoprecipitation and Western blotting of immunoprecipitates and cell lysates with 
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cleared by centrifugation before use for 
Western blotting. Equal amounts of protein 
were loaded for Western blot analysis. The 
following antibodies were used: rabbit poly-
clonal anti-Cul2 (51–1800; Zymed Laborato-
ries, San Francisco, CA), rabbit polyclonal 
anti-Cul3 (34-2200; Zymed Laboratories), 
goat polyclonal anti-CAND1 (10672; Santa 
Cruz Biotechnology, Santa Cruz, CA), mono-
clonal anti-α-tubulin (236–10501; Molecular 
Probes, Invitrogen), monoclonal anti-V5 
(AbD Serotec, Kidlington, UK), and mono-
clonal anti-FLAG M2 (Sigma-Aldrich, St. 
Louis, MO). Western blots shown are rep-
resentative of at least two independent 
experiments.
Immunoprecipitation
V5 antibody (2.5 μg), coupled to 20 μl 
of protein G-Sepharose (Amersham Biosci-
ences, GE Healthcare, Waukesha, WI), or 
20 μl of FLAG-agarose (Sigma) was used 
for immunoprecipitations, and 500 μl of 
precleared lysate from HEK293T cells 
transfected in 60-mm tissue culture plates 
was added. The samples were tumbled at 
4°C for 2 h, and the beads were then 
washed four times in 1 ml of NP40 cold ly-
sis buffer (containing 50 mM NaCl, 0.5% 
NP-40, 5% glycerol, 0.5 mM EDTA, 
50 mM Tris, pH 7.5, 1 mM dithiothreitol) 
and once in buffer containing 50 mM 
Tris (pH 7.5). The immunoprecipitated 
proteins were then denatured in SDS sam-
ple buffer and subjected to SDS–PAGE and 
Western blotting. The immunoprecipita-
tion experiments shown are representative 
of at least two independent experiments.
ATP measurements
ATP measurement in intact cells using transfected firefly 
luciferase. Cells in 12-well plates were transfected for 24 h with 
0.2 μg of a firefly luciferase-pcDNA3 plasmid (under control of the 
cytomegalovirus promoter). Cells were trypsinized and resuspended 
in Krebs buffer. Intracellular ATP concentrations were determined by 
measuring the luminescence of aliquots of cells treated with 
myxothiazol and iodoacetate for various periods of time. Twenty 
microliters of the cells were then mixed with 100 μl of luciferase 
substrate, d-luciferin (Sigma) and used for ATP measurement.
ATP measurement in cell extracts. Cells in 12-well plates were 
treated with myxothiazol and iodoacetate for different periods of 
time. Perchloric acid (6%) was used to extract the ATP from cells and 
the extract was spun for 1 min. The supernatant was collected and 
neutralized with 1.6 M K2CO3 containing 0.43 M triethanolamine 
buffer. The supernatant was spun for 1 min and used for ATP 
measurement by using the ENLITEN ATP assay system (Promega, 
Madison, WI).
FIGURE 6: CSN5 binds preferentially to active CRLs. (A and B) HEK293T cells were transfected 
in 60-mm cell culture plates for 2 d with expression constructs for the full-length or extreme 
C-terminal deletion mutants of Cul2 and Cul3, as indicated at the top of each panel. The SFE 
mutant of Cul3 corresponds to the S53A/F54A/E55A mutant of Cul3, which is unable to bind 
to substrate-receptor subunits. The cells were lysed, and the lysates were subjected to V5 
immunoprecipitation (IP), as described in Materials and Methods. Immunoprecipitates and 



















amplified from MGC I.M.A.G.E. clones and subcloned into modi-
fied pcDNA3.1 with N-terminal FLAG tag. FLAG-CSN5 was subse-
quently transferred into the puro-MaRX retroviral expression vector 
(a kind gift from David Beach) and used to generate a stable FLAG-
CSN5–expressing HEK293T cell line, as previously described (Gan 
et al., 2009). For DNA transfections, subconfluent cells were trans-
fected using Genejuice (Novagen, San Diego, CA) according to the 
manufacturer’s instructions.
siRNA-mediated gene silencing
For siRNA transfections, RNAi Max Lipofectamine (Invitrogen, 
Carlsbad, CA) was used as the transfection agent according to the 
manufacturer’s instructions with the following annealed Silencer 
predesigned siRNA duplexes (Ambion, Austin, TX) at a final con-
centration of 25 nM: CAND1: siRNA ID 140584; CSN5: siRNA ID 
214069; negative controls: Silencer negative control siRNA #2 or 
Mdm2 siRNA 122297. Cells were lysed 3 d after siRNA transfec-
tions for Western blot analysis.
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For immunoblotting, the cells were washed with ice-cold phosphate-
buffered saline and then lysed in Triton X-100-containing lysis buffer, 
as previously described (Culbert et al., 2001). Lysates were pre-
ACKNOWLEDGMENTS
We thank Jong-Bok Yoon (Yonsei University, Korea) for providing 
CAND1 cDNA, David Beach (Institute of Cell and Molecular 
Volume 22 December 15, 2011 Role of CSN in regulating CRL activity | 4715 
Lyapina S, Cope G, Shevchenko A, Serino G, Tsuge T, Zhou C, Wolf DA, 
Wei N, Shevchenko A, Deshaies RJ (2001). Promotion of NEDD-CUL1 
conjugate cleavage by COP9 signalosome. Science 292, 1382–1385.
Min KW, Kwon MJ, Park HS, Park Y, Yoon SK, Yoon JB (2005). CAND1 en-
hances deneddylation of CUL1 by COP9 signalosome. Biochem Biophys 
Res Commun 334, 867–874.
Miyauchi Y, Kato M, Tokunaga F, Iwai K (2008). The COP9/signalosome 
increases the efficiency of von Hippel-Lindau protein ubiquitin ligase-
mediated hypoxia-inducible factor-α ubiquitination. J Biol Chem 283, 
16622–16631.
Orsborn AM, Li W, McEwen TJ, Mizuno T, Kuzmin E, Matsumoto K, Bennett 
KL (2007). GLH-1, the C. elegans P granule protein, is controlled by 
the JNK KGB-1 and by the COP9 subunit CSN-5. Development 134, 
3383–3392.
Petroski MD, Deshaies RJ (2005). Function and regulation of cullin-RING 
ubiquitin ligases. Nat Rev Mol Cell Biol 6, 9–20.
Read MA et al. (2000). Nedd8 modification of Cul-1 activates SCFβTrCP-
dependent ubiquitination of IĸBα. Mol Cell Biol 20, 2326–2333.
Saha A, Deshaies RJ (2008). Multimodal activation of the ubiquitin ligase 
SCF by Nedd8 conjugation. Mol Cell 32, 21–31.
Sakata E, Yamaguchi Y, Miyauchi Y, Iwai K, Chiba T, Saeki Y, Matsuda N, 
Tanaka K, Kato K (2007). Direct interactions between NEDD8 and ubiq-
uitin E2 conjugating enzymes upregulate cullin-based E3 ligase activity. 
Nat Struct Mol Biol 14, 167–168.
Schmidt MW, McQuary PR, Wee S, Hofmann K, Wolf DA (2009). F-box-di-
rected CRL complex assembly and regulation by the CSN and CAND1. 
Mol Cell 35, 586–597.
Schoenfeld AR, Davidowitz EJ, Burk RD (2000). Elongin BC complex 
prevents degradation of von Hippel-Lindau tumor suppressor gene 
products. Proc Natl Acad Sci USA 97, 8507–8512.
Schulman BA, Carrano AC, Jeffrey PD, Bowen Z, Kinnucan ER, Finnin MS, 
Elledge SJ, Harper JW, Pagano M, Pavletich NP (2000). Insights into 
SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex. 
Nature 408, 381–386.
Schwechheimer C (2004). The COP9 signalosome (CSN): an evolutionary 
conserved proteolysis regulator in eukaryotic development. Biochim 
Biophys Acta 1695, 45–54.
Soucy TA et al. (2009). An inhibitor of NEDD8-activating enzyme as a new 
approach to treat cancer. Nature 458, 732–737.
Spoel SH, Mou Z, Tada Y, Spivey NW, Genschik P, Dong X (2009). Protea-
some-mediated turnover of the transcription coactivator NPR1 plays 
dual roles in regulating plant immunity. Cell 137, 860–872.
Sufan RI, Ohh M (2006). Role of the NEDD8 modification of Cul2 in the 
sequential activation of ECV complex. Neoplasia 8, 956–963.
Uhle S et al. (2003). Protein kinase CK2 and protein kinase D are associated 
with the COP9 signalosome. EMBO J 22, 1302–1312.
Wei N, Serino G, Deng XW (2008). The COP9 signalosome: more than a 
protease. Trends Biochem Sci 33, 592–600.
Wei W, Ayad NG, Wan Y, Zhang GJ, Kirschner MW, Kaelin WG Jr (2004). 
Degradation of the SCF component Skp2 in cell-cycle phase G1 by the 
anaphase-promoting complex. Nature 428, 194–198.
Wolf DA, Zhou C, Wee S (2003). The COP9 signalosome: an assembly 
and maintenance platform for cullin ubiquitin ligases?. Nat Cell Biol 5, 
1029–1033.
Wu K, Chen A, Tan P, Pan ZQ (2002). The Nedd8-conjugated ROC1-CUL1 
core ubiquitin ligase utilizes Nedd8 charged surface residues for ef-
ficient polyubiquitin chain assembly catalyzed by Cdc34. J Biol Chem 
277, 516–527.
Yamoah K, Oashi T, Sarikas A, Gazdoiu S, Osman R, Pan ZQ (2008). Auto-
inhibitory regulation of SCF-mediated ubiquitination by human cullin1’s 
C-terminal tail. Proc Natl Acad Sci USA 105, 12230–12235.
Yan J, Walz K, Nakamura H, Carattini-Rivera S, Zhao Q, Vogel H, Wei N, 
Justice MJ, Bradley A, Lupski JR (2003). COP9 signalosome subunit 3 is 
essential for maintenance of cell proliferation in the mouse embryonic 
epiblast. Mol Cell Biol 23, 6798–6808.
Yoshida A, Yoneda-Kato N, Panattoni M, Pardi R, Kato J (2010). YCSN5/
Jab1 controls multiple events in the mammalian cell cycle. FEBS Lett 
584, 4545–4552.
Zheng J, Yang X, Harrell JM, Ryzhikov S, Shim EH, Lykke-Andersen K, Wei 
N, Sun H, Kobayashi R, Zhang H (2002). CAND1 binds to unneddylated 
CUL1 and regulates the formation of SCF ubiquitin E3 ligase complex. 
Mol Cell 10, 1519–1526.
Zhou C, Wee S, Rhee E, Naumann M, Dubiel W, Wolf DA (2003). Fission 
yeast COP9/signalosome suppresses cullin activity through recruitment 
of the deubiquitylating enzyme Ubp12p. Mol Cell 11, 927–938.
Science, London) for providing the retroviral expression vector 
Puro-MaRX, and all the members of our laboratory for helpful dis-
cussions. This study was supported by grant number 07/1/21/19/500 
from the Singapore Biomedical Research Council.
REFERENCES
Bashir T, Dorrello NV, Amador V, Guardavaccaro D, Pagano M (2004). Con-
trol of the SCFSkp2–Cks1 ubiquitin ligase by the APC/CCdh1 ubiquitin ligase. 
Nature 428, 190–193.
Boh BK, Smith PG, Hagen T (2011). Neddylation-induced conformational 
control regulates Cullin RING ligase activity in vivo. J Mol Biol 409, 
136–145.
Bornstein G, Ganoth D, Hershko A (2006). Regulation of neddylation and 
deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein 
and substrate. Proc Natl Acad Sci USA 103, 11515–11520.
Bosu DR, Kipreos ET (2008). Cullin-RING ubiquitin ligases: global regulation 
and activation cycles. Cell Div 3, 7.
Brownell JE et al. (2010). Substrate-assisted inhibition of ubiquitin-like 
protein-activating enzymes: the NEDD8 E1 inhibitor MLN4924 forms a 
NEDD8-AMP mimetic in situ. Mol Cell 37, 102–111.
Chamovitz DA, Wei N, Osterlund MT, von Arnim AG, Staub JM, Matsui 
M, Deng XW (1996). The COP9 complex, a novel multisubunit nuclear 
regulator involved in light control of a plant developmental switch. Cell 
86, 115–121.
Chew EH, Hagen T (2007). Substrate-mediated regulation of cullin neddyla-
tion. J Biol Chem 282, 17032–17040.
Chew EH, Poobalasingam T, Hawkey CJ, Hagen T (2007). Characterization 
of cullin-based E3 ubiquitin ligases in intact mammalian cells—evidence 
for cullin dimerization. Cell Signal 19, 1071–1080.
Chua YS, Boh BK, Ponyeam W, Hagen T (2011). Regulation of cullin RING 
E3 ubiquitin ligases by CAND1 in vivo. PLoS One 6, e6071.
Cope GA, Deshaies RJ (2003). COP9 signalosome: a multifunctional regula-
tor of SCF and other cullin-based ubiquitin ligases. Cell 114, 663–671.
Cope GA, Suh GS, Aravind L, Schwarz SE, Zipursky SL, Koonin EV, Deshaies 
RJ (2002). Role of predicted metalloprotease motif of Jab1/Csn5 in 
cleavage of Nedd8 from Cul1. Science 298, 608–611.
Culbert AA, Brown MJ, Frame SM, Hagen T, Cross DAE, Bax B, Reith AD 
(2001). GSK-3 inhibition by adenoviral FRAT1 overexpression is neuro-
protective and induces Tau dephosphorylation and β-catenin stabilisation 
without elevation of glycogen synthase activity. FEBS Lett 507, 288–294.
Dohmann EM, Levesque MP, De Veylder L, Reichardt I, Jürgens G, Schmid 
M, Schwechheimer C (2008). The Arabidopsis COP9 signalosome is 
essential for G2 phase progression and genomic stability. Development 
135, 2013–2022.
Duda DM, Borg LA, Scott DC, Hunt HW, Hammel M, Schulman BA (2008). 
Structural insights into NEDD8 activation of cullin-RING ligases: confor-
mational control of conjugation. Cell 134, 995–1006.
Djagaeva I, Doronkin S (2009). COP9 limits dendritic branching via Cullin3-
dependent degradation of the actin-crosslinking BTB-domain protein 
Kelch. PLoS One 4, e7598.
Freilich S, Oron E, Kapp Y, Nevo-Caspi Y, Orgad S, Segal D, Chamovitz DA 
(1999). The COP9 signalosome is essential for development of Droso-
phila melanogaster. Curr Biol 9, 1187–1190.
Gan FF, Chua YS, Scarmagnani S, Palaniappan P, Franks M, Poobalasingam 
T, Bradshaw TD, Westwell AD, Hagen T (2009). Structure-activity analysis 
of 2ĸ-modified cinnamaldehyde analogues as potential anticancer 
agents. Biochem Biophys Res Commun 387, 741–747.
Haan S, Ferguson P, Sommer U, Hiremath M, McVicar DW, Heinrich PC, 
Johnston JA, Cacalano NA (2003). Tyrosine phosphorylation disrupts 
elongin interaction and accelerates SOCS3 degradation. J Biol Chem 
278, 31972–31979.
Hetfeld BK, Helfrich A, Kapelari B, Scheel H, Hofmann K, Guterman A, 
Glickman M, Schade R, Kloetzel PM, Dubiel W (2005). The zinc finger 
of the CSN-associated deubiquitinating enzyme USP15 is essential to 
rescue the E3 ligase Rbx1. Curr Biol 15, 1217–1221.
Kamura T, Brower CS, Conaway RC, Conaway JW (2002). A molecular 
basis for stabilization of the von Hippel-Lindau (VHL) tumor suppressor 
protein by components of the VHL ubiquitin ligase. J Biol Chem 277, 
30388–30393.
Kawakami T et al. (2001). NEDD8 recruits E2-ubiquitin to SCF E3 ligase. 
EMBO J 20, 4003–4012.
Lo SC, Hannink M (2006). CAND1-mediated substrate adaptor recycling 
is required for efficient repression of Nrf2 by Keap1. Mol Cell Biol 26, 
1235–1244.
SUPPLEMENTAL FIGURE LEGENDS 
 
Fig.S1 P63A mutation induces Fbxo4 polyubiquitination. (a) HEK293T cells transfected with 
the wild type or P63A V5-Fbxo4 plasmids were treated for 6 hours with 40 μM cycloheximide, 
20 μM MG-132 or 3 μM MLN4924 and cell lysates analyzed by Western blotting with V5 
antibody. (b) Cells were transfected with negative control or Skp2 siRNA for three days and with 
wild type or mutant V5-Fbxo4 or V5-Fbxo4 for the last two days. MG-132 (20 μM) was added 
to all cells 6 hours before cell lysis and cells lysates analyzed by Western blotting with the 
indicated antibodies. (c) Cells were transfected with P63A V5-Fbxo4 and cotransfected with 
empty vector or dominant-negative Cul1 (dnCul1) expression plasmids and treated with MG-132 
(20 μM) and MLN4924 (3 μM) for the last 6 hours before cell lysis as indicated. 
 Fig.S2 Role of the conserved F-box proline residue in β-TrCP. (a) HEK293T cells were 
transfected with the indicated expression plasmids and treated for 6 hours with 20 μM MG-132, 
3 μM MLN-4924, or DMSO (control). Cell lysates were analyzed by Western blotting with V5 
antibody. The right panel shows the quantification of the V5-β-TrCP, V5-Skp2 and V5-Fbxo4 
abundant by densitometry. The results represent the average of three independent experiments (N 
= 3 + SEM). (b) Amino acid sequence alignment of the N-terminal portion of the F-box domain 
of the indicated human F-box proteins. (c) Cells were transfected with the indicated plasmids. 
Cell lysates were subjected to V5 immunoprecipitation and immunoprecipitates analyzed by 
Western blotting with Cul1 and V5 antibodies. 
 Fig.S3 In vivo cullin deneddylation rates in the presence and absence of ongoing substrate 
ubiquitination. HEK293, HCT116 and HeLa cells were pre-treated for 5 mins with myxothiazol 
(1 μM) and iodoacetate (2.5 mM) prior to addition of MLN4924 at time zero. The cells were 

















 Fig.S4 In vivo Cul1 deneddylation. Cullin deneddylation rates were determined by growing 
HEK293 cells in 12-well plates. 3 μM MLN4924 was added at time zero to cells that were 
pretreated with 20 μM MG-132 for 20 min (a), transfected with empty vector or cdc34-HA 
expression plasmid (b), as indicated. Cells were lysed at the indicated time-points and cell lysates 


















Fig.S5 Effect of K441E/R442E mutation in the Cul2 extreme C-terminal deletion mutant. 
(a) HEK293T cells were transfected in 60-mm cell culture plates for 2 days with expression 
constructs for the extreme C-terminal deletion mutants of Cul2, as indicated at the top of each 
panel. The KR mutant of Cul2 corresponds to the K441E/R442E mutant of Cul2 which is unable 
to bind to the CSN complex. The lysates were subjected to V5 immunoprecipitation (IP), 
Immunoprecipitates and aliquots of the cell lysates were analyzed by Western blotting with the 
indicated antibodies. (b) HEK293T cells were transfected with WT Cul2-V5, Cul2(1–697 aa)-
V5, Cul2(1-697aa)-V5 K441E/R442E and empty vector for 24 h. Prior to lysis, cells were treated 
with dimethyl sulfoxide (DMSO) as vehicle control or with 1 μM of MLN4924 for 4 h to inhibit 
the intact cellular neddylation pathway, where indicated. Equal amounts of cell lysates were then 
prepared and subjected to Western blot analysis with the indicated antibodies. An asterisk (*) 
indicates a nonspecific band associated with anti-α-tubulin. 
